data_2kky_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kky _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.209 0.052 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.489 HG22 HD12 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HA ' HD11 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.42 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.495 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.423 HG11 ' HG2' ' A' ' 126' ' ' PRO . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' HG21 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.575 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.575 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.558 ' HZ3' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.408 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.586 HG22 HG21 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.571 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.489 HD12 HG22 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.495 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.536 0.207 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.621 ' HA ' HD13 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 146' ' ' ALA . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.673 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.495 ' HB2' HG23 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.458 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.451 ' HA ' HD13 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.464 HG22 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.603 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.64 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.676 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.676 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.446 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.499 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.619 0.247 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.438 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' HD22 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.588 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.551 ' HB2' HD22 ' A' ' 114' ' ' LEU . 29.1 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.501 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.477 ' HG ' HG23 ' A' ' 162' ' ' THR . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.529 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.45 HG21 HD12 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' HG21 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.45 HD12 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HG2' HG21 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.561 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.513 ' HB3' HD13 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 130' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.423 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.555 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.408 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' ILE . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.61 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.432 ' HB3' HG11 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.408 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.508 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.425 ' ND2' HG22 ' A' ' 140' ' ' VAL . 10.0 t30 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.428 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.3 0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.72 HG22 HG13 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.534 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.599 ' HZ3' HG13 ' A' ' 172' ' ' VAL . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.403 ' HB3' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.405 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.542 ' O ' HG21 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.492 HG21 HD13 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 HD13 HG21 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.599 HG13 ' HZ3' ' A' ' 133' ' ' LYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.506 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.409 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.543 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.65 ' HA ' HD22 ' A' ' 185' ' ' ASN . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.489 HG21 HD13 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 149' ' ' PHE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.546 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.522 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.65 HD22 ' HA ' ' A' ' 140' ' ' VAL . 21.2 t30 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt . . . . . 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.621 0.248 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.538 HG21 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.522 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.504 ' HB2' HD21 ' A' ' 114' ' ' LEU . 23.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.546 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.455 ' HB3' HG12 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG21 ' ND2' ' A' ' 185' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.486 ' ND2' HG21 ' A' ' 140' ' ' VAL . 9.8 t30 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.415 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.577 HG23 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.603 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.577 HG11 HG23 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.425 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.491 HD12 HG22 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.458 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.509 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.494 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.479 HG23 HD13 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.489 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' HD22 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.489 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 31.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.618 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.404 ' HB3' HG12 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.448 HG21 HD12 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.505 HD22 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.561 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.496 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 149' ' ' PHE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.448 HD12 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.484 HG21 HG21 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB3' ' HZ3' ' A' ' 97' ' ' LYS . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 97' ' ' LYS . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.435 HG22 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.552 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.537 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.506 ' HB2' HD23 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.668 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HB3' HG11 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.549 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.422 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' O ' HG21 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.451 HG22 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.436 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.451 HD12 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.448 0.166 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.412 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.55 HG22 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.583 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.616 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.524 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.493 ' O ' HG21 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 149' ' ' PHE . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.411 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.446 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp . . . . . 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.516 ' HA ' HD13 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.539 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.565 HG21 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.506 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.526 HG22 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.511 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.441 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.543 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD23 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.562 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.412 ' HB3' HG12 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.526 ' HB2' HG21 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.42 HG22 ' ND2' ' A' ' 185' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.593 HG21 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.528 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.481 ' HG2' HG21 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.593 HG21 HG21 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 136' ' ' ASP . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.675 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' HG22 ' A' ' 140' ' ' VAL . 7.9 t30 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.529 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.51 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.589 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.477 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.603 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.412 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.467 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.484 ' O ' HG21 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.546 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.432 ' HB2' ' HZ2' ' A' ' 173' ' ' LYS . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 183' ' ' ARG . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.468 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.614 HG21 HG13 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.457 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.503 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.514 ' HB2' HD22 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.634 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.512 ' HB2' HD22 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.461 ' HA ' HD13 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 159' ' ' HIS . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.428 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? . . . . . 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.415 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.669 HG22 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.499 ' HA ' HD13 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.567 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.596 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.542 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.417 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.512 ' HB2' HD22 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.645 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.491 ' HB3' HG11 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.419 HD21 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.596 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.481 ' O ' HG21 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 149' ' ' PHE . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.479 ' HA ' HD13 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.476 HD13 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.416 ' O ' HG13 ' A' ' 98' ' ' ILE . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.402 HG13 ' HG2' ' A' ' 126' ' ' PRO . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.472 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.558 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.476 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.667 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.476 ' HB3' HG12 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG21 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' HG23 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.55 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.667 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.876 -0.046 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.644 HG22 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HB3' HG23 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.406 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.525 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 22.7 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.635 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HB3' HG12 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.403 ' HB2' HD13 ' A' ' 188' ' ' ILE . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.511 HG22 HD12 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.644 HG11 HG22 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.511 HD12 HG22 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 159' ' ' HIS . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.588 HG23 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.569 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.51 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.461 HD13 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.747 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.449 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.403 HG21 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.464 0.173 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.423 ' HB ' HD22 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HB2' HD22 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.59 ' HD3' HD13 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.461 ' HB3' HG12 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.462 HG23 HD12 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.423 HD22 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.551 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.462 HD12 HG23 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.465 HG23 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' HIS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ILE . . . . . 0.59 HD13 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? . . . . . 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.481 ' HG3' HG13 ' A' ' 153' ' ' VAL . 34.8 tt0 -60.14 -39.65 87.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.148 0.979 . . . . 0.0 111.289 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.67 -34.51 78.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.283 0.633 . . . . 0.0 111.032 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.489 HG22 HD12 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HA ' HD11 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.42 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.495 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.423 HG11 ' HG2' ' A' ' 126' ' ' PRO . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.42 ' HB2' HG21 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.42 HG21 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.575 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.521 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.575 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.558 ' HZ3' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.408 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.586 HG21 HG22 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.586 HG22 HG21 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.571 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.489 HD12 HG22 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.562 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.495 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.562 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.436 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? -141.88 89.78 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.91 0.31 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.807 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.692 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.42 0.153 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.3 tp60 -65.41 -42.95 92.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.768 . . . . 0.0 110.78 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.26 -26.09 66.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.91 0.884 . . . . 0.0 110.84 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.621 ' HA ' HD13 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.414 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 146' ' ' ALA . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.623 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.484 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.64 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.673 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.495 ' HB2' HG23 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.458 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.468 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.437 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.518 ' O ' HG22 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.544 HG23 HG23 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.451 ' HA ' HD13 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.464 HG22 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.544 HG23 HG23 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.458 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.603 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.64 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.676 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.676 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.623 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.446 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.499 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -142.57 89.69 2.16 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.12 -18.38 29.28 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.378 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.255 1.022 . . . . 0.0 108.353 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 35.6 tt0 -54.84 -40.84 70.02 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.358 1.063 . . . . 0.0 111.584 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.12 -44.44 94.89 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.237 1.015 . . . . 0.0 110.804 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 101' ' ' CYS . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.438 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.551 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' HD22 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.588 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.551 ' HB2' HD22 ' A' ' 114' ' ' LEU . 29.1 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.588 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.409 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.501 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.477 ' HG ' HG23 ' A' ' 162' ' ' THR . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.529 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.45 HG21 HD12 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' O ' HG21 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.513 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.417 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.439 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.45 HD12 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.51 HG21 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HG2' HG21 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.561 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.48 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.513 ' HB3' HD13 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.485 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.529 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -127.07 101.36 6.5 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -102.26 20.05 46.4 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.974 0.796 . . . . 0.0 114.01 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.487 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.93 -42.82 94.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 0.0 110.839 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.48 -31.83 70.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.332 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.434 ' HA ' HD13 ' A' ' 130' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.555 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.423 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.555 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.408 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.434 HD13 ' HA ' ' A' ' 98' ' ' ILE . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.582 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.61 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.432 ' HB3' HG11 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.408 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.418 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.535 ' O ' HG21 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.424 HD11 HG22 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.411 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.508 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.425 ' ND2' HG22 ' A' ' 140' ' ' VAL . 10.0 t30 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.428 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -153.26 78.5 1.16 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.09 -61.9 1.38 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.67 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.332 -0.842 . . . . 0.0 108.8 -178.849 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.51 -39.32 90.56 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.797 0.685 . . . . 0.0 110.226 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.5 -37.27 80.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.831 0.852 . . . . 0.0 110.889 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.72 HG22 HG13 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.506 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.409 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.534 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.534 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.405 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.506 HD12 ' HA ' ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.458 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.599 ' HZ3' HG13 ' A' ' 172' ' ' VAL . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.403 ' HB3' HG12 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.526 HG22 HD12 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.405 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.542 ' O ' HG21 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.454 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.72 HG13 HG22 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.492 HG21 HD13 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 HD13 HG21 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.599 HG13 ' HZ3' ' A' ' 133' ' ' LYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.458 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -157.16 94.9 1.44 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 130.27 115.68 1.78 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.561 1.377 0 C-N-CA 123.271 0.628 . . . . 0.0 110.318 177.462 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.243 -0.408 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.473 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 1.0 OUTLIER -57.12 -45.14 83.73 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.599 0.76 . . . . 0.0 112.013 -171.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -51.77 -51.91 52.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.527 0.731 . . . . 0.0 112.423 -172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.538 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.506 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.409 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.562 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.4 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.543 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.442 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.65 ' HA ' HD22 ' A' ' 185' ' ' ASN . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.489 HG21 HD13 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.562 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 149' ' ' PHE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.481 HG21 HG21 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.546 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.469 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.469 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.522 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.65 HD22 ' HA ' ' A' ' 140' ' ' VAL . 21.2 t30 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt -123.76 117.4 24.84 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 169.82 -31.5 0.16 Allowed Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.595 1.158 . . . . 0.0 110.241 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.537 ' HG3' HG13 ' A' ' 153' ' ' VAL . 2.3 mp0 -51.61 -46.61 63.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.68 -49.42 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.834 0.454 . . . . 0.0 111.402 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.538 HG21 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.525 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.498 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.444 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.525 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.522 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.439 ' HG2' ' HB1' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.504 ' HB2' HD21 ' A' ' 114' ' ' LEU . 23.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.522 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.546 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.455 ' HB3' HG12 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG21 ' ND2' ' A' ' 185' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.43 HG21 HD13 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.57 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.43 HD13 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG23 HG23 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.498 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.477 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.486 ' ND2' HG21 ' A' ' 140' ' ' VAL . 9.8 t30 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? -119.21 87.65 2.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.65 -26.3 6.88 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.246 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 45.9 t30 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.137 0.975 . . . . 0.0 109.356 -179.183 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -52.5 -44.37 65.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.448 1.099 . . . . 0.0 111.839 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.27 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.609 0.568 . . . . 0.0 111.311 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.415 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.577 HG23 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.559 ' HB3' HG22 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.502 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.424 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 126' ' ' PRO . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.432 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.495 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.531 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.424 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.407 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.603 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.491 HG22 HD12 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.531 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG21 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.577 HG11 HG23 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.425 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.491 HD12 HG22 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.458 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.509 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.559 HG22 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.494 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.494 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -151.93 102.89 2.86 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -177.16 -55.14 0.07 OUTLIER Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.463 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 94' ' ' ILE . 15.7 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.467 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.0 tt0 -56.24 -39.72 73.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.336 0.654 . . . . 0.0 110.744 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -49.32 -52.01 30.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.537 1.135 . . . . 0.0 111.097 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.479 HG23 HD13 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.493 ' HA ' HD13 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.489 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.505 ' HB ' HD22 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.489 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 31.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.561 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.504 HD11 HG21 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.618 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.522 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.404 ' HB3' HG12 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.448 HG21 HD12 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.505 HD22 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.561 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 149' ' ' PHE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD12 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.484 HG21 HG21 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB3' ' HZ3' ' A' ' 97' ' ' LYS . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.52 HG23 ' HB3' ' A' ' 97' ' ' LYS . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt -138.9 94.9 2.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -169.11 22.27 0.09 OUTLIER Glycine 0 N--CA 1.467 0.703 0 CA-C-O 119.891 -0.394 . . . . 0.0 113.158 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.002 -179.604 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.577 0.227 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.61 -41.96 99.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 0.0 110.897 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.96 -26.14 65.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.561 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.435 HG22 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.552 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.537 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.468 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.506 ' HB2' HD23 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.547 HD13 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.668 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.492 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HB3' HG11 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.452 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.549 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.422 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' O ' HG21 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HG22 ' A' ' 153' ' ' VAL . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.451 HG22 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.436 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.543 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.451 HD12 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -155.73 77.86 0.98 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -98.35 -71.17 1.01 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.646 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.123 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.523 ' HG3' HG13 ' A' ' 153' ' ' VAL . 35.4 tt0 -53.17 -47.03 69.14 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.287 1.035 . . . . 0.0 112.671 -168.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.75 -44.42 90.52 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.638 0.586 . . . . 0.0 110.924 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.412 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.55 HG22 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.583 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.616 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.539 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.524 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.493 ' O ' HG21 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.471 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG13 ' HG3' ' A' ' 91' ' ' GLN . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.489 HG22 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG22 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.411 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.446 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp -111.92 91.84 3.81 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 150.56 39.14 0.03 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.256 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.669 1.188 . . . . 0.0 107.999 -175.782 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.248 0.07 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.429 ' HA ' HD11 ' A' ' 94' ' ' ILE . 2.8 mp0 -61.34 -33.37 73.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.52 -38.09 89.81 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.469 0.577 . . . . 0.0 110.497 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.451 HG22 HD13 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.496 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.527 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.494 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.557 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.44 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.494 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.429 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.692 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.538 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.516 ' HA ' HD13 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.602 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.572 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.45 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.539 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.565 HG21 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.539 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.602 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.421 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.506 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.496 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? -109.83 84.65 1.96 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.31 86.67 0.12 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.344 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.935 0.894 . . . . 0.0 108.997 175.112 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.52 ' HG3' HG13 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -51.06 -43.53 60.98 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.311 1.044 . . . . 0.0 113.277 -171.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.27 -41.61 84.68 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.664 0.666 . . . . 0.0 111.324 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.526 HG22 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.508 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.455 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.511 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.441 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.543 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.447 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.553 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD23 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.553 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.562 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.412 ' HB3' HG12 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.526 ' HB2' HG21 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.42 HG22 ' ND2' ' A' ' 185' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.474 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.416 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.593 HG21 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.514 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.514 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.528 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.481 HG21 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.481 ' HG2' HG21 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.593 HG21 HG21 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 136' ' ' ASP . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.675 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.675 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.562 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.42 ' ND2' HG22 ' A' ' 140' ' ' VAL . 7.9 t30 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.432 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt -147.13 94.64 2.43 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 175.38 97.05 0.1 Allowed Glycine 0 C--O 1.238 0.387 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 0.0 110.046 -174.152 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.639 0.257 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.03 -32.6 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.794 0.838 . . . . 0.0 110.217 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.6 -28.74 69.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.17 0.988 . . . . 0.0 111.918 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' HE3' ' HB3' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.403 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.529 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.412 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.51 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.518 ' HB2' HD23 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.51 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.513 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.529 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.589 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.477 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.477 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.603 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.463 HG23 HD13 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.412 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.467 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.484 ' O ' HG21 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.52 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.481 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.481 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.546 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.432 ' HB2' ' HZ2' ' A' ' 173' ' ' LYS . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' A' ' 183' ' ' ARG . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.4 ' HB2' ' HB3' ' A' ' 180' ' ' ASP . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.481 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.468 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? -147.48 97.03 2.79 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -153.41 -75.31 0.01 OUTLIER Glycine 0 C--N 1.341 0.849 0 CA-C-N 116.491 -0.322 . . . . 0.0 112.669 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.259 1.556 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.507 0.67 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.54 ' HG3' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -71.21 -37.26 72.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.853 -174.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -58.53 -34.91 71.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.848 0.459 . . . . 0.0 111.565 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.408 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.614 HG21 HG13 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.518 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.457 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.619 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.503 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.514 ' HB2' HD22 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.571 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.634 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.614 HG13 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.512 ' HB2' HD22 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.461 ' HA ' HD13 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.461 HD13 ' HA ' ' A' ' 159' ' ' HIS . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.518 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.496 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.428 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -147.92 84.06 1.52 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.55 -116.35 3.84 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.238 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.244 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 153' ' ' VAL . 1.6 mp0 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.607 0.763 . . . . 0.0 112.101 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -51.64 -46.88 63.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.904 0.882 . . . . 0.0 112.093 -169.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.415 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.669 HG22 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 24.8 mm-40 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.514 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.499 ' HA ' HD13 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.567 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.596 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.417 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.417 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.419 ' HB ' HD21 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.462 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.512 ' HB2' HD22 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.596 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.596 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.645 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.491 ' HB3' HG11 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.468 HG23 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.419 HD21 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.596 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.48 ' HB3' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.481 ' O ' HG21 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 HG12 ' HG3' ' A' ' 91' ' ' GLN . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.479 ' HA ' HD13 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.468 HD11 HG23 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.488 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.48 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.476 HD13 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -147.52 103.59 3.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.97 1.28 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.554 1.128 0 C-N-CA 123.846 0.859 . . . . 0.0 109.381 177.716 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.423 ' O ' HG13 ' A' ' 94' ' ' ILE . 25.4 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -56.07 -40.05 72.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.995 0.918 . . . . 0.0 111.417 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.74 -39.13 87.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 111.186 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 90' ' ' SER . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.514 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.43 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.402 HG13 ' HG2' ' A' ' 126' ' ' PRO . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.444 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.472 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.558 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.476 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.667 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.476 ' HB3' HG12 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.558 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.435 ' O ' HG21 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.423 ' HB2' HG23 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.499 HG22 HG23 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.499 HG23 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.55 ' HB2' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.667 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.443 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.429 ' HG3' HD13 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.429 HD13 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.563 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -144.08 99.77 3.45 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -140.43 34.37 1.98 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.783 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 124.849 1.259 . . . . 0.0 107.995 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.68 -49.1 77.61 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.543 0.737 . . . . 0.0 112.479 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.2 -27.34 66.31 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.445 0.298 . . . . 0.0 110.876 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.644 HG22 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.544 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.588 ' HB3' HG23 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.544 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.552 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.406 ' HG2' ' HB3' ' A' ' 116' ' ' ALA . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 113' ' ' PRO . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.525 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.433 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 22.7 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.552 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.635 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HB3' HG12 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.452 HG12 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.403 ' HB2' HD13 ' A' ' 188' ' ' ILE . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.511 HG22 HD12 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.535 ' O ' HG22 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.444 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.644 HG11 HG22 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.511 HD12 HG22 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 159' ' ' HIS . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.588 HG23 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.569 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.51 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.461 HD13 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -144.68 91.16 2.14 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -141.46 1.09 1.81 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.065 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 108.106 179.063 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.419 HE22 HG13 ' A' ' 153' ' ' VAL . 7.5 tp-100 -52.98 -42.26 65.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.388 1.075 . . . . 0.0 111.898 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -53.05 -43.66 66.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.022 0.929 . . . . 0.0 111.666 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.421 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.747 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.536 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.449 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.544 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.487 HG22 HG22 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.503 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.406 HG11 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.562 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.503 ' HA ' HD13 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.505 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.403 HG21 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.724 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.473 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.724 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.441 HD13 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 108.26 2.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 158.22 -72.92 0.23 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 124.981 1.313 . . . . 0.0 110.518 177.095 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -61.97 -33.95 75.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.638 0.775 . . . . 0.0 110.055 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.49 -41.59 85.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.431 1.092 . . . . 0.0 111.129 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.459 HG22 HD12 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 153' ' ' VAL . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.536 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 168' ' ' ALA . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.469 ' HA ' HD13 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.536 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.422 ' HE2' ' HB2' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD22 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.423 ' HB ' HD22 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.562 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.46 ' HB2' HD22 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.538 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.469 HD13 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.497 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.59 ' HD3' HD13 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.461 ' HB3' HG12 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG12 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.462 HG23 HD12 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.423 HD22 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.567 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 102' ' ' LYS . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' O ' HG21 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.551 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.488 HG22 HG23 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.462 HD12 HG23 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.426 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.413 ' HB3' ' HE3' ' A' ' 97' ' ' LYS . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.459 HD12 HG22 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.465 HG23 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' CYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ILE . . . . . 0.59 HD13 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? -127.62 74.64 1.54 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.51 -12.11 49.04 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.047 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.688 0.795 . . . . 0.0 109.62 -175.008 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.209 0.052 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 HD11 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.449 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.423 ' HB2' HG23 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HB2' HD21 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' NZ ' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.657 HG21 HG22 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.619 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.549 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.536 0.207 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 171' ' ' ILE . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 188' ' ' ILE . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.459 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HA ' HD11 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.466 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HG2' HG23 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.665 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.665 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.665 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmtp? . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.619 0.247 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.474 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HD21 ' A' ' 114' ' ' LEU . 18.4 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.463 HG21 HD11 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.482 HD23 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.635 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.491 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HB3' HD12 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 172' ' ' VAL . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 5.3 m-20 -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 94' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HD21 ' A' ' 110' ' ' LEU . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 103' ' ' PHE . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.567 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HB2' HD21 ' A' ' 114' ' ' LEU . 14.1 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.576 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.413 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.542 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 170' ' ' ILE . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.3 0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.768 HG21 HG11 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.466 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.487 HG23 HG21 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.402 HG23 ' ND2' ' A' ' 185' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.768 HG11 HG21 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.46 HG21 ' SG ' ' A' ' 177' ' ' CYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.562 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.547 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.53 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 140' ' ' VAL . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 135' ' ' SER . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.502 HG21 HD11 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.459 ' HB2' HG21 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 166' ' ' ILE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.525 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt . . . . . 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.621 0.248 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 117' ' ' ILE . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 105' ' ' VAL . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.527 ' HB2' HD21 ' A' ' 114' ' ' LEU . 15.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.499 ' HB3' HG13 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.444 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 164' ' ' GLU . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.493 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.591 HD11 HG23 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.492 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 129' ' ' GLY . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.594 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD11 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.428 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' THR . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 170' ' ' ILE . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 167' ' ' THR . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.447 HG21 HD11 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.509 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.57 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 166' ' ' ILE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 164' ' ' GLU . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 94' ' ' ILE . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 129' ' ' GLY . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.55 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.661 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.441 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.425 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.448 ' HA ' HD11 ' A' ' 170' ' ' ILE . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.448 0.166 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.603 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.603 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.502 HG21 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp . . . . . 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 4.1 m-20 -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.685 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.632 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.571 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.424 ' HA ' HD11 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.571 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.616 HG23 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 129' ' ' GLY . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' HD21 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.531 ' HB2' HG22 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.45 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.474 ' HG2' HG23 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.546 HD11 HG23 ' A' ' 166' ' ' ILE . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.663 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.663 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.549 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.512 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.475 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.556 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.584 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.469 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.637 HG21 HG11 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HB2' HD21 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.624 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB2' HD23 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 142' ' ' THR . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 164' ' ' GLU . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 162' ' ' THR . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 170' ' ' ILE . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.458 HD11 HG23 ' A' ' 166' ' ' ILE . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.531 HD11 HG23 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.433 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.572 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? . . . . . 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.417 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.595 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.586 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.648 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 188' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.486 ' HB3' HG13 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.48 HG21 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.586 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 149' ' ' PHE . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.467 ' HA ' HD11 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.715 HD11 HG23 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.498 HD11 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 171' ' ' ILE . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 5.5 m-20 -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 129' ' ' GLY . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.477 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.652 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.422 HG21 HD11 ' A' ' 161' ' ' LEU . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.416 ' HB2' HG21 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 157' ' ' LEU . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 142' ' ' THR . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.577 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 94' ' ' ILE . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.445 HD11 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 133' ' ' LYS . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.876 -0.046 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.656 HG21 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.547 HG21 HD11 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.421 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.452 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.492 ' HA ' HD11 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.536 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.752 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 HG21 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 HG23 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.413 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.752 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.5 ' HA ' HD11 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.508 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.73 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.464 0.173 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 4.3 m-20 -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.581 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.698 ' HD3' HD11 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.478 ' HB3' HG13 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.484 HG21 HD11 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 170' ' ' ILE . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.492 HD11 HG23 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.445 HG21 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' HIS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ILE . . . . . 0.698 HD11 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? . . . . . 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HG3' HG12 ' A' ' 153' ' ' VAL . 34.8 tt0 -60.14 -39.65 87.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.148 0.979 . . . . 0.0 111.289 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.67 -34.51 78.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.283 0.633 . . . . 0.0 111.032 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 HD11 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.449 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.423 ' HB2' HG23 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HB2' HD21 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' NZ ' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.657 HG21 HG22 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.619 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.549 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? -141.88 89.78 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.91 0.31 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.807 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.692 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.42 0.153 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -65.41 -42.95 92.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.768 . . . . 0.0 110.78 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.26 -26.09 66.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.91 0.884 . . . . 0.0 110.84 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 171' ' ' ILE . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 188' ' ' ILE . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.459 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HA ' HD11 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.466 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HG2' HG23 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.665 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.665 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.665 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmtp? -142.57 89.69 2.16 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.12 -18.38 29.28 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.378 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.255 1.022 . . . . 0.0 108.353 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 35.6 tt0 -54.84 -40.84 70.02 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.358 1.063 . . . . 0.0 111.584 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.12 -44.44 94.89 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.237 1.015 . . . . 0.0 110.804 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.474 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HD21 ' A' ' 114' ' ' LEU . 18.4 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.463 HG21 HD11 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.482 HD23 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.635 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.491 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HB3' HD12 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 172' ' ' VAL . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -127.07 101.36 6.5 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -102.26 20.05 46.4 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.974 0.796 . . . . 0.0 114.01 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.487 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.93 -42.82 94.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 0.0 110.839 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.48 -31.83 70.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.332 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 5.3 m-20 -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 94' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HD21 ' A' ' 110' ' ' LEU . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 103' ' ' PHE . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.567 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HB2' HD21 ' A' ' 114' ' ' LEU . 14.1 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.576 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.413 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.542 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 170' ' ' ILE . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -153.26 78.5 1.16 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.09 -61.9 1.38 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.67 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.332 -0.842 . . . . 0.0 108.8 -178.849 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.51 -39.32 90.56 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.797 0.685 . . . . 0.0 110.226 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.5 -37.27 80.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.831 0.852 . . . . 0.0 110.889 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.768 HG21 HG11 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.466 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.487 HG23 HG21 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.402 HG23 ' ND2' ' A' ' 185' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.768 HG11 HG21 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.46 HG21 ' SG ' ' A' ' 177' ' ' CYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -157.16 94.9 1.44 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 130.27 115.68 1.78 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.561 1.377 0 C-N-CA 123.271 0.628 . . . . 0.0 110.318 177.462 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.243 -0.408 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.487 ' HG3' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -57.12 -45.14 83.73 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.599 0.76 . . . . 0.0 112.013 -171.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -51.77 -51.91 52.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.527 0.731 . . . . 0.0 112.423 -172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.547 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.53 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 140' ' ' VAL . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.43 HG13 ' H ' ' A' ' 135' ' ' SER . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.502 HG21 HD11 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.459 ' HB2' HG21 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 166' ' ' ILE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.525 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt -123.76 117.4 24.84 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 169.82 -31.5 0.16 Allowed Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.8 p30 . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.595 1.158 . . . . 0.0 110.241 172.847 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.543 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.3 mp0 -51.61 -46.61 63.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.68 -49.42 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.834 0.454 . . . . 0.0 111.402 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 117' ' ' ILE . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 105' ' ' VAL . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.527 ' HB2' HD21 ' A' ' 114' ' ' LEU . 15.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.499 ' HB3' HG13 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.444 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 164' ' ' GLU . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.493 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.591 HD11 HG23 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.492 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? -119.21 87.65 2.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.65 -26.3 6.88 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.246 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 45.9 t30 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.137 0.975 . . . . 0.0 109.356 -179.183 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -52.5 -44.37 65.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.448 1.099 . . . . 0.0 111.839 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.27 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.609 0.568 . . . . 0.0 111.311 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 129' ' ' GLY . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.594 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD11 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.428 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' THR . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 170' ' ' ILE . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 167' ' ' THR . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -151.93 102.89 2.86 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -177.16 -55.14 0.07 OUTLIER Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.463 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 94' ' ' ILE . 15.7 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.0 tt0 -56.24 -39.72 73.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.336 0.654 . . . . 0.0 110.744 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -49.32 -52.01 30.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.537 1.135 . . . . 0.0 111.097 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.447 HG21 HD11 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.509 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.57 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 166' ' ' ILE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 164' ' ' GLU . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 94' ' ' ILE . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt -138.9 94.9 2.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -169.11 22.27 0.09 OUTLIER Glycine 0 N--CA 1.467 0.703 0 CA-C-O 119.891 -0.394 . . . . 0.0 113.158 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.002 -179.604 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.577 0.227 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.61 -41.96 99.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 0.0 110.897 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.96 -26.14 65.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.561 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 129' ' ' GLY . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.55 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.661 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.441 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.425 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.448 ' HA ' HD11 ' A' ' 170' ' ' ILE . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -155.73 77.86 0.98 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -98.35 -71.17 1.01 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.646 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.123 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HG3' HG12 ' A' ' 153' ' ' VAL . 35.4 tt0 -53.17 -47.03 69.14 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.287 1.035 . . . . 0.0 112.671 -168.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.75 -44.42 90.52 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.638 0.586 . . . . 0.0 110.924 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.603 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.603 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 91' ' ' GLN . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.502 HG21 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp -111.92 91.84 3.81 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 150.56 39.14 0.03 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.256 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.669 1.188 . . . . 0.0 107.999 -175.782 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.248 0.07 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.8 mp0 -61.34 -33.37 73.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.52 -38.09 89.81 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.469 0.577 . . . . 0.0 110.497 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 4.1 m-20 -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.685 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.632 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.571 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.424 ' HA ' HD11 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.571 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? -109.83 84.65 1.96 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.31 86.67 0.12 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.344 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.935 0.894 . . . . 0.0 108.997 175.112 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -51.06 -43.53 60.98 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.311 1.044 . . . . 0.0 113.277 -171.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.27 -41.61 84.68 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.664 0.666 . . . . 0.0 111.324 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.616 HG23 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 129' ' ' GLY . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' HD21 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.531 ' HB2' HG22 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.45 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.474 ' HG2' HG23 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.546 HD11 HG23 ' A' ' 166' ' ' ILE . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.663 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.663 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.549 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt -147.13 94.64 2.43 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 175.38 97.05 0.1 Allowed Glycine 0 C--O 1.238 0.387 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 61.6 t30 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 0.0 110.046 -174.152 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.639 0.257 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.03 -32.6 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.794 0.838 . . . . 0.0 110.217 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.6 -28.74 69.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.17 0.988 . . . . 0.0 111.918 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.512 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.475 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.556 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.584 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.469 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? -147.48 97.03 2.79 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -153.41 -75.31 0.01 OUTLIER Glycine 0 C--N 1.341 0.849 0 CA-C-N 116.491 -0.322 . . . . 0.0 112.669 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.259 1.556 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.507 0.67 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.564 ' HG3' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -71.21 -37.26 72.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.853 -174.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -58.53 -34.91 71.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.848 0.459 . . . . 0.0 111.565 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.637 HG21 HG11 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HB2' HD21 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.624 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB2' HD23 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 142' ' ' THR . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 164' ' ' GLU . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 162' ' ' THR . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 170' ' ' ILE . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.458 HD11 HG23 ' A' ' 166' ' ' ILE . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.531 HD11 HG23 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.433 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.572 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -147.92 84.06 1.52 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.55 -116.35 3.84 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.238 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.244 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 153' ' ' VAL . 1.6 mp0 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.607 0.763 . . . . 0.0 112.101 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -51.64 -46.88 63.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.904 0.882 . . . . 0.0 112.093 -169.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.417 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 12.8 mm100 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.595 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.586 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.648 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 188' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.486 ' HB3' HG13 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.48 HG21 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.586 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 149' ' ' PHE . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.467 ' HA ' HD11 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.715 HD11 HG23 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.498 HD11 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -147.52 103.59 3.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.97 1.28 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.554 1.128 0 C-N-CA 123.846 0.859 . . . . 0.0 109.381 177.716 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 94' ' ' ILE . 25.4 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -56.07 -40.05 72.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.995 0.918 . . . . 0.0 111.417 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.74 -39.13 87.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 111.186 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 90' ' ' SER . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 5.5 m-20 -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 129' ' ' GLY . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.477 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.652 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.422 HG21 HD11 ' A' ' 161' ' ' LEU . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.416 ' HB2' HG21 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 157' ' ' LEU . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 142' ' ' THR . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.577 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 94' ' ' ILE . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.445 HD11 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 133' ' ' LYS . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -144.08 99.77 3.45 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -140.43 34.37 1.98 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.783 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 124.849 1.259 . . . . 0.0 107.995 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.68 -49.1 77.61 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.543 0.737 . . . . 0.0 112.479 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.2 -27.34 66.31 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.445 0.298 . . . . 0.0 110.876 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.656 HG21 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.547 HG21 HD11 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.452 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.492 ' HA ' HD11 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.536 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -144.68 91.16 2.14 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -141.46 1.09 1.81 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.065 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 108.106 179.063 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.449 HE22 HG12 ' A' ' 153' ' ' VAL . 7.5 tp-100 -52.98 -42.26 65.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.388 1.075 . . . . 0.0 111.898 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -53.05 -43.66 66.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.022 0.929 . . . . 0.0 111.666 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.752 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 HG21 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 HG23 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.413 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.752 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.5 ' HA ' HD11 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.508 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.73 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 108.26 2.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 158.22 -72.92 0.23 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 124.981 1.313 . . . . 0.0 110.518 177.095 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -61.97 -33.95 75.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.638 0.775 . . . . 0.0 110.055 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.49 -41.59 85.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.431 1.092 . . . . 0.0 111.129 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 4.3 m-20 -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.581 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.698 ' HD3' HD11 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.478 ' HB3' HG13 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.484 HG21 HD11 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 170' ' ' ILE . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.492 HD11 HG23 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.445 HG21 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' HIS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ILE . . . . . 0.698 HD11 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? -127.62 74.64 1.54 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.51 -12.11 49.04 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.047 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.688 0.795 . . . . 0.0 109.62 -175.008 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.209 0.052 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 HD11 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.449 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.423 ' HB2' HG23 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HB2' HD21 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' NZ ' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.657 HG21 HG22 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.619 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.549 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? . . . . . 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 N--CA 1.475 0.795 0 CA-C-O 120.536 0.207 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 171' ' ' ILE . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 188' ' ' ILE . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.459 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.483 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HA ' HD11 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.466 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HG2' HG23 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.665 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.665 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.665 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmtp? . . . . . 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 120.619 0.247 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.474 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HD21 ' A' ' 114' ' ' LEU . 29.1 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.463 HG21 HD11 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.482 HD23 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.635 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.491 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HB3' HD12 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 172' ' ' VAL . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp . . . . . 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 111.332 0.123 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 94' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HD21 ' A' ' 110' ' ' LEU . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 103' ' ' PHE . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.567 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HB2' HD21 ' A' ' 114' ' ' LEU . 21.9 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.576 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.413 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.542 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 170' ' ' ILE . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.414 ' ND2' HG23 ' A' ' 140' ' ' VAL . 10.0 t30 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 CA--C 1.541 0.624 0 CA-C-O 120.3 0.095 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.768 HG21 HG11 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.466 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.487 HG23 HG21 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.47 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.402 HG23 ' ND2' ' A' ' 185' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.768 HG11 HG21 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.46 HG21 ' SG ' ' A' ' 177' ' ' CYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.562 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.547 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.53 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 140' ' ' VAL . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.689 ' HA ' HD21 ' A' ' 185' ' ' ASN . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.502 HG21 HD11 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.459 ' HB2' HG21 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 166' ' ' ILE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.525 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.689 HD21 ' HA ' ' A' ' 140' ' ' VAL . 21.2 t30 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt . . . . . 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 120.621 0.248 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 117' ' ' ILE . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 105' ' ' VAL . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.527 ' HB2' HD21 ' A' ' 114' ' ' LEU . 23.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.499 ' HB3' HG13 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.508 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.444 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 164' ' ' GLU . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.493 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.591 HD11 HG23 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.492 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.478 ' ND2' HG23 ' A' ' 140' ' ' VAL . 9.8 t30 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? . . . . . 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 111.311 0.115 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 129' ' ' GLY . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.594 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD11 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.428 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' THR . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 170' ' ' ILE . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 167' ' ' THR . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.495 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 31.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.447 HG21 HD11 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.509 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.57 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 166' ' ' ILE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 164' ' ' GLU . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 94' ' ' ILE . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 110.561 -0.163 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 129' ' ' GLY . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.55 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.445 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.661 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.441 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.425 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.448 ' HA ' HD11 ' A' ' 170' ' ' ILE . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.448 0.166 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.603 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.418 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.603 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.502 HG21 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp . . . . . 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.685 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.632 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.571 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.424 ' HA ' HD11 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.571 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.566 0.222 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.616 HG23 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.45 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 129' ' ' GLY . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' HD21 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.531 ' HB2' HG22 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.424 HG23 ' ND2' ' A' ' 185' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.45 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.474 ' HG2' HG23 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.546 HD11 HG23 ' A' ' 166' ' ' ILE . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.663 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.663 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 140' ' ' VAL . 7.9 t30 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.549 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.512 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.475 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.556 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.584 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.469 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? . . . . . 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.637 HG21 HG11 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HB2' HD21 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.624 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB2' HD23 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 142' ' ' THR . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 164' ' ' GLU . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 162' ' ' THR . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 170' ' ' ILE . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.458 HD11 HG23 ' A' ' 166' ' ' ILE . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.531 HD11 HG23 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.433 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.572 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? . . . . . 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.417 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.589 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.595 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.586 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.648 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 188' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.486 ' HB3' HG13 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.48 HG21 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.586 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 149' ' ' PHE . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.467 ' HA ' HD11 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.715 HD11 HG23 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.498 HD11 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.186 0.069 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 171' ' ' ILE . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 129' ' ' GLY . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.477 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.652 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.422 HG21 HD11 ' A' ' 161' ' ' LEU . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.416 ' HB2' HG21 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 157' ' ' LEU . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 142' ' ' THR . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.577 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 94' ' ' ILE . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.445 HD11 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 133' ' ' LYS . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp . . . . . 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.876 -0.046 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.656 HG21 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.434 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.434 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 22.7 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.547 HG21 HD11 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.421 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.452 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.492 ' HA ' HD11 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.536 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.752 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 HG21 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 HG23 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.413 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.752 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.5 ' HA ' HD11 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.508 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.73 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.464 0.173 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.581 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.698 ' HD3' HD11 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.478 ' HB3' HG13 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.484 HG21 HD11 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 170' ' ' ILE . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.492 HD11 HG23 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.445 HG21 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' HIS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ILE . . . . . 0.698 HD11 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? . . . . . 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.4 m . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.496 ' HG3' HG12 ' A' ' 153' ' ' VAL . 34.8 tt0 -60.14 -39.65 87.05 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.148 0.979 . . . . 0.0 111.289 -174.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.67 -34.51 78.46 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.283 0.633 . . . . 0.0 111.032 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.0 m -71.01 -31.49 68.0 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.277 0.631 . . . . 0.0 109.929 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.543 HG23 HD11 ' A' ' 171' ' ' ILE . 69.9 mt -70.16 -41.97 79.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.427 175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 32.0 mm-40 -61.42 -46.46 90.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.589 0.756 . . . . 0.0 110.459 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.498 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 34.7 m-80 -59.95 -43.31 95.09 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 123.513 0.508 . . . . 0.0 109.996 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.9 tppt? -56.68 -56.05 26.3 Favored 'General case' 0 C--O 1.199 -1.585 0 O-C-N 124.247 0.967 . . . . 0.0 110.462 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.496 ' HA ' HD12 ' A' ' 130' ' ' ILE . 67.6 mt -64.29 -26.2 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.943 -174.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.449 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 65.9 m -71.54 -40.35 70.09 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.287 0.635 . . . . 0.0 112.539 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.4 pt20 -104.07 -37.27 7.41 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.3 m -74.13 -11.39 60.29 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.738 1.215 . . . . 0.0 112.197 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.0 171.02 3.12 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.383 0.611 . . . . 0.0 111.536 172.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -163.24 162.72 25.46 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.83 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.504 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 45.7 m -67.04 95.35 0.38 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.44 0.696 . . . . 0.0 111.506 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.3 t -81.76 90.54 2.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.699 0.762 . . . . 0.0 110.244 177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.415 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 74.9 m -139.37 143.06 34.48 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 114.863 -1.062 . . . . 0.0 108.297 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.53 -22.1 73.61 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.781 2.321 . . . . 0.0 112.225 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.26 -37.09 82.92 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.651 0.78 . . . . 0.0 111.285 173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.415 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 38.3 mmt180 -83.02 -54.91 4.7 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.73 0.776 . . . . 0.0 110.553 -175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 75.4 mt -82.59 -16.23 49.26 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.407 -1.27 . . . . 0.0 112.922 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 62.74 21.3 12.67 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.501 1.12 . . . . 0.0 112.747 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.423 ' HB2' HG23 ' A' ' 117' ' ' ILE . 23.8 m -111.68 154.11 44.08 Favored Pre-proline 0 C--O 1.243 0.756 0 C-N-CA 124.042 0.937 . . . . 0.0 109.162 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.19 159.76 17.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.405 2.07 . . . . 0.0 112.059 172.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.494 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -55.57 -49.8 71.75 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.859 0.864 . . . . 0.0 109.942 -177.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -53.23 -40.03 64.24 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.706 1.202 . . . . 0.0 112.555 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.98 -37.23 85.43 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.44 0.696 . . . . 0.0 111.465 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 112' ' ' CYS . 37.0 pt -101.77 5.95 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.315 0.646 . . . . 0.0 111.061 -175.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -71.61 134.48 46.42 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 123.296 0.638 . . . . 0.0 110.94 -169.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.594 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.2 t -67.1 119.53 65.2 Favored Pre-proline 0 CA--C 1.536 0.434 0 O-C-N 123.734 0.646 . . . . 0.0 109.474 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.55 -26.56 76.12 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.763 2.308 . . . . 0.0 111.962 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 54.7 mt -73.58 -52.22 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.539 0.736 . . . . 0.0 110.29 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.6 p -100.92 3.48 41.78 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.607 0.763 . . . . 0.0 112.437 -174.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 45.18 31.5 0.79 Allowed 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 126.068 1.747 . . . . 0.0 114.067 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.33 176.39 9.59 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HB2' HD21 ' A' ' 114' ' ' LEU . 19.6 tt0 -63.04 119.43 52.04 Favored Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 73.1 Cg_exo -51.92 -44.92 41.91 Favored 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 122.439 2.093 . . . . 0.0 112.77 172.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 75.46 -45.03 0.54 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 125.431 1.492 . . . . 0.0 110.124 -173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.504 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.5 mmmm -136.45 105.46 5.94 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.919 1.688 . . . . 0.0 106.681 168.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.99 -168.02 11.2 Favored Glycine 0 CA--C 1.506 -0.509 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.9 tt -150.76 138.66 14.13 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 CA-C-N 117.256 0.528 . . . . 0.0 111.131 -169.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 14.3 m-85 -75.14 112.52 11.48 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.186 175.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 72.5 t -130.7 137.33 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' NZ ' HG11 ' A' ' 172' ' ' VAL . 37.3 mmtm -59.52 146.45 40.47 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.476 0.71 . . . . 0.0 111.639 176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -66.48 -49.94 64.94 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 162.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.1 p -140.19 142.03 35.93 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.109 0.963 . . . . 0.0 108.615 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.72 -51.8 56.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.072 0.949 . . . . 0.0 112.408 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.93 34.84 3.15 Favored Glycine 0 C--N 1.35 1.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 113.301 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 m -139.24 168.36 19.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.176 0.99 . . . . 0.0 109.397 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -89.58 -13.04 38.12 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.792 0.437 . . . . 0.0 111.314 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.35 104.06 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-O 122.043 0.925 . . . . 0.0 111.022 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 45.5 t -108.57 141.59 40.26 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.975 176.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.1 m -129.98 144.15 51.18 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.423 0.689 . . . . 0.0 109.396 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.8 tp -95.36 122.57 38.21 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.104 0.478 . . . . 0.0 109.787 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -113.89 168.29 9.92 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.106 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 29.6 t70 -78.18 139.56 38.97 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 170.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -65.35 -48.26 73.6 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.636 0.585 . . . . 0.0 111.148 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.51 -37.29 74.12 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.517 0.327 . . . . 0.0 110.898 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.23 -41.4 63.78 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.078 0.951 . . . . 0.0 112.047 -175.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 42.0 t80 -73.07 -40.68 64.85 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.5 t -60.47 -48.76 80.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.932 0.493 . . . . 0.0 111.509 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.1 ptm180 -65.59 -35.29 80.38 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.475 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.7 tt -59.59 -44.79 93.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.166 0.986 . . . . 0.0 110.45 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.657 HG22 HG21 ' A' ' 166' ' ' ILE . 61.5 t -62.46 -41.65 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.036 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.95 -31.78 82.04 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 124.173 0.921 . . . . 0.0 112.83 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 24.1 mm-40 -73.42 -13.44 61.08 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.085 0.554 . . . . 0.0 110.973 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.19 29.09 57.11 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.246 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.463 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 90.0 mt -84.65 155.62 62.05 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 123.546 0.738 . . . . 0.0 110.128 -177.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.03 173.84 13.4 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.049 1.833 . . . . 0.0 110.746 170.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -57.94 132.06 83.34 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 122.959 0.503 . . . . 0.0 111.023 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -54.65 -40.93 81.95 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.655 2.237 . . . . 0.0 112.978 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 33.4 mt -84.76 -53.33 5.43 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.372 -172.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.0 t -114.01 -9.43 12.99 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -167.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? 63.74 24.05 13.69 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.605 1.162 . . . . 0.0 112.552 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -79.38 163.95 56.66 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.798 0.839 . . . . 0.0 110.367 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.34 116.28 3.66 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.288 1.992 . . . . 0.0 111.686 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.657 HG21 HG22 ' A' ' 153' ' ' VAL . 76.9 mt -69.3 131.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 CA-C-O 121.32 0.581 . . . . 0.0 109.853 174.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.3 t -141.78 174.97 10.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.382 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.619 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -77.17 -24.0 51.53 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.085 0.554 . . . . 0.0 109.924 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 23.0 t -62.29 -32.21 72.91 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.945 0.898 . . . . 0.0 111.757 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.479 HD11 HG23 ' A' ' 166' ' ' ILE . 37.0 pt -79.38 -24.21 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 122.245 0.218 . . . . 0.0 111.34 176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 94' ' ' ILE . 64.2 mt -72.34 119.12 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.549 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 23.9 m -125.03 170.63 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 123.652 0.781 . . . . 0.0 111.474 -172.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.05 175.98 7.67 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.838 0.855 . . . . 0.0 113.202 -174.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 51.1 t-80 -68.33 -42.05 79.88 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.838 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 2.9 mp0 -62.58 -42.36 99.5 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.592 0.757 . . . . 0.0 110.508 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.549 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 14.4 mm-40 -42.43 -73.72 0.04 OUTLIER 'General case' 0 C--N 1.355 0.827 0 O-C-N 125.324 1.64 . . . . 0.0 111.084 172.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 25.8 m -90.0 111.0 21.95 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.841 0.456 . . . . 0.0 110.118 -166.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 187' ' ' ILE . 11.7 pt -124.53 120.13 58.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 124.223 1.009 . . . . 0.0 108.581 -175.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -61.76 107.99 0.92 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.703 0.287 . . . . 0.0 111.082 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -99.75 115.06 28.65 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -63.66 -35.48 80.68 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.214 0.946 . . . . 0.0 112.046 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 57.8 m -63.55 -40.92 98.25 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.081 0.552 . . . . 0.0 110.96 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -81.55 -30.38 33.11 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.72 24.28 67.73 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.71 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -153.03 162.49 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.185 0.594 . . . . 0.0 109.676 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.2 m-85 -80.15 119.38 22.86 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.752 0.821 . . . . 0.0 109.982 178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 178' ' ' ILE . 33.0 mm -101.4 160.0 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -175.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 36.7 mm -92.06 139.97 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -170.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 9.3 tmtt? -141.88 89.78 2.22 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 159.66 -24.91 0.31 Allowed Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.807 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.692 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 120.42 0.153 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.3 tp60 -65.41 -42.95 92.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.619 0.768 . . . . 0.0 110.78 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -67.26 -26.09 66.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.91 0.884 . . . . 0.0 110.84 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.3 m -67.21 -37.21 83.24 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.579 0.752 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.419 HG23 HD11 ' A' ' 171' ' ' ILE . 45.9 mt -70.03 -44.89 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.091 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -59.75 -54.52 45.3 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.923 0.889 . . . . 0.0 111.577 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -61.49 -33.55 73.97 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.408 0.683 . . . . 0.0 110.966 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.2 tppt? -55.52 -56.29 21.97 Favored 'General case' 0 C--O 1.2 -1.512 0 O-C-N 123.814 0.696 . . . . 0.0 110.006 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.648 ' HA ' HD12 ' A' ' 130' ' ' ILE . 87.2 mt -58.69 -24.82 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 124.45 1.094 . . . . 0.0 111.012 -176.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 25.1 t -73.51 -36.97 65.81 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.3 0.64 . . . . 0.0 110.831 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -17.63 14.19 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t -89.45 -15.66 32.64 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.457 1.103 . . . . 0.0 110.68 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -66.17 175.43 2.12 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 122.033 0.92 . . . . 0.0 111.99 173.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -161.29 160.63 30.03 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 114.08 -1.418 . . . . 0.0 107.73 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 12.5 m -72.88 98.64 2.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 121.202 0.525 . . . . 0.0 110.644 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -73.03 96.54 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.365 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.1 m -125.2 137.38 29.64 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.107 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.65 -31.0 60.1 Favored 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 122.977 2.451 . . . . 0.0 112.517 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.8 pt-20 -66.37 -39.21 88.97 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.182 0.993 . . . . 0.0 111.477 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 15.8 mmt180 -78.79 -34.9 45.09 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.455 0.702 . . . . 0.0 111.243 -174.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.5 mt -86.99 -10.99 51.81 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.789 0.836 . . . . 0.0 113.239 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 55.22 35.79 25.62 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.871 0.868 . . . . 0.0 111.301 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.626 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 85.2 m -136.9 143.43 42.42 Favored Pre-proline 0 C--O 1.242 0.687 0 C-N-CA 124.073 0.949 . . . . 0.0 109.055 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.55 165.76 7.3 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.902 2.402 . . . . 0.0 112.428 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -45.22 92.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.848 0.459 . . . . 0.0 110.21 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.7 -40.01 65.66 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.867 0.867 . . . . 0.0 111.732 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.31 -33.13 75.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.845 0.858 . . . . 0.0 111.917 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.9 pt -105.32 0.02 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.4 0.68 . . . . 0.0 110.975 -176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -71.71 127.44 32.59 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -170.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.501 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 20.9 t -65.45 122.66 81.43 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 123.279 0.632 . . . . 0.0 110.137 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.29 -23.09 60.92 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 123.275 2.65 . . . . 0.0 113.407 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.8 mt -85.9 -56.89 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 123.707 0.803 . . . . 0.0 110.223 -174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.3 p -92.25 3.25 55.76 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.36 31.01 0.77 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 126.04 1.736 . . . . 0.0 113.703 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.54 176.04 9.69 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.276 0.63 . . . . 0.0 109.961 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -64.57 119.0 53.37 Favored Pre-proline 0 N--CA 1.475 0.783 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 168.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.501 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 58.4 Cg_exo -52.59 -46.46 33.15 Favored 'Trans proline' 0 C--N 1.366 1.455 0 C-N-CA 122.447 2.098 . . . . 0.0 114.076 175.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 76.73 -47.43 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.987 1.315 . . . . 0.0 109.513 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -131.9 112.09 12.13 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.157 1.783 . . . . 0.0 106.21 171.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -146.32 -177.01 20.64 Favored Glycine 0 CA--C 1.507 -0.45 0 N-CA-C 112.15 -0.38 . . . . 0.0 112.15 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.665 HD11 HG23 ' A' ' 171' ' ' ILE . 7.6 tt -143.2 133.67 22.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 C-N-CA 122.852 0.461 . . . . 0.0 110.261 -167.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.662 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 9.5 m-85 -75.84 112.86 12.68 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.697 172.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.8 t -127.97 139.37 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.261 1.024 . . . . 0.0 108.703 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.604 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 21.2 mmtm -59.9 144.84 47.84 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.894 0.878 . . . . 0.0 111.272 174.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -69.76 -48.03 60.8 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 162.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.8 p -142.12 140.24 32.41 Favored 'General case' 0 C--O 1.246 0.896 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.075 175.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.481 ' HB2' HG22 ' A' ' 170' ' ' ILE . 21.3 t70 -67.54 -51.84 45.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.422 0.689 . . . . 0.0 111.26 -169.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.81 32.25 3.77 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.95 -175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 62.2 m -139.99 162.54 34.96 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.368 1.067 . . . . 0.0 108.872 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -88.19 23.97 1.99 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.315 0.646 . . . . 0.0 111.868 -176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 6.1 p -106.14 114.09 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 121.722 0.773 . . . . 0.0 110.621 -177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.441 ' HB2' HD11 ' A' ' 188' ' ' ILE . 44.8 t -114.63 164.91 13.37 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.731 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.459 HG21 HD11 ' A' ' 161' ' ' LEU . 63.4 m -148.41 143.13 26.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.947 0.899 . . . . 0.0 109.394 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.5 tp -92.77 126.61 37.93 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -117.78 165.82 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 123.676 0.79 . . . . 0.0 109.074 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.483 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 12.5 t70 -75.33 137.64 41.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 170.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.417 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -63.25 -44.79 94.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 123.758 0.661 . . . . 0.0 111.771 -173.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -76.38 -34.0 58.9 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.049 0.54 . . . . 0.0 111.246 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -73.17 -41.96 63.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.012 0.925 . . . . 0.0 111.528 -176.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -72.45 -40.17 67.24 Favored 'General case' 0 C--O 1.22 -0.47 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.3 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 30.6 t -62.51 -41.36 98.78 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.149 0.58 . . . . 0.0 111.915 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 7.6 ptp180 -68.46 -38.49 81.12 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -59.49 -44.01 93.18 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.75 1.22 . . . . 0.0 110.208 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 166' ' ' ILE . 66.1 t -65.1 -41.07 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.141 0.976 . . . . 0.0 110.657 174.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.69 -19.3 74.78 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.088 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 22.8 mm-40 -79.39 -27.32 41.84 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.958 0.503 . . . . 0.0 110.398 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.84 35.59 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 -171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 42.8 mt -82.86 144.98 49.03 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.994 0.918 . . . . 0.0 110.377 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.39 174.55 8.08 Favored 'Trans proline' 0 C--N 1.38 2.184 0 C-N-CA 123.217 2.611 . . . . 0.0 112.227 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.441 ' HA ' HD11 ' A' ' 166' ' ' ILE . 32.8 t-80 -57.97 126.16 76.17 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 122.936 0.494 . . . . 0.0 111.153 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.35 -25.94 75.15 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.226 2.618 . . . . 0.0 112.774 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.459 HD11 HG21 ' A' ' 142' ' ' THR . 41.6 mt -88.68 -68.54 0.76 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.633 0.373 . . . . 0.0 111.443 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.466 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -109.87 -0.92 18.1 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -162.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 77.8 mmt-85 68.26 19.65 8.98 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.517 1.127 . . . . 0.0 113.061 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HG2' HG23 ' A' ' 162' ' ' THR . 44.8 mm-40 -76.64 158.92 80.35 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.231 0.612 . . . . 0.0 110.721 174.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -66.1 108.94 1.42 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.596 2.197 . . . . 0.0 111.918 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 153' ' ' VAL . 77.5 mt -66.98 113.39 2.98 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-O 121.511 0.672 . . . . 0.0 109.688 175.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.4 t -130.83 168.25 17.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.862 -176.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.45 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.44 -28.68 70.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.07 0.548 . . . . 0.0 111.168 176.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 27.7 t -56.09 -41.73 75.66 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.13 0.972 . . . . 0.0 112.692 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.6 pt -78.48 -18.13 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.665 HG23 HD11 ' A' ' 130' ' ' ILE . 56.3 mt -69.97 113.78 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.665 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.6 m -112.64 167.74 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.108 0.563 . . . . 0.0 111.55 -174.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -76.86 178.27 7.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.172 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.513 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 53.2 t-80 -72.8 -26.27 61.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.692 0.797 . . . . 0.0 112.616 -172.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -75.54 -57.96 3.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 109.809 -169.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.665 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 24.7 mm-40 -12.0 -78.19 0.0 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.024 2.129 . . . . 0.0 114.93 162.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 4.1 m -88.21 111.81 22.05 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -164.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.2 pt -124.81 116.06 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 65.6 t80 -63.34 112.04 2.54 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-O 121.055 0.455 . . . . 0.0 110.128 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -103.4 116.38 32.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -66.6 -33.18 75.1 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.951 0.901 . . . . 0.0 112.004 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.2 m -65.84 -41.75 91.34 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 122.567 0.347 . . . . 0.0 110.748 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -80.63 -25.94 38.06 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.349 0.659 . . . . 0.0 109.981 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.63 22.04 67.81 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.665 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -165.52 169.41 15.53 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 117.395 0.598 . . . . 0.0 111.242 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 94.5 m-85 -71.49 125.02 25.94 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.632 1.173 . . . . 0.0 111.132 177.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -108.96 155.39 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.851 1.26 . . . . 0.0 107.739 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 133' ' ' LYS . 23.4 mm -85.3 139.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -170.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmtp? -142.57 89.69 2.16 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 125.555 1.542 . . . . 0.0 107.455 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.12 -18.38 29.28 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.378 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 124.255 1.022 . . . . 0.0 108.353 179.872 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 35.6 tt0 -54.84 -40.84 70.02 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.358 1.063 . . . . 0.0 111.584 -178.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.12 -44.44 94.89 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.237 1.015 . . . . 0.0 110.804 -178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.4 m -68.06 -29.87 68.94 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.569 0.747 . . . . 0.0 110.479 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.55 HG23 HD11 ' A' ' 171' ' ' ILE . 60.9 mt -72.41 -43.28 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.38 176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 31.3 mm-40 -60.04 -44.94 94.32 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.709 0.804 . . . . 0.0 111.122 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 62.4 m-80 -60.64 -44.85 95.9 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.83 0.706 . . . . 0.0 109.732 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -54.49 -54.91 34.72 Favored 'General case' 0 C--O 1.207 -1.154 0 O-C-N 124.405 1.066 . . . . 0.0 110.985 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' HA ' HD12 ' A' ' 130' ' ' ILE . 54.3 mt -64.63 -25.73 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.674 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.474 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 58.7 m -75.36 -42.76 53.41 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.297 0.639 . . . . 0.0 112.669 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -93.98 -44.16 8.19 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 123.347 0.659 . . . . 0.0 112.177 -175.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 90.9 m -75.86 -8.58 57.23 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.436 1.495 . . . . 0.0 113.131 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.2 ptpt -64.42 173.67 1.99 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.759 0.424 . . . . 0.0 111.613 173.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -164.42 166.27 20.76 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.32 0.648 . . . . 0.0 110.551 -176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.8 p -71.24 97.49 1.56 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.163 0.585 . . . . 0.0 110.754 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 66.2 t -79.79 93.65 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.365 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.2 m -135.85 141.33 36.37 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.497 174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -64.31 -37.69 38.87 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.493 2.795 . . . . 0.0 113.035 -169.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -71.74 -21.86 61.69 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.209 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -83.83 -45.56 13.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.318 0.58 . . . . 0.0 110.082 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.08 -6.41 59.48 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 61.76 14.47 6.21 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 123.491 0.717 . . . . 0.0 112.458 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 59.3 m -121.85 142.8 36.96 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 124.05 0.94 . . . . 0.0 109.261 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.3 165.29 15.37 Favored 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.979 2.452 . . . . 0.0 112.395 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -58.03 -52.27 66.22 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.618 0.767 . . . . 0.0 111.24 -173.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -57.88 -33.97 69.28 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.308 0.643 . . . . 0.0 111.885 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.92 -36.59 83.78 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.59 0.756 . . . . 0.0 111.057 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 143' ' ' LEU . 37.1 pt -104.17 6.24 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 123.635 0.774 . . . . 0.0 111.449 -176.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -70.43 129.37 39.09 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 123.422 0.689 . . . . 0.0 110.539 -169.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.616 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.2 t -64.9 115.44 20.86 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.17 -31.9 93.79 Favored 'Trans proline' 0 C--N 1.374 1.879 0 C-N-CA 123.085 2.523 . . . . 0.0 112.783 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 49.2 mt -68.7 -47.98 73.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.132 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 76.6 p -99.34 3.03 45.86 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.682 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 40.55 37.68 0.5 Allowed 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 126.267 1.827 . . . . 0.0 113.652 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.85 177.04 11.59 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.785 -175.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HD21 ' A' ' 114' ' ' LEU . 29.1 tt0 -61.99 125.06 84.35 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.883 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.616 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.4 Cg_exo -54.28 -49.7 16.06 Favored 'Trans proline' 0 CA--C 1.55 1.299 0 C-N-CA 122.413 2.075 . . . . 0.0 113.897 170.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 78.02 -44.47 0.4 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.284 1.434 . . . . 0.0 109.892 -168.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -136.85 111.78 8.9 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.538 1.535 . . . . 0.0 107.153 171.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -148.58 -169.05 15.03 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.021 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.5 tt -149.02 139.42 16.59 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.086 0.554 . . . . 0.0 110.349 -171.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.49 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 34.2 m-85 -74.25 116.57 15.05 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.311 0.644 . . . . 0.0 110.096 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -136.19 133.35 50.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.889 0.875 . . . . 0.0 108.772 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 10.4 mmmm -57.95 137.47 56.73 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.272 1.029 . . . . 0.0 111.689 175.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 31.8 t30 -69.67 -51.99 29.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.645 167.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.428 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 50.4 m -131.96 124.67 29.86 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -55.14 -54.44 43.26 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.354 1.461 . . . . 0.0 112.524 -171.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 37.94 3.2 Favored Glycine 0 N--CA 1.475 1.28 0 CA-C-N 116.296 -0.411 . . . . 0.0 113.723 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.7 m -136.64 -171.53 2.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.448 1.099 . . . . 0.0 109.408 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -106.46 5.0 28.92 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 123.39 0.676 . . . . 0.0 110.971 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.03 102.2 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 121.974 0.893 . . . . 0.0 110.073 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 188' ' ' ILE . 43.9 t -100.17 151.74 21.07 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 114.677 -1.147 . . . . 0.0 108.638 172.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.463 HG21 HD11 ' A' ' 161' ' ' LEU . 25.6 m -141.6 141.18 33.46 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.482 HD23 ' HB ' ' A' ' 117' ' ' ILE . 12.1 tp -94.93 122.27 37.41 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -112.78 164.75 13.0 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.281 1.032 . . . . 0.0 108.752 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.6 t70 -78.0 140.88 39.2 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 171.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.434 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.14 -44.06 80.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.426 0.69 . . . . 0.0 111.335 -174.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.45 73.03 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.12 -47.34 71.43 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.004 0.922 . . . . 0.0 111.365 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' O ' HG23 ' A' ' 153' ' ' VAL . 25.3 t80 -74.05 -37.04 64.41 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.321 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.1 t -64.86 -44.37 89.94 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.548 0.339 . . . . 0.0 111.701 -179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.519 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 18.2 ptt180 -64.24 -40.82 96.81 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 157' ' ' LEU . 6.4 tt -56.78 -47.39 80.26 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.988 1.315 . . . . 0.0 110.825 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.635 HG22 HG21 ' A' ' 166' ' ' ILE . 67.9 t -63.4 -42.37 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.56 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.49 -28.68 72.8 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.173 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.554 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 22.4 mm-40 -71.51 -29.05 64.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.25 0.62 . . . . 0.0 110.321 174.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.63 29.45 18.74 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.021 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 95.1 mt -83.42 152.96 65.1 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.804 0.842 . . . . 0.0 110.356 -178.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -70.3 177.12 6.29 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.344 2.029 . . . . 0.0 111.307 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 37.8 t-80 -59.49 132.52 88.39 Favored Pre-proline 0 CA--C 1.554 1.117 0 C-N-CA 123.096 0.559 . . . . 0.0 111.283 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.93 -35.38 98.6 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.033 2.488 . . . . 0.0 113.019 -176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 142' ' ' THR . 53.5 mt -85.82 -70.68 0.58 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.328 -176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 164' ' ' GLU . 10.5 t -105.74 -2.13 23.62 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.402 0.681 . . . . 0.0 112.272 -166.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.92 28.79 12.61 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.407 1.083 . . . . 0.0 112.535 173.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 162' ' ' THR . 19.0 mm-40 -73.12 157.89 87.77 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 123.728 0.811 . . . . 0.0 111.061 170.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.33 109.34 1.55 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.423 2.082 . . . . 0.0 111.293 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.635 HG21 HG22 ' A' ' 153' ' ' VAL . 87.5 mt -65.9 126.78 25.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 CA-C-O 120.911 0.386 . . . . 0.0 110.24 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.8 t -149.89 170.8 17.95 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.833 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.49 64.17 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.656 0.382 . . . . 0.0 111.078 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.6 t -63.75 -38.82 92.55 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.724 0.81 . . . . 0.0 111.727 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.521 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 48.7 pt -78.4 -27.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-O 119.772 -0.156 . . . . 0.0 110.905 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.55 HD11 HG23 ' A' ' 94' ' ' ILE . 57.8 mt -66.91 117.8 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.491 HG23 ' SG ' ' A' ' 177' ' ' CYS . 11.0 m -123.2 170.14 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.007 0.923 . . . . 0.0 111.518 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -87.59 176.6 7.37 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.789 0.804 . . . . 0.0 112.918 -174.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -63.76 -35.91 82.15 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.208 -1.36 . . . . 0.0 111.255 171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -64.58 -41.41 96.29 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.662 1.185 . . . . 0.0 110.226 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HB3' HD12 ' A' ' 188' ' ' ILE . 25.8 mm-40 -60.25 -66.1 0.58 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.341 175.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 172' ' ' VAL . 31.1 m -84.91 114.18 21.93 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.547 0.339 . . . . 0.0 111.386 -166.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 pt -125.21 127.9 72.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -67.3 106.14 1.97 Allowed 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.73 -0.606 . . . . 0.0 110.006 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -90.85 117.23 29.3 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -62.81 -37.29 86.16 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.854 0.862 . . . . 0.0 111.617 -177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 59.1 m -73.66 -27.52 61.28 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.26 -175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -85.59 -33.17 21.75 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 76.48 27.38 61.49 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.606 -172.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -161.61 161.4 29.66 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 122.871 0.468 . . . . 0.0 111.008 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.486 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 79.5 m-85 -72.29 124.65 25.54 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.529 0.732 . . . . 0.0 110.792 175.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.0 mm -113.0 141.16 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.597 1.159 . . . . 0.0 108.542 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 141' ' ' CYS . 47.8 mm -80.6 134.94 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.467 0.651 . . . . 0.0 112.318 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -127.07 101.36 6.5 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 126.051 1.74 . . . . 0.0 107.126 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -102.26 20.05 46.4 Favored Glycine 0 C--N 1.346 1.113 0 O-C-N 123.974 0.796 . . . . 0.0 114.01 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 . . . . . 0 C--O 1.248 1.026 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.487 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -64.93 -42.82 94.36 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.133 0.573 . . . . 0.0 110.839 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -60.48 -31.83 70.84 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.332 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -72.59 -36.89 68.26 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.779 0.431 . . . . 0.0 109.934 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' O ' HG13 ' A' ' 98' ' ' ILE . 48.0 mt -66.12 -51.26 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.379 177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -57.87 -47.86 81.5 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.886 0.874 . . . . 0.0 111.237 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.485 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -62.09 -37.29 84.48 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.321 178.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -51.08 71.27 Favored 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 121.623 0.725 . . . . 0.0 109.364 175.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 94' ' ' ILE . 43.0 mt -64.28 -17.15 20.42 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.262 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.4 m -87.41 -43.74 11.87 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.529 0.731 . . . . 0.0 112.653 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 12.6 pt20 -110.74 -29.29 8.05 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.5 t -83.61 -6.42 59.44 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.56 0.744 . . . . 0.0 111.085 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.81 176.69 1.11 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.134 0.574 . . . . 0.0 111.229 171.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HD21 ' A' ' 110' ' ' LEU . 17.4 p90 -156.5 164.42 38.25 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 109.532 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 34.4 m -75.67 100.35 4.63 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.731 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 63.4 t -79.91 89.34 1.48 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.05 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.454 178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 57.5 m -123.18 137.46 28.34 Favored Pre-proline 0 CA--C 1.552 1.021 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.65 -28.84 52.28 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 123.218 2.612 . . . . 0.0 114.193 -166.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.44 -21.29 28.81 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.901 0.48 . . . . 0.0 111.414 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -68.92 -53.93 18.27 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 121.791 0.805 . . . . 0.0 109.328 171.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' HE2' ' A' ' 103' ' ' PHE . 86.3 mt -72.8 -19.35 61.36 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.109 -1.405 . . . . 0.0 112.407 177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 59.63 23.47 12.24 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 124.597 1.159 . . . . 0.0 112.005 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.6 m -109.09 148.96 39.02 Favored Pre-proline 0 C--O 1.244 0.773 0 C-N-CA 124.389 1.076 . . . . 0.0 109.636 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -59.1 153.29 53.21 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.381 2.054 . . . . 0.0 111.3 173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.426 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -57.77 -44.67 86.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.411 0.685 . . . . 0.0 110.894 -174.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -53.82 -40.19 66.18 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.658 0.783 . . . . 0.0 112.481 177.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.87 76.64 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.479 0.711 . . . . 0.0 111.547 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.3 pt -105.91 3.21 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.821 0.848 . . . . 0.0 111.571 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.82 126.27 29.3 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 122.862 0.465 . . . . 0.0 110.121 -169.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.567 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 27.8 t -61.21 117.39 26.08 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 124.039 0.837 . . . . 0.0 110.556 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.81 3.87 5.13 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.752 2.302 . . . . 0.0 112.673 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.425 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.2 mt -94.69 -52.48 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.812 0.845 . . . . 0.0 109.105 172.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 41.8 p -103.78 9.11 37.16 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 44.82 29.59 0.46 Allowed 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 125.997 1.719 . . . . 0.0 114.289 177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.06 176.73 9.71 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.17 0.588 . . . . 0.0 110.419 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HB2' HD21 ' A' ' 114' ' ' LEU . 21.9 tt0 -62.2 120.19 56.05 Favored Pre-proline 0 C--N 1.357 0.893 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 170.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.567 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 54.5 Cg_exo -52.46 -46.52 32.53 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.234 1.956 . . . . 0.0 113.255 173.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 76.67 -46.87 0.52 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.477 1.511 . . . . 0.0 109.453 -169.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.8 mmtm -132.91 112.98 12.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.843 -1.91 . . . . 0.0 105.843 171.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.13 -175.28 17.11 Favored Glycine 0 CA--C 1.502 -0.722 0 N-CA-C 111.959 -0.456 . . . . 0.0 111.959 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 tt -148.55 137.46 15.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.936 0 CA-C-N 116.929 0.364 . . . . 0.0 110.528 -173.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.576 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 17.4 m-85 -75.9 109.99 9.98 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.912 0.885 . . . . 0.0 110.675 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.02 141.7 45.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.051 0.94 . . . . 0.0 108.579 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.585 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 30.3 mmtm -50.77 141.41 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.162 0.985 . . . . 0.0 112.391 174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 14.9 t30 -62.88 -45.7 91.33 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 162.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 p -146.47 146.55 30.59 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.482 1.113 . . . . 0.0 109.083 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -60.76 -58.46 8.36 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.209 1.004 . . . . 0.0 111.739 -172.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.01 38.38 3.22 Favored Glycine 0 C--N 1.344 1.009 0 CA-C-N 116.196 -0.456 . . . . 0.0 113.702 -173.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 58.5 m -148.93 139.99 23.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.045 0.938 . . . . 0.0 108.565 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -76.86 19.86 0.27 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.819 0.847 . . . . 0.0 112.895 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.8 p -90.66 116.21 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.642 0.734 . . . . 0.0 110.004 174.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -103.21 161.94 13.39 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.718 1.207 . . . . 0.0 109.49 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.437 HG21 HD11 ' A' ' 161' ' ' LEU . 29.4 m -146.67 142.63 28.08 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.477 0.711 . . . . 0.0 109.287 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 16.3 tp -94.5 119.82 33.79 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.342 0.591 . . . . 0.0 109.554 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -108.81 172.28 6.94 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.331 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.0 t70 -82.82 141.91 31.93 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 167.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.413 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -68.64 -47.93 65.35 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.076 0.55 . . . . 0.0 111.042 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.03 -31.66 68.2 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 120.949 0.404 . . . . 0.0 111.254 -176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.55 -41.02 40.51 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.984 0.913 . . . . 0.0 111.274 -177.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 153' ' ' VAL . 31.6 t80 -74.31 -39.99 62.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.616 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.41 -44.24 91.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.737 0.415 . . . . 0.0 111.406 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 5.8 ptm180 -62.88 -43.4 98.91 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.46 -48.28 74.75 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.062 1.345 . . . . 0.0 111.568 -176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 149' ' ' PHE . 42.5 t -59.26 -47.51 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.845 174.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.76 73.44 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.616 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 15.9 mm-40 -70.44 -27.6 64.39 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.264 0.626 . . . . 0.0 109.776 173.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.19 17.72 49.41 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.901 -170.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.97 146.45 48.87 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.961 0.904 . . . . 0.0 109.683 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.06 -171.91 1.01 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.538 2.159 . . . . 0.0 111.184 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -63.1 134.58 95.86 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-O 119.152 -0.452 . . . . 0.0 111.485 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.45 -35.88 86.37 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 123.279 2.652 . . . . 0.0 113.636 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.437 HD11 HG21 ' A' ' 142' ' ' THR . 38.4 mt -92.05 -58.56 2.36 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.008 -172.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -103.12 -16.21 15.81 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -170.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? 65.06 32.55 10.28 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.397 1.079 . . . . 0.0 111.895 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.496 ' H ' HG23 ' A' ' 162' ' ' THR . 18.1 mm-40 -81.91 159.76 65.11 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.117 0.967 . . . . 0.0 110.302 169.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.56 111.07 1.39 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.382 2.055 . . . . 0.0 111.206 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.542 HG21 HG22 ' A' ' 153' ' ' VAL . 89.7 mt -64.08 121.68 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 122.956 0.503 . . . . 0.0 109.694 176.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 170' ' ' ILE . 2.0 t -125.28 164.38 20.46 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.652 1.181 . . . . 0.0 108.831 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.81 -23.76 64.31 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.942 0.497 . . . . 0.0 110.562 174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.2 t -64.12 -42.14 96.97 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.262 1.025 . . . . 0.0 112.59 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.585 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.4 pt -69.12 -21.89 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 117.892 0.315 . . . . 0.0 111.148 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 60.7 mt -72.52 114.92 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' CG2' ' SG ' ' A' ' 177' ' ' CYS . 9.3 m -112.43 179.77 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 124.291 1.036 . . . . 0.0 111.297 -169.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -82.66 167.43 18.26 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.664 0.745 . . . . 0.0 111.799 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -68.42 -38.16 80.98 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.364 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -60.48 -37.4 80.94 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.751 1.221 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.31 -60.89 2.79 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 124.652 1.22 . . . . 0.0 111.791 174.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.576 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 58.1 m -84.54 110.4 18.67 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.037 0.38 . . . . 0.0 110.556 -168.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.27 124.62 70.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.692 -174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -63.34 110.01 1.77 Allowed 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 120.938 0.399 . . . . 0.0 109.99 177.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.69 121.15 41.5 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.78 -38.39 86.45 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.845 0.858 . . . . 0.0 112.218 -177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -65.65 -31.84 73.09 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.291 0.636 . . . . 0.0 111.088 -178.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 46.1 mmm-85 -86.67 -32.79 20.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.493 0.717 . . . . 0.0 110.488 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.63 72.67 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 123.615 0.572 . . . . 0.0 112.369 -173.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.414 ' ND2' HG23 ' A' ' 140' ' ' VAL . 10.0 t30 -159.18 159.4 34.27 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.282 0.633 . . . . 0.0 110.973 -168.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -71.75 125.77 27.99 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.046 0.938 . . . . 0.0 110.993 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.8 mm -117.65 151.01 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.082 0.953 . . . . 0.0 108.709 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.43 HG13 ' HE3' ' A' ' 133' ' ' LYS . 36.8 mm -82.16 139.33 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.609 0.764 . . . . 0.0 111.941 -173.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -153.26 78.5 1.16 Allowed 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 -177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -89.09 -61.9 1.38 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.67 -176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.332 -0.842 . . . . 0.0 108.8 -178.849 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -61.51 -39.32 90.56 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.797 0.685 . . . . 0.0 110.226 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.5 -37.27 80.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.831 0.852 . . . . 0.0 110.889 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.7 t -68.74 -40.56 79.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.115 0.566 . . . . 0.0 109.811 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.768 HG21 HG11 ' A' ' 153' ' ' VAL . 64.2 mt -64.75 -48.36 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.289 -0.868 . . . . 0.0 109.94 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -62.39 -45.41 93.24 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.837 0.855 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 18.3 m-80 -58.89 -41.03 86.2 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.081 0.552 . . . . 0.0 110.526 175.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.466 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -56.87 -56.94 15.23 Favored 'General case' 0 C--O 1.209 -1.077 0 O-C-N 123.951 0.782 . . . . 0.0 109.523 178.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.487 HG23 HG21 ' A' ' 130' ' ' ILE . 42.0 mt -65.36 -20.23 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.292 -174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.2 m -74.15 -43.06 58.85 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.133 0.573 . . . . 0.0 112.329 176.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.8 pt20 -110.47 -38.09 5.31 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -172.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 94.9 m -67.31 -12.91 61.35 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.192 0.997 . . . . 0.0 112.558 175.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.61 170.03 3.52 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.1 0.476 . . . . 0.0 111.199 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -155.52 160.09 40.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.829 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.7 p -70.81 95.55 1.15 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.137 0.575 . . . . 0.0 111.156 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.49 91.79 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.248 1.01 0 C-N-CA 123.685 0.794 . . . . 0.0 110.629 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m -127.14 135.38 27.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.484 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.82 -20.13 58.67 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.105 2.536 . . . . 0.0 112.744 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.03 -39.35 72.39 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.357 0.663 . . . . 0.0 110.783 173.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mmt-85 -76.62 -54.15 7.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.515 0.726 . . . . 0.0 110.159 -176.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 90.5 mt -70.76 -20.61 62.61 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.997 -1.002 . . . . 0.0 112.307 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 58.92 21.55 9.3 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.367 1.067 . . . . 0.0 112.078 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.7 m -112.65 149.79 41.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.67 1.188 . . . . 0.0 108.455 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.23 157.74 24.72 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.693 2.262 . . . . 0.0 112.442 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -56.22 -50.02 72.44 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.019 0.927 . . . . 0.0 110.147 -174.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 33.2 mt-10 -60.4 -34.61 74.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.511 0.724 . . . . 0.0 112.182 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.65 -36.62 84.84 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.186 0.594 . . . . 0.0 111.099 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 34.2 pt -103.97 7.11 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 123.531 0.732 . . . . 0.0 111.252 -175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 7.4 tt0 -69.82 138.65 52.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.704 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -71.21 120.24 78.39 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 171.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.69 -24.66 47.42 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 0.0 112.382 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.464 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 67.6 mt -72.3 -48.87 46.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 123.546 0.738 . . . . 0.0 110.189 -177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 56.9 p -100.83 3.13 41.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.053 0.541 . . . . 0.0 112.005 -175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.85 28.66 0.25 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.402 1.881 . . . . 0.0 113.944 -175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.49 175.66 10.17 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.114 0.566 . . . . 0.0 110.132 -176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.408 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.1 tt0 -58.66 122.3 60.08 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 123.366 0.666 . . . . 0.0 109.781 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.549 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 50.3 Cg_exo -53.98 -46.71 31.64 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 122.424 2.083 . . . . 0.0 113.651 172.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 75.42 -47.97 0.61 Allowed 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 124.92 1.288 . . . . 0.0 109.923 -170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm -130.75 112.96 13.55 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.626 1.97 . . . . 0.0 105.722 169.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.0 -175.3 16.99 Favored Glycine 0 CA--C 1.501 -0.803 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.487 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -151.12 140.47 15.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -173.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.47 ' HD2' ' HA ' ' A' ' 174' ' ' HIS . 40.4 m-85 -81.11 122.38 27.28 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.805 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.5 t -135.45 138.69 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.852 1.261 . . . . 0.0 108.189 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 33.4 mmtm -55.7 139.98 43.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.194 0.998 . . . . 0.0 112.244 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.84 -48.2 72.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 168.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.1 p -136.72 139.62 42.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.724 1.21 . . . . 0.0 108.997 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.76 -45.6 91.75 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.729 1.212 . . . . 0.0 112.788 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -88.97 16.46 55.32 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.659 -173.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.6 m -134.3 151.52 51.3 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.375 0.67 . . . . 0.0 109.966 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -75.84 -3.86 37.51 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.721 0.808 . . . . 0.0 112.775 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.402 HG23 ' ND2' ' A' ' 185' ' ' ASN . 3.4 p -68.05 107.46 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.9 t -103.24 147.49 26.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.98 0.912 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.544 HG21 HD11 ' A' ' 161' ' ' LEU . 26.8 m -135.79 139.51 43.56 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.552 0.741 . . . . 0.0 109.904 -177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 14.4 tp -93.42 121.03 34.4 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.21 0.604 . . . . 0.0 109.734 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -113.46 163.12 15.31 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.154 0.981 . . . . 0.0 108.814 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 21.4 t70 -73.74 133.37 43.3 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -62.53 -42.78 99.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.303 0.641 . . . . 0.0 111.698 -173.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.03 -43.88 61.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.526 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.509 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -69.57 -35.11 75.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.919 0.887 . . . . 0.0 111.692 -175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 153' ' ' VAL . 49.3 t80 -77.15 -42.98 35.6 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.025 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.6 t -61.33 -43.11 99.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.74 0.416 . . . . 0.0 111.838 -178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 15.1 ptm180 -66.48 -38.22 86.81 Favored 'General case' 0 C--O 1.217 -0.63 0 O-C-N 123.37 0.419 . . . . 0.0 110.337 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.6 tt -56.29 -47.02 79.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.098 0.959 . . . . 0.0 110.461 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.768 HG11 HG21 ' A' ' 94' ' ' ILE . 4.8 t -66.99 -40.28 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.369 177.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.28 -26.43 72.6 Favored Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.925 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 17.5 mm-40 -77.11 -15.38 59.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.803 0.841 . . . . 0.0 110.751 174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 82.64 18.36 66.14 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.367 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 90.7 mt -81.98 143.38 49.52 Favored Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 123.767 0.827 . . . . 0.0 109.603 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.31 179.7 4.31 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.82 2.346 . . . . 0.0 111.682 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -61.38 127.52 88.44 Favored Pre-proline 0 CA--C 1.55 0.977 0 CA-C-O 119.098 -0.477 . . . . 0.0 110.555 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -55.19 -32.32 79.8 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 123.112 2.542 . . . . 0.0 112.971 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 HG21 ' A' ' 142' ' ' THR . 48.9 mt -83.82 -54.7 4.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.456 -173.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 164' ' ' GLU . 14.9 t -130.04 3.63 4.84 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -169.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 66.05 28.01 10.48 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 124.262 1.025 . . . . 0.0 113.09 169.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 162' ' ' THR . 76.1 mt-10 -76.36 145.11 75.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 168.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.85 110.96 1.24 Allowed 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.452 2.102 . . . . 0.0 110.865 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.486 HG23 HD11 ' A' ' 170' ' ' ILE . 93.3 mt -59.29 130.59 22.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 123.434 0.694 . . . . 0.0 111.069 -176.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.9 t -139.0 169.53 17.62 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.421 1.089 . . . . 0.0 109.587 -173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.466 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -70.42 -25.62 63.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.567 0.747 . . . . 0.0 110.632 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.6 t -65.64 -30.08 70.74 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.354 1.062 . . . . 0.0 112.656 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.486 HD11 HG23 ' A' ' 166' ' ' ILE . 37.8 pt -84.79 -25.22 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 117.676 0.216 . . . . 0.0 111.348 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 94' ' ' ILE . 75.7 mt -69.76 118.56 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.46 HG21 ' SG ' ' A' ' 177' ' ' CYS . 18.7 m -114.45 169.14 5.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.001 0.921 . . . . 0.0 110.812 -176.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -77.95 156.79 30.02 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 123.953 0.901 . . . . 0.0 110.715 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 17.0 t-80 -62.65 -36.19 82.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.648 171.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -61.24 -34.3 74.91 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.759 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 44.8 mt-10 -64.59 -56.28 14.92 Favored 'General case' 0 C--N 1.351 0.653 0 C-N-CA 123.994 0.918 . . . . 0.0 111.962 176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' A' ' 172' ' ' VAL . 57.2 m -89.4 112.01 23.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -166.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 49.0 pt -123.74 132.18 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -174.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.58 108.16 3.22 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 -174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -101.2 107.79 19.28 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -66.76 -33.27 75.26 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.574 0.75 . . . . 0.0 111.761 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 7.3 m -66.02 -36.9 84.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.27 0.628 . . . . 0.0 110.912 178.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -76.53 -30.43 57.13 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.467 0.707 . . . . 0.0 109.847 171.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.77 17.21 75.71 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.814 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' A' ' 140' ' ' VAL . 66.7 t30 -161.48 168.36 23.84 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 111.071 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.425 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 71.0 m-85 -76.31 129.52 36.77 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.689 1.196 . . . . 0.0 111.244 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.7 mm -112.8 145.14 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.335 1.054 . . . . 0.0 108.958 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.27 139.13 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 123.754 0.822 . . . . 0.0 111.375 -175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.0 OUTLIER -157.16 94.9 1.44 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -174.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 130.27 115.68 1.78 Allowed Glycine 0 N--CA 1.467 0.766 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.561 1.377 0 C-N-CA 123.271 0.628 . . . . 0.0 110.318 177.462 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.24 0.596 0 CA-C-O 119.243 -0.408 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.487 ' HG3' HG12 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -57.12 -45.14 83.73 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.599 0.76 . . . . 0.0 112.013 -171.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -51.77 -51.91 52.74 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.527 0.731 . . . . 0.0 112.423 -172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.0 m -67.94 -32.05 72.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.132 0.573 . . . . 0.0 110.759 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.585 HG23 HD11 ' A' ' 171' ' ' ILE . 69.5 mt -72.9 -47.83 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.248 -178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.9 mm-40 -61.0 -47.28 87.17 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.093 0.957 . . . . 0.0 110.299 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -60.88 -38.65 86.37 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.835 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -57.83 -54.44 46.87 Favored 'General case' 0 C--O 1.195 -1.793 0 O-C-N 123.898 0.749 . . . . 0.0 109.946 172.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' HA ' HD12 ' A' ' 130' ' ' ILE . 74.9 mt -62.29 -17.48 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 123.388 0.675 . . . . 0.0 111.218 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 54.8 m -79.18 -47.35 16.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.999 0.52 . . . . 0.0 111.064 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.99 -23.92 14.43 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 -172.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.8 t -90.45 -11.78 39.34 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.716 1.206 . . . . 0.0 110.642 -176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 9.3 ptpp? -66.79 168.81 8.97 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-O 121.313 0.578 . . . . 0.0 110.839 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -159.42 163.21 35.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.688 0.795 . . . . 0.0 109.062 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.525 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.3 m -72.09 97.34 1.9 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.16 0.505 . . . . 0.0 110.214 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 93.6 t -75.85 98.64 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.241 177.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 56.0 m -135.05 132.45 20.28 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 114.293 -1.322 . . . . 0.0 108.536 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.34 -41.5 12.14 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.21 2.607 . . . . 0.0 114.095 -165.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.47 -28.81 61.19 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.27 0.628 . . . . 0.0 111.48 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -75.52 -41.03 56.16 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.474 0.709 . . . . 0.0 110.686 175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.73 -3.09 52.84 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 62.17 11.67 4.55 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.74 0.816 . . . . 0.0 112.478 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 65.0 m -126.79 138.53 32.77 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.718 0.807 . . . . 0.0 109.283 -170.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.34 170.04 5.75 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.28 2.654 . . . . 0.0 112.823 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -52.0 67.5 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.378 -173.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -56.34 -36.43 68.75 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.005 0.922 . . . . 0.0 112.792 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.36 -34.33 77.72 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.37 0.668 . . . . 0.0 111.573 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 43.3 pt -104.83 2.28 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.139 -176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -72.51 133.41 44.77 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 122.977 0.511 . . . . 0.0 110.506 -167.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.547 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 32.6 t -67.62 117.69 50.06 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 124.014 0.821 . . . . 0.0 109.679 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.27 -32.28 95.57 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.968 2.446 . . . . 0.0 112.926 177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 52.0 mt -68.01 -53.68 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.83 0.852 . . . . 0.0 110.068 -175.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.8 p -97.38 1.73 49.67 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.281 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.63 29.54 0.66 Allowed 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 126.246 1.819 . . . . 0.0 113.804 -177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -146.05 174.03 11.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.351 0.66 . . . . 0.0 109.931 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -59.32 122.58 64.85 Favored Pre-proline 0 C--N 1.353 0.737 0 C-N-CA 123.453 0.701 . . . . 0.0 109.301 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.552 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 76.4 Cg_exo -51.66 -47.37 26.62 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.278 1.985 . . . . 0.0 113.238 172.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 76.22 -48.68 0.58 Allowed 'General case' 0 C--N 1.376 1.741 0 C-N-CA 124.557 1.143 . . . . 0.0 109.647 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.525 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.3 mmtm -134.25 106.11 6.97 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 168.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.14 -172.21 12.51 Favored Glycine 0 CA--C 1.5 -0.884 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.5 tt -147.53 138.25 17.5 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 C-N-CA 122.6 0.36 . . . . 0.0 110.373 -172.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.53 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.6 m-85 -73.93 116.99 15.19 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.539 174.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.7 t -134.44 131.87 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 136' ' ' ASP . 3.8 mmmm -59.37 133.15 55.83 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.137 0.975 . . . . 0.0 110.9 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.456 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 39.7 t30 -64.53 -48.01 76.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 167.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.43 ' H ' HG13 ' A' ' 140' ' ' VAL . 51.3 m -144.77 117.86 8.88 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 172.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.594 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 20.0 t70 -71.62 -28.87 64.09 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.979 0.511 . . . . 0.0 111.944 -171.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.94 -22.85 67.04 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.228 0.33 . . . . 0.0 112.901 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.8 m -110.5 163.26 13.87 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.471 1.109 . . . . 0.0 110.253 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -83.76 50.13 1.75 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.446 0.698 . . . . 0.0 111.104 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.689 ' HA ' HD21 ' A' ' 185' ' ' ASN . 7.4 p -123.44 104.34 14.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 CA-C-O 122.061 0.934 . . . . 0.0 110.295 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -109.87 133.55 53.03 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.916 174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.502 HG21 HD11 ' A' ' 161' ' ' LEU . 8.1 m -118.61 144.25 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.7 tp -96.89 121.81 39.17 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -114.32 172.41 7.03 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.29 1.036 . . . . 0.0 109.523 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.552 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.5 t70 -82.39 141.72 32.56 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 170.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.98 -47.29 72.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.146 0.578 . . . . 0.0 111.193 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.29 -33.38 65.18 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 122.792 0.437 . . . . 0.0 111.333 -176.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.58 -40.63 56.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.873 0.869 . . . . 0.0 111.325 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 153' ' ' VAL . 34.8 t80 -74.43 -39.59 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.679 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.459 ' HB2' HG21 ' A' ' 98' ' ' ILE . 22.4 t -65.61 -40.98 93.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.78 0.432 . . . . 0.0 111.416 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -69.49 -35.88 75.99 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.8 tt -59.68 -48.43 81.71 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.472 1.109 . . . . 0.0 110.284 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 166' ' ' ILE . 60.4 t -63.82 -41.01 91.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.433 175.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.68 -24.85 72.81 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.732 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.58 -20.72 49.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.666 0.786 . . . . 0.0 111.095 173.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.38 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 116.335 -0.393 . . . . 0.0 112.779 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.64 152.93 55.11 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 123.551 0.74 . . . . 0.0 110.083 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.15 -175.25 2.29 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.619 2.213 . . . . 0.0 111.426 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.456 ' CE1' ' HA ' ' A' ' 134' ' ' ASN . 34.3 t-80 -61.4 129.9 91.39 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.175 -0.441 . . . . 0.0 110.609 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.53 -35.39 96.82 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.882 2.388 . . . . 0.0 112.887 -176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.502 HD11 HG21 ' A' ' 142' ' ' THR . 42.9 mt -88.49 -66.22 0.94 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.909 -174.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 12.8 t -103.66 -2.78 26.02 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -168.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 68.85 16.45 8.85 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.14 0.976 . . . . 0.0 112.701 174.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -71.22 157.78 89.44 Favored Pre-proline 0 N--CA 1.48 1.066 0 C-N-CA 123.471 0.708 . . . . 0.0 111.363 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -65.85 111.36 1.92 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.245 1.963 . . . . 0.0 111.442 177.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 153' ' ' VAL . 85.4 mt -67.91 120.11 14.74 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 CA-C-O 120.988 0.423 . . . . 0.0 110.037 176.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -138.44 171.22 14.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.547 1.139 . . . . 0.0 109.232 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.562 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.44 -21.83 65.53 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.207 0.603 . . . . 0.0 111.39 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.5 t -60.63 -41.82 95.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.861 0.864 . . . . 0.0 111.93 177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.583 HG22 ' HB2' ' A' ' 136' ' ' ASP . 46.8 pt -77.16 -21.34 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 117.502 0.137 . . . . 0.0 111.358 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.585 HD11 HG23 ' A' ' 94' ' ' ILE . 59.5 mt -68.81 122.47 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.919 -0.488 . . . . 0.0 110.328 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.29 174.01 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.885 0.874 . . . . 0.0 112.31 -175.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -105.07 -174.3 2.5 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.702 0.801 . . . . 0.0 112.345 -173.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -72.54 -25.91 61.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.229 1.012 . . . . 0.0 111.343 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 189' ' ' LYS . 32.8 tt0 -66.62 -48.91 67.99 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.463 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.9 mm-40 -52.09 -68.04 0.2 Allowed 'General case' 0 C--O 1.213 -0.849 0 O-C-N 124.606 1.191 . . . . 0.0 110.749 173.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.9 m -90.05 116.93 28.46 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 122.889 0.476 . . . . 0.0 112.02 -166.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.3 pt -128.95 121.78 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 123.526 0.73 . . . . 0.0 109.499 174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.525 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 48.4 t80 -68.29 114.54 6.84 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.222 0.534 . . . . 0.0 111.063 -176.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -107.99 122.48 46.93 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.9 -43.66 95.32 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.054 0.941 . . . . 0.0 112.748 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 95.7 m -58.98 -38.74 79.82 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.121 0.568 . . . . 0.0 111.419 -177.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -85.74 -29.32 23.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.299 0.64 . . . . 0.0 110.481 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.32 27.5 67.86 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.121 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.689 HD21 ' HA ' ' A' ' 140' ' ' VAL . 21.2 t30 -153.88 156.5 37.68 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.906 0.882 . . . . 0.0 109.969 -169.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.407 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 84.7 m-85 -78.64 122.58 26.13 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.802 0.841 . . . . 0.0 109.756 172.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 26.6 mm -99.79 145.39 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.563 1.145 . . . . 0.0 108.562 -172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 40.0 mm -88.59 126.45 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.342 0.657 . . . . 0.0 112.75 -168.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 175' ' ' GLU . 73.3 mmtt -123.76 117.4 24.84 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.797 1.239 . . . . 0.0 108.571 173.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 169.82 -31.5 0.16 Allowed Glycine 0 N--CA 1.463 0.438 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.558 1.253 0 C-N-CA 124.595 1.158 . . . . 0.0 110.241 172.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.543 ' HG3' HG12 ' A' ' 153' ' ' VAL . 2.3 mp0 -51.61 -46.61 63.66 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -168.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -54.68 -49.42 70.69 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.834 0.454 . . . . 0.0 111.402 -174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.9 m -68.25 -33.39 74.28 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.244 0.617 . . . . 0.0 111.251 -177.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.591 HG23 HD11 ' A' ' 171' ' ' ILE . 80.1 mt -71.81 -43.73 68.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.597 0.759 . . . . 0.0 110.336 -178.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 33.1 mm-40 -57.86 -48.29 80.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.943 0.897 . . . . 0.0 111.452 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.538 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 57.4 m-80 -61.77 -40.77 96.33 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.632 0.582 . . . . 0.0 110.262 177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.493 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 2.4 tppt? -56.17 -56.76 17.01 Favored 'General case' 0 C--O 1.204 -1.297 0 O-C-N 124.105 0.878 . . . . 0.0 110.805 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.9 mt -64.24 -22.36 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.932 -175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.6 m -72.06 -47.42 51.73 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.278 0.631 . . . . 0.0 112.593 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.538 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 24.4 pt20 -103.41 -31.23 10.11 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -170.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.9 m -78.29 -15.26 58.92 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.65 1.18 . . . . 0.0 111.906 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -62.07 171.91 1.59 Allowed 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 121.542 0.686 . . . . 0.0 111.572 175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -156.81 161.72 39.74 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.533 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 20.7 m -70.11 98.68 1.36 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 121.416 0.627 . . . . 0.0 111.094 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG12 HD12 ' A' ' 117' ' ' ILE . 99.9 t -84.11 91.72 2.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.645 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 35.8 m -129.7 135.07 26.95 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.98 -45.05 8.64 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 123.382 2.721 . . . . 0.0 113.853 -164.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.52 -29.24 62.35 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.044 0.537 . . . . 0.0 111.171 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.6 mmp_? -67.1 -54.13 24.31 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.234 0.54 . . . . 0.0 110.053 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.19 -17.34 64.79 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.275 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 63.64 18.55 11.18 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.444 1.498 . . . . 0.0 111.892 -178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 55.7 m -113.55 141.88 26.69 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.443 1.097 . . . . 0.0 108.097 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.1 Cg_endo -57.76 164.83 7.18 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.489 2.126 . . . . 0.0 112.602 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.6 OUTLIER -59.02 -49.16 78.95 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.247 0.619 . . . . 0.0 110.628 -176.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -55.94 -36.35 67.67 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.485 0.714 . . . . 0.0 112.149 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -60.88 -41.36 95.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.613 0.765 . . . . 0.0 111.201 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 105' ' ' VAL . 32.1 pt -101.7 1.3 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.322 -173.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -69.38 128.94 38.34 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.048 0.539 . . . . 0.0 110.626 -166.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.475 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 23.0 t -64.4 122.8 80.25 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.5 0.5 . . . . 0.0 109.842 175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -69.57 -17.37 38.46 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 122.452 2.101 . . . . 0.0 113.042 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 24.1 mt -83.06 -47.49 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.461 0.704 . . . . 0.0 110.007 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p -102.46 2.77 36.9 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.91 33.8 0.81 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.902 1.681 . . . . 0.0 113.674 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -147.18 176.86 9.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.986 0.514 . . . . 0.0 110.253 -174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.527 ' HB2' HD21 ' A' ' 114' ' ' LEU . 23.5 tt0 -63.89 120.8 66.79 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.584 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 72.2 Cg_exo -53.4 -45.04 43.94 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.327 2.018 . . . . 0.0 113.817 171.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 75.55 -49.44 0.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 125.651 1.58 . . . . 0.0 109.679 -169.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.1 mmtm -131.75 114.81 15.19 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -145.2 -169.67 13.7 Favored Glycine 0 CA--C 1.499 -0.961 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 98' ' ' ILE . 16.0 tt -152.31 138.15 11.62 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-O 120.822 0.344 . . . . 0.0 110.223 -171.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.537 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.6 m-85 -75.01 114.58 13.65 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.268 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.1 t -132.1 138.2 53.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 9.2 mmtp -54.75 136.05 46.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.358 1.063 . . . . 0.0 112.794 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.499 ' HB3' HG13 ' A' ' 140' ' ' VAL . 5.5 t30 -59.41 -45.35 91.76 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.304 166.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 31.9 m -140.89 152.8 45.35 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.911 0.885 . . . . 0.0 109.833 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.508 ' HA ' HG22 ' A' ' 170' ' ' ILE . 16.0 t70 -63.24 -51.79 64.77 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.907 0.883 . . . . 0.0 112.344 -168.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -84.37 -37.73 10.64 Favored Glycine 0 N--CA 1.469 0.854 0 CA-C-N 116.568 -0.287 . . . . 0.0 113.154 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 15.8 m -67.2 133.52 49.93 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.026 0.931 . . . . 0.0 111.456 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.22 2.89 5.21 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.361 1.065 . . . . 0.0 113.347 -173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.499 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.5 p -76.31 113.02 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-O 121.499 0.666 . . . . 0.0 110.842 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.9 t -97.98 150.88 20.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.2 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.444 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -137.74 139.56 40.19 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 0.0 109.495 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.9 tp -92.0 122.75 34.8 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.284 0.564 . . . . 0.0 109.992 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -110.63 170.51 8.04 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.049 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.584 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 25.1 t70 -83.13 138.2 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.8 -47.77 76.86 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.55 0.531 . . . . 0.0 110.935 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.99 -35.06 71.95 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 123.399 0.437 . . . . 0.0 111.451 -175.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.07 -45.12 35.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.835 0.854 . . . . 0.0 111.373 -174.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -69.94 -38.67 76.23 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.804 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.1 t -64.55 -46.43 82.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 122.706 0.403 . . . . 0.0 111.444 -179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -68.72 -29.67 68.14 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.134 0.173 . . . . 0.0 110.999 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.1 tt -61.63 -47.83 83.62 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.938 0.895 . . . . 0.0 110.248 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 149' ' ' PHE . 48.5 t -64.63 -41.25 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.269 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.48 -33.21 83.93 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.781 0.676 . . . . 0.0 113.22 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -62.82 -38.75 91.98 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.334 0.653 . . . . 0.0 110.87 172.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.21 34.97 5.18 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 -172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.99 149.99 38.52 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 123.627 0.771 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.13 -176.96 1.47 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.66 2.24 . . . . 0.0 111.756 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -64.55 131.43 95.1 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.094 -177.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.98 -33.84 90.42 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.258 2.639 . . . . 0.0 113.419 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 142' ' ' THR . 52.1 mt -89.47 -54.43 4.09 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.072 0.549 . . . . 0.0 112.223 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 164' ' ' GLU . 14.5 t -113.83 -11.76 12.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -167.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? 65.39 29.67 11.3 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.297 1.039 . . . . 0.0 112.289 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 162' ' ' THR . 18.7 mm-40 -83.58 163.9 47.44 Favored Pre-proline 0 N--CA 1.482 1.142 0 C-N-CA 123.506 0.723 . . . . 0.0 110.809 170.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.41 114.88 2.08 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.482 2.121 . . . . 0.0 111.98 171.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.525 HG21 HG22 ' A' ' 153' ' ' VAL . 73.2 mt -69.54 122.92 22.06 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -138.93 168.33 20.07 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.155 0.982 . . . . 0.0 109.323 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.493 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -68.38 -26.03 65.36 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.055 0.542 . . . . 0.0 110.575 174.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.3 t -64.76 -36.9 85.79 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.867 0.867 . . . . 0.0 111.941 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 46.8 pt -77.57 -23.85 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 122.124 0.169 . . . . 0.0 111.317 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.591 HD11 HG23 ' A' ' 94' ' ' ILE . 68.3 mt -70.95 114.31 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.34 165.29 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.46 0.704 . . . . 0.0 110.466 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.673 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 29.2 mtpt -67.18 174.15 3.37 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.371 1.069 . . . . 0.0 113.199 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.492 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.3 t-80 -63.3 -34.31 77.42 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.777 169.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 6.7 mp0 -75.55 -39.41 58.29 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.175 0.99 . . . . 0.0 110.831 -176.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.673 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 43.3 mm-40 -66.24 11.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 -175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 61.2 m -151.14 114.02 4.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 120.21 1.368 . . . . 0.0 109.08 -176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.7 pt -128.53 123.59 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.672 0.789 . . . . 0.0 108.893 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -67.17 106.38 1.99 Allowed 'General case' 0 C--N 1.349 0.579 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -86.76 125.27 33.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -67.29 -36.02 80.67 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.694 . . . . 0.0 111.855 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 20.8 m -71.17 -37.45 72.19 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 122.918 0.487 . . . . 0.0 111.218 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -86.87 -31.49 20.75 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.194 0.598 . . . . 0.0 110.431 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.28 33.13 45.35 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.313 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.478 ' ND2' HG23 ' A' ' 140' ' ' VAL . 9.8 t30 -169.17 158.68 8.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 122.979 0.512 . . . . 0.0 111.594 -173.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 93.3 m-85 -70.96 127.72 33.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 124.389 1.076 . . . . 0.0 111.2 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 24.7 mm -115.55 152.67 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 124.052 0.941 . . . . 0.0 108.774 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 44.0 mm -63.4 121.64 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.214 0.53 . . . . 0.0 112.374 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 5.4 tmtm? -119.21 87.65 2.78 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -103.65 -26.3 6.88 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.316 -0.856 . . . . 0.0 112.246 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 45.9 t30 . . . . . 0 C--O 1.249 1.03 0 C-N-CA 124.137 0.975 . . . . 0.0 109.356 -179.183 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.478 0.943 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -52.5 -44.37 65.62 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.448 1.099 . . . . 0.0 111.839 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.27 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 123.609 0.568 . . . . 0.0 111.311 -177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.409 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 33.9 t -74.55 -38.85 62.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.238 0.615 . . . . 0.0 109.792 -177.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.587 HG21 HG11 ' A' ' 153' ' ' VAL . 94.1 mt -60.89 -47.63 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.684 174.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 59.4 mm-40 -58.09 -43.59 87.16 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.342 1.057 . . . . 0.0 111.734 175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 79.5 m-20 -59.48 -42.5 92.21 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.452 0.701 . . . . 0.0 110.449 177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.3 OUTLIER -64.26 -47.07 80.99 Favored 'General case' 0 C--O 1.207 -1.152 0 O-C-N 123.691 0.62 . . . . 0.0 110.008 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.501 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.4 mt -67.27 -15.74 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-O 120.757 0.313 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.79 -42.36 11.96 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.783 0.833 . . . . 0.0 111.19 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.571 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.0 pt20 -99.1 -38.35 8.97 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.261 0.624 . . . . 0.0 112.632 -176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.1 t -78.54 -10.38 59.7 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.112 0.965 . . . . 0.0 111.746 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.416 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.1 ptpt -63.53 173.06 1.77 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.232 0.613 . . . . 0.0 111.649 172.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -165.06 165.62 19.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.238 0.615 . . . . 0.0 110.923 -177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 34.3 p -67.19 88.6 0.18 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.378 1.071 . . . . 0.0 112.4 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 129' ' ' GLY . 58.1 t -80.85 88.07 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-O 121.837 0.827 . . . . 0.0 109.659 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.446 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 37.2 m -130.53 142.75 46.62 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.35 -25.35 76.32 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.129 1.886 . . . . 0.0 111.58 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.24 -46.99 75.25 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.338 1.055 . . . . 0.0 111.103 174.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 85.2 mmt-85 -70.75 -55.51 8.45 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.867 -175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.26 -13.14 59.98 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.598 -1.183 . . . . 0.0 112.885 -174.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 61.73 16.49 7.89 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 124.168 0.987 . . . . 0.0 112.166 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.57 143.49 30.03 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.812 1.245 . . . . 0.0 108.281 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.99 171.94 8.02 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.507 2.138 . . . . 0.0 112.765 -177.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -58.79 -52.02 67.48 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.25 1.02 . . . . 0.0 111.252 -172.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -38.08 68.43 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.03 0.932 . . . . 0.0 112.633 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.95 71.05 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.612 0.765 . . . . 0.0 112.128 -177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 33.1 pt -115.07 9.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.885 0.874 . . . . 0.0 111.332 -174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.93 131.56 38.6 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.498 0.719 . . . . 0.0 111.185 -166.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.532 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -70.02 116.62 46.0 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.071 0.948 . . . . 0.0 111.053 177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -59.91 -22.27 67.98 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.36 2.707 . . . . 0.0 114.004 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.496 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 56.9 mt -71.58 -50.72 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.36 0.664 . . . . 0.0 110.036 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.2 p -104.3 -0.28 28.44 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.0 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 39.61 43.16 1.04 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 125.981 1.712 . . . . 0.0 113.186 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -155.08 175.82 13.34 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.798 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.473 ' HB2' HD21 ' A' ' 114' ' ' LEU . 26.6 tt0 -64.13 121.39 71.52 Favored Pre-proline 0 C--N 1.358 0.965 0 C-N-CA 123.484 0.714 . . . . 0.0 110.078 178.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.532 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 66.9 Cg_exo -54.68 -45.63 39.48 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.323 2.015 . . . . 0.0 114.234 170.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 75.23 -50.88 0.66 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 124.977 1.311 . . . . 0.0 109.477 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.426 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 13.0 mmmm -136.43 104.79 5.71 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.418 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -138.1 -173.1 12.8 Favored Glycine 0 CA--C 1.502 -0.779 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.5 tt -145.06 140.16 22.76 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 121.07 0.462 . . . . 0.0 110.997 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.594 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 14.5 m-85 -75.09 115.86 15.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.909 172.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.76 133.73 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 10.6 mmtm -56.05 148.37 17.83 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.954 0.902 . . . . 0.0 110.845 173.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -63.85 -50.08 70.24 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 166.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.5 p -142.65 152.07 42.08 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.611 0.764 . . . . 0.0 109.285 170.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -63.46 -52.94 59.26 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.833 0.853 . . . . 0.0 111.938 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.7 3.52 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 116.801 -0.181 . . . . 0.0 113.176 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 m -148.34 143.8 27.11 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.121 0.968 . . . . 0.0 109.124 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.45 36.45 0.59 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.84 0.856 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.87 116.62 49.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.81 0 C-N-CA 123.4 0.68 . . . . 0.0 109.808 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.9 t -107.06 157.5 17.78 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 123.67 0.788 . . . . 0.0 109.574 175.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.501 HG21 HD11 ' A' ' 161' ' ' LEU . 33.1 m -140.2 139.78 35.72 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.43 0.692 . . . . 0.0 109.449 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.5 tp -96.35 121.48 38.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.212 0.53 . . . . 0.0 109.64 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.88 173.65 6.37 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.218 1.007 . . . . 0.0 109.44 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 23.1 t70 -83.27 138.68 33.47 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 170.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.72 -46.05 73.3 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.411 0.444 . . . . 0.0 111.137 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.33 -37.46 77.72 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.719 0.408 . . . . 0.0 111.039 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.477 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.79 -37.58 48.49 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.849 0.86 . . . . 0.0 111.781 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 153' ' ' VAL . 44.3 t80 -72.89 -41.08 65.04 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.5 t -59.62 -51.27 70.53 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.659 0.784 . . . . 0.0 111.799 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 2.8 ptm180 -64.19 -35.18 79.95 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 123.263 0.352 . . . . 0.0 110.762 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.9 tt -56.93 -47.95 79.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.842 1.257 . . . . 0.0 110.559 176.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 94' ' ' ILE . 15.8 t -64.7 -37.02 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.243 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.42 -35.76 92.34 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.988 -178.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 34.5 mm-40 -73.5 -18.34 61.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.125 0.57 . . . . 0.0 110.984 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.01 38.64 34.9 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.498 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 77.8 mt -89.58 147.0 36.83 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.487 0.715 . . . . 0.0 109.714 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.02 163.31 25.99 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.619 2.212 . . . . 0.0 112.341 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.428 ' O ' ' HD3' ' A' ' 163' ' ' ARG . 54.1 t-80 -52.12 130.59 40.89 Favored Pre-proline 0 N--CA 1.481 1.111 0 C-N-CA 123.733 0.813 . . . . 0.0 111.149 -176.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -52.28 -31.02 44.74 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 123.42 2.747 . . . . 0.0 113.477 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 142' ' ' THR . 17.4 mt -95.3 -79.5 0.43 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.315 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.8 t -82.51 -11.26 58.59 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -167.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 159' ' ' HIS . 36.8 mmt180 69.1 21.23 7.37 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.645 1.178 . . . . 0.0 112.433 178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.455 ' H ' HG23 ' A' ' 162' ' ' THR . 27.9 mm-40 -73.08 160.13 83.57 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 123.404 0.681 . . . . 0.0 111.021 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.62 109.39 0.76 Allowed 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.468 2.112 . . . . 0.0 110.764 170.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.471 HG21 HG22 ' A' ' 153' ' ' VAL . 90.4 mt -60.31 123.71 13.35 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 C-N-CA 122.98 0.512 . . . . 0.0 109.941 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 170' ' ' ILE . 1.7 t -135.78 161.92 34.24 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.094 -172.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.526 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -64.17 -23.79 67.44 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.451 0.701 . . . . 0.0 110.746 172.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.8 t -64.91 -42.05 95.06 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.342 1.057 . . . . 0.0 111.768 179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.435 ' H ' HG23 ' A' ' 167' ' ' THR . 37.9 pt -75.66 -29.37 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-N 117.885 0.311 . . . . 0.0 110.394 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.577 HG21 ' HB3' ' A' ' 97' ' ' LYS . 73.1 mt -66.27 117.34 6.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.481 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 15.5 m -121.95 168.09 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.317 0.647 . . . . 0.0 111.601 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -85.03 -176.55 6.25 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.675 0.79 . . . . 0.0 111.944 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 46.7 t-80 -61.96 -48.12 81.79 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.635 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -54.67 -48.4 72.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 124.293 0.996 . . . . 0.0 110.987 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.481 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 16.0 mm-40 -43.0 -66.57 0.36 Allowed 'General case' 0 N--CA 1.467 0.418 0 O-C-N 125.544 1.778 . . . . 0.0 112.544 177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 8.8 m -90.85 109.55 20.76 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 122.879 0.472 . . . . 0.0 110.244 -168.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.9 pt -119.26 120.89 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -66.31 117.5 8.66 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.919 -0.488 . . . . 0.0 110.635 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -101.05 130.36 47.05 Favored 'General case' 0 C--O 1.243 0.743 0 O-C-N 124.099 0.874 . . . . 0.0 110.211 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.18 -39.06 78.93 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.098 1.359 . . . . 0.0 112.009 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 28.5 m -69.67 -37.53 76.73 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.314 0.646 . . . . 0.0 111.075 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 14.8 mmm-85 -87.78 -32.88 18.87 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.14 0.576 . . . . 0.0 111.794 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 70.85 34.25 65.92 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.969 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -161.65 159.72 27.83 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.884 0.474 . . . . 0.0 111.145 -174.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 89.5 m-85 -76.64 119.97 21.19 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.656 1.182 . . . . 0.0 111.246 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.8 mm -106.99 159.69 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 125.019 1.328 . . . . 0.0 108.27 -175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 32.4 mm -91.38 138.51 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -166.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -151.93 102.89 2.86 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.375 1.47 . . . . 0.0 108.559 -172.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -177.16 -55.14 0.07 OUTLIER Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.463 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.409 ' O ' HG13 ' A' ' 94' ' ' ILE . 15.7 m . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 94' ' ' ILE . 35.0 tt0 -56.24 -39.72 73.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.336 0.654 . . . . 0.0 110.744 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -49.32 -52.01 30.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.537 1.135 . . . . 0.0 111.097 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 44.1 m -70.36 -34.93 73.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.517 -172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.541 HG23 HD11 ' A' ' 171' ' ' ILE . 62.6 mt -59.52 -50.17 80.92 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.082 0.864 . . . . 0.0 108.843 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -58.56 -44.66 89.8 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.169 0.988 . . . . 0.0 111.181 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 41.2 m-80 -55.89 -49.36 73.64 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 123.572 0.545 . . . . 0.0 110.957 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.0 OUTLIER -63.23 -42.18 99.2 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.559 0.537 . . . . 0.0 110.868 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 130' ' ' ILE . 51.8 mt -64.05 -24.3 35.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.324 0 CA-C-N 118.802 0.728 . . . . 0.0 110.296 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -75.25 -44.24 47.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.706 0.802 . . . . 0.0 112.328 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.521 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 9.9 pt20 -98.05 -48.34 5.17 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.396 0.679 . . . . 0.0 111.58 -173.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 81.7 m -70.52 -5.93 32.57 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.169 1.388 . . . . 0.0 112.952 -178.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.33 174.41 2.13 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 121.124 0.488 . . . . 0.0 110.54 169.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -160.58 166.02 29.73 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.611 176.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 12.3 p -76.27 91.23 3.2 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.583 0.706 . . . . 0.0 110.33 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.9 t -70.83 92.57 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.253 1.242 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.329 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 74.5 m -122.65 138.68 29.76 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.71 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.495 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 56.9 Cg_endo -70.99 -37.4 6.26 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.059 2.506 . . . . 0.0 114.207 -163.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -30.44 61.74 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 122.989 0.516 . . . . 0.0 111.109 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -65.58 -53.84 36.22 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.335 0.588 . . . . 0.0 109.586 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 84.9 mt -66.75 -20.15 65.9 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.12 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 60.58 29.04 18.72 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.656 1.182 . . . . 0.0 111.327 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 28.4 m -117.74 147.23 40.57 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.19 0.996 . . . . 0.0 109.84 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.28 156.76 38.77 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.671 2.248 . . . . 0.0 111.74 172.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.6 -48.35 79.65 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.853 0.861 . . . . 0.0 111.695 -172.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.563 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.3 mt-10 -61.9 -29.52 70.27 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.037 0.535 . . . . 0.0 112.246 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.0 -29.26 66.3 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.508 0.723 . . . . 0.0 111.834 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.498 ' HB ' HD23 ' A' ' 143' ' ' LEU . 40.3 pt -106.91 4.06 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.576 0.75 . . . . 0.0 111.229 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 6.4 tt0 -73.78 127.35 32.59 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.223 0.609 . . . . 0.0 110.139 -167.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.505 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 18.1 t -63.35 114.97 14.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 124.074 0.859 . . . . 0.0 109.93 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.15 -30.08 85.8 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 123.45 2.767 . . . . 0.0 113.073 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mt -70.89 -46.68 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.801 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p -102.6 4.95 38.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER 43.09 30.4 0.27 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 125.906 1.683 . . . . 0.0 113.526 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.89 175.93 12.39 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.127 0.571 . . . . 0.0 110.011 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 31.3 tt0 -61.35 127.56 88.47 Favored Pre-proline 0 C--O 1.241 0.658 0 C-N-CA 123.493 0.717 . . . . 0.0 110.039 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 51.9 Cg_exo -54.3 -54.55 4.47 Favored 'Trans proline' 0 C--N 1.365 1.398 0 C-N-CA 122.283 1.989 . . . . 0.0 113.819 171.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 76.69 -42.77 0.44 Allowed 'General case' 0 C--N 1.371 1.507 0 C-N-CA 124.879 1.271 . . . . 0.0 110.461 -170.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 45.6 mmtm -132.07 111.98 11.95 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 166.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -151.41 -176.84 24.61 Favored Glycine 0 CA--C 1.504 -0.598 0 O-C-N 123.399 0.437 . . . . 0.0 112.081 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.5 HD11 HG23 ' A' ' 171' ' ' ILE . 11.5 tt -142.39 138.7 29.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.769 0 C-N-CA 123.111 0.564 . . . . 0.0 109.862 -171.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.7 m-85 -74.45 113.25 11.47 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.219 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.408 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 70.2 t -133.75 136.13 54.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.339 1.056 . . . . 0.0 108.451 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -53.77 137.22 38.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.224 1.01 . . . . 0.0 112.009 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.401 ' HB3' HG13 ' A' ' 140' ' ' VAL . 36.5 t-20 -64.56 -50.82 65.77 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 165.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 51.6 p -133.58 145.08 49.74 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.47 -49.53 66.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.606 0.763 . . . . 0.0 111.116 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.75 -46.11 55.18 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.693 0.621 . . . . 0.0 114.018 -174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 m -82.14 145.99 29.82 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.698 0.399 . . . . 0.0 110.288 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -83.14 52.16 2.12 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.789 0.836 . . . . 0.0 112.253 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.401 HG13 ' HB3' ' A' ' 134' ' ' ASN . 2.9 p -113.0 109.13 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 109.96 177.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 46.0 t -90.35 153.12 20.67 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.219 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.447 HG21 HD11 ' A' ' 161' ' ' LEU . 98.0 m -142.55 136.22 29.05 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.369 0.667 . . . . 0.0 109.299 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.498 HD23 ' HB ' ' A' ' 117' ' ' ILE . 19.6 tp -95.61 116.27 28.61 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-O 121.532 0.682 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -107.72 169.38 8.63 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.06 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 20.0 t70 -81.81 138.0 35.19 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 170.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.42 -43.77 93.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.413 0.685 . . . . 0.0 111.439 -175.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.83 68.25 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.141 0.576 . . . . 0.0 111.216 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.48 -38.85 68.09 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.747 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.509 ' O ' HG23 ' A' ' 153' ' ' VAL . 54.6 t80 -75.21 -39.86 59.72 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.372 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -64.02 -45.74 87.57 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.519 0.328 . . . . 0.0 111.405 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.57 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 28.4 ptt180 -63.43 -40.42 97.12 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.8 tt -55.51 -47.48 76.17 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.766 1.226 . . . . 0.0 110.767 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.53 HG22 HG21 ' A' ' 166' ' ' ILE . 59.2 t -64.14 -40.42 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.611 176.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.91 -18.65 70.84 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.993 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 151' ' ' ARG . 41.5 mt-10 -86.45 -20.6 27.9 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.502 0.721 . . . . 0.0 110.804 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.12 27.97 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.852 0.72 . . . . 0.0 111.905 -177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.5 mt -97.39 144.21 27.52 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.531 0.732 . . . . 0.0 110.225 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.97 171.93 5.5 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.914 2.41 . . . . 0.0 112.527 178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -64.02 130.04 94.28 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.28 0.632 . . . . 0.0 110.663 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.2 -27.33 74.22 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.933 2.422 . . . . 0.0 113.87 -173.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 142' ' ' THR . 56.4 mt -100.8 -44.36 5.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -172.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 164' ' ' GLU . 13.3 t -114.86 -13.48 11.98 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -173.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? 69.52 23.88 5.83 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.677 1.191 . . . . 0.0 111.703 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.457 ' H ' HG23 ' A' ' 162' ' ' THR . 31.3 mm-40 -77.6 158.25 78.82 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 123.895 0.878 . . . . 0.0 111.066 174.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -66.43 106.72 1.09 Allowed 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.651 2.234 . . . . 0.0 110.591 172.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 153' ' ' VAL . 93.1 mt -58.15 125.77 14.68 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 C-N-CA 123.258 0.623 . . . . 0.0 110.524 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 t -137.05 172.29 13.23 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.346 1.058 . . . . 0.0 109.529 -175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.85 -21.84 59.97 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.299 0.64 . . . . 0.0 110.502 176.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 46.1 t -60.48 -40.13 90.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.783 0.833 . . . . 0.0 111.957 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.5 pt -77.6 -20.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.541 HD11 HG23 ' A' ' 94' ' ' ILE . 61.3 mt -69.51 114.69 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 22.1 m -118.72 167.6 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.017 0.927 . . . . 0.0 110.413 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.97 -174.84 5.52 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 -176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -69.74 -55.05 10.98 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.841 0.856 . . . . 0.0 111.905 -174.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.4 -22.03 61.92 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.274 0.63 . . . . 0.0 111.277 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.567 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 4.9 mp0 -62.26 -16.28 52.61 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 125.794 1.638 . . . . 0.0 112.411 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 59.6 m -123.77 120.6 33.14 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 35.6 pt -122.61 124.0 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -67.68 118.01 10.37 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 120.746 0.308 . . . . 0.0 110.37 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -103.34 118.42 36.73 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 172.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.55 -37.64 86.93 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.251 1.021 . . . . 0.0 112.01 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.4 m -68.19 -30.02 69.02 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.824 0.45 . . . . 0.0 111.082 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 -86.57 -33.86 20.09 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.651 0.78 . . . . 0.0 110.622 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.69 23.73 63.97 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.538 0.524 . . . . 0.0 112.589 -172.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -163.64 166.22 22.56 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 122.94 0.496 . . . . 0.0 110.545 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.587 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.1 m-85 -76.16 132.26 39.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.612 1.165 . . . . 0.0 111.617 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 20.4 mm -115.93 157.79 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.151 1.38 . . . . 0.0 108.213 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 45.8 mm -81.23 133.87 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -170.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 78.3 tttt -138.9 94.9 2.87 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.283 1.433 . . . . 0.0 107.704 174.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -169.11 22.27 0.09 OUTLIER Glycine 0 N--CA 1.467 0.703 0 CA-C-O 119.891 -0.394 . . . . 0.0 113.158 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 53.4 t30 . . . . . 0 CA--C 1.559 1.294 0 C-N-CA 125.13 1.372 . . . . 0.0 111.002 -179.604 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.577 0.227 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -62.61 -41.96 99.3 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.794 0.838 . . . . 0.0 110.897 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -67.96 -26.14 65.79 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.561 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.9 m -72.08 -37.02 69.68 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.437 0.695 . . . . 0.0 109.263 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.435 HG21 HG11 ' A' ' 153' ' ' VAL . 76.6 mt -64.61 -42.0 93.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.803 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -66.05 -41.39 90.89 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.846 0.858 . . . . 0.0 111.824 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 28.2 m-80 -62.83 -36.52 83.5 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.91 0.484 . . . . 0.0 110.167 175.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.475 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.8 OUTLIER -56.87 -55.36 35.39 Favored 'General case' 0 C--O 1.204 -1.33 0 O-C-N 124.248 0.968 . . . . 0.0 109.578 176.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.549 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.5 mt -63.25 -25.74 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.805 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.9 t -71.64 -43.25 66.44 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.83 0.852 . . . . 0.0 112.262 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.6 pt20 -101.47 -40.7 6.94 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 79.5 m -70.35 -9.51 56.41 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.806 1.243 . . . . 0.0 112.647 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -65.66 176.57 1.48 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.144 0.578 . . . . 0.0 111.568 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -163.91 167.21 20.92 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.561 0.744 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.9 p -73.6 95.18 2.27 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.258 0.551 . . . . 0.0 110.237 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.445 HG23 ' H ' ' A' ' 129' ' ' GLY . 87.9 t -74.48 92.56 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.366 177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 58.1 m -131.93 129.86 22.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.685 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.66 -26.42 68.9 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 123.242 2.628 . . . . 0.0 112.158 -176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 11.4 pt-20 -60.54 -32.06 71.12 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.329 1.051 . . . . 0.0 111.907 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.553 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 20.4 mmt180 -94.17 -50.32 5.34 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.702 0.801 . . . . 0.0 110.476 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.29 -15.53 63.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.978 0.911 . . . . 0.0 113.248 -174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 62.33 29.45 17.29 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.067 0.947 . . . . 0.0 111.669 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 44.8 m -124.92 152.64 70.37 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.616 1.166 . . . . 0.0 109.623 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.14 167.83 20.81 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.237 1.958 . . . . 0.0 111.941 172.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -51.34 70.35 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 110.959 -176.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -52.1 -39.03 59.21 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.923 0.889 . . . . 0.0 112.468 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.53 -40.44 96.78 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.003 0.814 . . . . 0.0 111.397 -177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 39.8 pt -103.19 6.58 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.593 0.757 . . . . 0.0 111.337 -174.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -72.15 131.42 42.77 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.289 0.636 . . . . 0.0 110.304 -169.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.554 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.8 t -68.05 115.81 32.41 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 123.007 0.523 . . . . 0.0 110.064 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -59.93 -22.3 68.2 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.188 2.592 . . . . 0.0 113.543 177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.47 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 39.9 mt -73.87 -50.95 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.6 0.76 . . . . 0.0 110.003 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 40.9 p -104.08 4.4 34.24 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.681 0.792 . . . . 0.0 112.365 -171.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 42.86 29.45 0.18 Allowed 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 126.252 1.821 . . . . 0.0 114.143 -177.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.72 176.58 8.94 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.133 0.573 . . . . 0.0 109.984 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.55 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.4 tt0 -64.48 121.79 74.66 Favored Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 173.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.554 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 67.8 Cg_exo -51.73 -48.5 21.15 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 122.463 2.108 . . . . 0.0 113.374 172.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 76.11 -47.54 0.56 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.576 1.151 . . . . 0.0 110.266 -173.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -134.8 101.04 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.047 1.739 . . . . 0.0 106.667 169.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.445 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -139.48 -173.71 13.26 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.935 -0.466 . . . . 0.0 111.935 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.549 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -145.14 138.16 21.6 Favored 'Isoleucine or valine' 0 C--O 1.246 0.915 0 C-N-CA 122.929 0.492 . . . . 0.0 110.224 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.661 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 25.2 m-85 -74.58 115.85 14.61 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.796 172.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -131.49 137.95 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.723 0.809 . . . . 0.0 108.93 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.2 mmmm -62.52 154.05 29.9 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.695 1.198 . . . . 0.0 111.968 178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.441 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.9 t-20 -65.97 -50.32 64.73 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.2 p -152.39 158.52 42.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.506 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.55 -58.21 3.93 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.261 0.625 . . . . 0.0 111.769 -171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.23 -40.54 98.72 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.878 0.736 . . . . 0.0 113.654 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.0 m -71.87 135.6 46.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.182 0.593 . . . . 0.0 109.797 175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.72 37.46 0.79 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.436 0.694 . . . . 0.0 111.62 -174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.441 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -113.65 120.09 62.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 123.859 0.864 . . . . 0.0 109.585 -176.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 41.8 t -110.13 157.21 19.62 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.964 0.906 . . . . 0.0 109.763 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.3 m -143.83 144.34 31.73 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.728 0.811 . . . . 0.0 109.405 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.8 tp -98.62 123.26 42.71 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.016 0.526 . . . . 0.0 109.833 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -114.95 171.94 7.35 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.303 1.041 . . . . 0.0 109.445 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 27.8 t70 -81.01 139.28 35.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.425 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -67.07 -44.43 80.14 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.077 0.551 . . . . 0.0 111.469 -173.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.66 -39.63 61.92 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.767 0.427 . . . . 0.0 110.912 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.88 -37.42 73.04 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.634 0.774 . . . . 0.0 111.17 -178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.511 ' O ' HG23 ' A' ' 153' ' ' VAL . 43.7 t80 -75.94 -39.74 55.49 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.256 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.1 t -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.723 0.409 . . . . 0.0 111.054 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -64.1 -36.75 85.06 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.5 tt -58.48 -49.56 76.89 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 123.978 0.911 . . . . 0.0 110.689 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 149' ' ' PHE . 21.6 t -62.75 -50.32 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.282 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.04 -35.9 88.76 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 124.197 0.936 . . . . 0.0 113.503 -173.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -68.99 -25.14 64.37 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.746 0.818 . . . . 0.0 110.984 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.92 21.79 15.05 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.283 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.9 mt -87.29 146.54 40.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.848 0.859 . . . . 0.0 111.276 -174.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -72.47 167.26 27.49 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.255 2.636 . . . . 0.0 112.567 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -56.66 129.78 76.93 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 123.91 0.884 . . . . 0.0 111.881 -172.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.09 -18.2 56.64 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.235 2.623 . . . . 0.0 113.826 -174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.8 mt -94.84 -70.58 0.7 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.469 0.308 . . . . 0.0 111.273 174.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.9 t -101.7 -9.29 21.0 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -164.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 83.8 mmt-85 71.84 22.31 3.93 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 124.854 1.261 . . . . 0.0 112.402 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -72.99 155.31 90.54 Favored Pre-proline 0 N--CA 1.484 1.239 0 C-N-CA 122.906 0.482 . . . . 0.0 111.201 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.21 104.94 0.78 Allowed 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.203 1.935 . . . . 0.0 110.654 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.448 ' HA ' HD11 ' A' ' 170' ' ' ILE . 79.4 mt -59.28 127.07 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.653 0.781 . . . . 0.0 111.129 -176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.0 t -140.58 161.48 37.64 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.075 -170.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.13 -27.91 66.06 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.938 0.895 . . . . 0.0 111.129 172.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 25.4 t -60.89 -39.6 89.86 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.089 0.956 . . . . 0.0 111.867 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 42.6 pt -88.51 -18.08 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-O 119.616 -0.231 . . . . 0.0 111.5 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 64.0 mt -71.64 121.3 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.483 0.583 . . . . 0.0 109.57 174.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.449 HG21 ' SG ' ' A' ' 177' ' ' CYS . 8.0 m -119.45 167.51 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.447 0.641 . . . . 0.0 111.653 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -80.52 -170.6 2.67 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.852 1.261 . . . . 0.0 111.589 -176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -78.94 -37.12 40.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.419 0.688 . . . . 0.0 111.964 -176.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -74.03 -36.19 64.4 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.043 0.937 . . . . 0.0 111.532 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -51.3 -57.0 10.06 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.674 1.234 . . . . 0.0 111.251 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 16.6 m -92.76 119.16 31.84 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.628 -171.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 34.9 pt -129.14 122.71 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.777 0.831 . . . . 0.0 109.383 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.439 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 43.4 t80 -64.17 115.5 5.06 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.04 127.31 53.67 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 171.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -65.78 -43.15 89.64 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.074 0.95 . . . . 0.0 112.818 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -62.83 -37.06 85.29 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.821 0.7 . . . . 0.0 110.74 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -83.48 -31.64 26.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.436 0.636 . . . . 0.0 109.524 175.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.98 17.91 73.58 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 114.62 -1.173 . . . . 0.0 113.452 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -161.04 170.71 19.98 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 117.546 0.673 . . . . 0.0 110.737 -173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.566 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 85.9 m-85 -73.3 125.48 27.9 Favored 'General case' 0 C--N 1.351 0.67 0 C-N-CA 124.473 1.109 . . . . 0.0 111.324 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 22.5 mm -113.27 159.98 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.723 1.209 . . . . 0.0 108.391 -178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.478 HD11 ' HD3' ' A' ' 133' ' ' LYS . 33.6 mm -84.08 138.85 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -171.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -155.73 77.86 0.98 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.205 1.802 . . . . 0.0 106.244 -176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -98.35 -71.17 1.01 Allowed Glycine 0 C--N 1.34 0.78 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.646 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 CA--C 1.552 1.022 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.123 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.541 ' HG3' HG12 ' A' ' 153' ' ' VAL . 35.4 tt0 -53.17 -47.03 69.14 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.287 1.035 . . . . 0.0 112.671 -168.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.75 -44.42 90.52 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.638 0.586 . . . . 0.0 110.924 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 35.2 t -62.72 -38.84 92.06 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.534 0.734 . . . . 0.0 109.858 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.672 HG23 HD11 ' A' ' 171' ' ' ILE . 71.5 mt -68.32 -41.8 83.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.851 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.8 mm-40 -61.98 -50.61 71.39 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.934 0.894 . . . . 0.0 110.966 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 52.0 m-80 -58.7 -42.48 88.71 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.779 0.674 . . . . 0.0 110.397 176.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 93' ' ' SER . 0.5 OUTLIER -54.75 -59.79 4.24 Favored 'General case' 0 C--O 1.197 -1.681 0 O-C-N 124.236 0.96 . . . . 0.0 109.756 179.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.455 HG23 HG21 ' A' ' 130' ' ' ILE . 57.9 mt -63.16 -26.37 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.315 -173.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 52.4 m -71.23 -39.57 71.6 Favored 'General case' 0 CA--C 1.554 1.134 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.2 pt20 -104.88 -42.84 5.24 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 122.741 0.416 . . . . 0.0 111.936 -176.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.97 -4.28 23.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.408 1.483 . . . . 0.0 113.509 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.514 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.37 174.55 2.09 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.226 0.536 . . . . 0.0 110.976 167.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -162.33 165.73 26.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.934 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.433 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 56.0 p -70.31 98.29 1.37 Allowed 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.973 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.61 89.74 1.44 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.117 0.96 . . . . 0.0 109.674 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 79.0 m -125.13 125.4 25.28 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 113.752 -1.567 . . . . 0.0 107.771 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.34 -28.42 63.33 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.348 2.699 . . . . 0.0 112.359 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -66.45 -44.49 82.64 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.351 1.06 . . . . 0.0 111.22 173.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -69.09 -54.15 16.56 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.326 0.651 . . . . 0.0 110.371 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.53 -20.25 63.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.813 -1.085 . . . . 0.0 112.79 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 59.11 26.25 14.91 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 124.077 0.951 . . . . 0.0 112.086 -174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.5 m -114.02 143.6 29.96 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.288 1.035 . . . . 0.0 108.535 177.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -61.65 159.54 32.11 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 122.694 2.262 . . . . 0.0 112.136 178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -59.34 -47.63 84.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.514 0.726 . . . . 0.0 109.045 -177.146 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -44.69 -49.79 10.26 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.937 1.295 . . . . 0.0 112.275 174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.89 -38.22 90.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.905 0.882 . . . . 0.0 111.646 -175.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 40.2 pt -97.92 -0.41 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.269 -173.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -68.37 121.35 16.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.603 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 14.6 t -62.31 117.72 33.16 Favored Pre-proline 0 CA--C 1.536 0.441 0 O-C-N 123.966 0.791 . . . . 0.0 110.008 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -55.65 -29.16 69.4 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 123.574 2.849 . . . . 0.0 113.542 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.14 -45.11 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.497 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -103.57 3.61 34.8 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -175.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 41.21 37.35 0.59 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 126.086 1.754 . . . . 0.0 113.763 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.79 177.88 9.95 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.859 -0.525 . . . . 0.0 110.737 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.418 ' HB2' HD21 ' A' ' 114' ' ' LEU . 25.3 tt0 -63.24 118.0 39.1 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 172.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.603 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 53.3 Cg_exo -52.48 -43.89 51.24 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.503 2.135 . . . . 0.0 113.511 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 76.58 -49.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.838 1.255 . . . . 0.0 109.575 -171.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 34.3 mmtp -131.53 113.12 13.28 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 126.516 1.926 . . . . 0.0 106.251 170.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -147.06 -168.43 13.82 Favored Glycine 0 CA--C 1.505 -0.556 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.455 HG21 HG23 ' A' ' 98' ' ' ILE . 15.7 tt -150.14 137.99 14.09 Favored 'Isoleucine or valine' 0 C--O 1.248 0.981 0 CA-C-N 116.876 0.338 . . . . 0.0 110.45 -171.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.606 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 19.7 m-85 -74.51 114.23 12.67 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.255 0.622 . . . . 0.0 109.958 175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.9 t -132.89 134.76 57.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 141' ' ' CYS . 8.8 mmmm -60.03 141.25 56.02 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 124.683 1.193 . . . . 0.0 110.97 176.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -64.63 -51.2 63.88 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 60.8 p -138.84 143.32 38.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.086 175.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.96 -49.86 70.87 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.245 1.018 . . . . 0.0 111.371 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -87.58 35.3 3.51 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 115.899 -0.591 . . . . 0.0 114.081 -173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 140' ' ' VAL . 42.5 m -148.62 157.77 43.68 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.253 1.021 . . . . 0.0 108.364 173.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -86.0 44.2 1.11 Allowed 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.259 0.623 . . . . 0.0 111.006 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 138' ' ' SER . 7.4 p -117.79 111.52 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-O 121.791 0.805 . . . . 0.0 110.443 -178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 46.4 t -111.97 154.96 24.5 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.165 173.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 52.1 m -143.48 141.52 30.81 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 13.4 tp -94.32 123.25 37.6 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.143 0.497 . . . . 0.0 109.932 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -112.96 173.05 6.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.381 1.072 . . . . 0.0 109.475 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.56 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.8 t70 -83.0 143.85 30.36 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 170.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -67.5 -49.35 63.87 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.592 0.757 . . . . 0.0 110.843 -174.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.52 -34.39 65.23 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.972 -175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -75.0 -41.9 58.59 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.795 0.838 . . . . 0.0 111.616 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.514 ' O ' HG23 ' A' ' 153' ' ' VAL . 40.4 t80 -75.73 -39.8 56.65 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.831 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.5 t -61.41 -42.84 99.37 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.607 0.363 . . . . 0.0 111.019 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 9.3 ptm180 -68.26 -36.75 79.91 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-O 118.847 -0.596 . . . . 0.0 110.226 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.15 -44.5 92.11 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.305 1.042 . . . . 0.0 110.575 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.541 HG12 ' HG3' ' A' ' 91' ' ' GLN . 48.2 t -63.4 -44.42 98.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.968 174.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -69.26 -19.8 74.51 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-N 115.529 -0.76 . . . . 0.0 113.342 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 60.5 mm-40 -67.63 -29.41 68.72 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.11 0.564 . . . . 0.0 109.509 172.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.49 40.47 6.4 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.041 -173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.4 mt -115.83 149.92 44.02 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.836 0.854 . . . . 0.0 111.042 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.83 179.39 5.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.904 2.402 . . . . 0.0 112.395 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -57.48 133.45 81.89 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.509 1.124 . . . . 0.0 111.64 -171.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -54.65 -44.52 48.84 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.806 2.337 . . . . 0.0 112.368 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.5 mt -79.08 -66.15 0.9 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.849 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.9 t -101.65 -9.69 20.69 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 69.11 27.16 5.36 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.297 1.039 . . . . 0.0 112.84 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -80.3 155.66 74.25 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 123.464 0.706 . . . . 0.0 111.048 173.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.4 107.14 0.55 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.674 2.25 . . . . 0.0 111.284 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.502 HG21 HG22 ' A' ' 153' ' ' VAL . 91.0 mt -57.78 125.8 14.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.6 t -140.14 166.92 23.37 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.945 0.898 . . . . 0.0 109.883 -175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -62.88 -29.03 70.45 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.555 0.742 . . . . 0.0 111.0 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 26.3 t -63.18 -43.38 98.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.79 0.836 . . . . 0.0 112.011 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 49.1 pt -73.74 -23.24 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 117.906 0.321 . . . . 0.0 111.099 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.672 HD11 HG23 ' A' ' 94' ' ' ILE . 69.6 mt -68.65 112.77 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.413 HG23 ' SG ' ' A' ' 177' ' ' CYS . 14.0 m -119.32 166.26 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.517 0.727 . . . . 0.0 111.636 -173.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -78.23 177.64 8.24 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.631 1.172 . . . . 0.0 112.2 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.413 ' HA ' ' CD2' ' A' ' 131' ' ' PHE . 48.8 t60 -67.13 -47.7 70.3 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.592 0.757 . . . . 0.0 110.781 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.47 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 37.0 mt-10 -61.69 -38.97 89.8 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.45 -177.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 37.8 mm-40 -49.32 -60.62 2.66 Favored 'General case' 0 C--O 1.209 -1.038 0 C-N-CA 124.86 1.264 . . . . 0.0 111.771 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 30.0 m -89.41 109.43 20.34 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 122.192 -0.318 . . . . 0.0 110.687 -175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.9 pt -122.41 117.93 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.99 105.92 0.94 Allowed 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.021 0.439 . . . . 0.0 110.014 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -90.32 123.77 34.35 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.29 -31.73 70.43 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.049 0.94 . . . . 0.0 112.697 -177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -73.7 -39.47 64.34 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 122.786 0.434 . . . . 0.0 110.304 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -84.1 -29.64 26.62 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.512 0.725 . . . . 0.0 110.131 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.53 33.84 63.66 Favored Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.289 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -162.56 159.22 24.48 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.142 0.577 . . . . 0.0 110.256 -175.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.0 m-85 -75.8 120.92 21.82 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.845 0.858 . . . . 0.0 110.806 177.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.68 151.29 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 124.529 1.131 . . . . 0.0 108.375 -174.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 42.1 mm -80.96 113.84 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 121.441 0.638 . . . . 0.0 112.41 -168.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 25.6 tptp -111.92 91.84 3.81 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 176.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 150.56 39.14 0.03 OUTLIER Glycine 0 C--N 1.34 0.774 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.256 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.9 t30 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.669 1.188 . . . . 0.0 107.999 -175.782 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.248 0.07 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 94' ' ' ILE . 2.8 mp0 -61.34 -33.37 73.5 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -167.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.52 -38.09 89.81 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 118.469 0.577 . . . . 0.0 110.497 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.9 t -68.76 -38.5 80.13 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.799 0.44 . . . . 0.0 109.859 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.518 HG23 HD11 ' A' ' 171' ' ' ILE . 55.8 mt -64.84 -48.92 82.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.765 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -60.45 -40.35 90.82 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.992 0.917 . . . . 0.0 111.586 177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.511 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.39 -44.92 89.15 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 123.394 0.434 . . . . 0.0 110.282 174.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -59.74 -50.26 74.51 Favored 'General case' 0 C--O 1.201 -1.468 0 O-C-N 123.904 0.752 . . . . 0.0 109.458 179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.543 ' HA ' HD12 ' A' ' 130' ' ' ILE . 42.1 mt -66.14 -20.72 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.04 -176.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 22.9 t -77.84 -43.14 31.27 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 123.208 0.603 . . . . 0.0 111.708 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.9 pt20 -99.12 -44.27 6.34 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 123.065 0.546 . . . . 0.0 112.426 -176.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 73.7 m -70.23 -9.77 56.86 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.292 1.037 . . . . 0.0 112.579 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 17.9 ptpt -64.54 165.88 9.36 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.146 0.498 . . . . 0.0 110.624 169.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -164.62 163.1 21.82 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.347 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 29.7 t -69.51 99.83 1.32 Allowed 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.564 0.746 . . . . 0.0 110.999 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.1 t -84.3 97.78 5.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.585 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 78.5 m -143.71 143.85 25.02 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 114.717 -1.128 . . . . 0.0 107.994 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.3 -23.18 52.09 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.929 2.419 . . . . 0.0 112.11 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.23 -27.56 66.47 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.438 1.095 . . . . 0.0 111.401 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 19.8 mmt85 -93.56 -56.65 2.84 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.776 0.798 . . . . 0.0 110.326 -176.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 55.0 mt -76.37 -12.28 60.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.779 -173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 63.8 9.78 4.69 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 124.446 1.098 . . . . 0.0 112.451 177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 61.0 m -110.43 147.7 36.9 Favored Pre-proline 0 C--O 1.242 0.698 0 C-N-CA 124.264 1.026 . . . . 0.0 109.262 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -59.99 159.85 24.17 Favored 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 122.892 2.395 . . . . 0.0 112.234 -178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.33 -49.94 75.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.351 0.661 . . . . 0.0 110.84 -173.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -57.55 -35.65 70.6 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.319 0.648 . . . . 0.0 112.455 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.6 -42.71 95.38 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.953 0.501 . . . . 0.0 110.321 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 31.8 pt -94.88 4.59 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.371 -175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -74.73 133.36 42.03 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 123.188 0.595 . . . . 0.0 110.112 -170.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.574 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 38.7 t -65.78 119.86 64.09 Favored Pre-proline 0 CA--C 1.538 0.519 0 O-C-N 123.841 0.713 . . . . 0.0 110.453 176.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.54 -3.87 13.9 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.748 2.299 . . . . 0.0 113.096 178.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.442 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 45.7 mt -93.49 -46.55 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.357 0.663 . . . . 0.0 110.103 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 64.6 p -108.22 4.45 24.75 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -173.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 46.37 26.69 0.5 Allowed 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 126.365 1.866 . . . . 0.0 114.442 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.56 176.66 8.5 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.301 0.64 . . . . 0.0 109.549 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -65.96 117.13 39.31 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 171.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.594 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 82.8 Cg_exo -49.39 -42.47 41.04 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.081 2.521 . . . . 0.0 113.939 176.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.65 -48.51 0.55 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 125.163 1.385 . . . . 0.0 110.131 -174.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.2 mmtm -134.71 106.69 7.06 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -140.43 -172.13 12.76 Favored Glycine 0 CA--C 1.503 -0.688 0 O-C-N 123.131 0.269 . . . . 0.0 112.678 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 98' ' ' ILE . 12.8 tt -146.69 135.71 16.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 122.657 0.383 . . . . 0.0 110.159 -170.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.685 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 16.1 m-85 -74.2 114.73 12.89 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.207 173.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.2 t -131.36 143.33 40.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 124.291 1.036 . . . . 0.0 108.401 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.545 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 26.5 mmtm -48.83 134.51 16.44 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.032 0.933 . . . . 0.0 112.944 176.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.533 ' HA ' HD12 ' A' ' 161' ' ' LEU . 3.3 t30 -62.62 -39.48 93.95 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.411 166.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.632 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 5.6 p -153.28 143.98 22.69 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.526 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.54 -55.4 34.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.393 1.077 . . . . 0.0 111.301 -174.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -89.99 51.64 3.5 Favored Glycine 0 N--CA 1.468 0.793 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.072 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -147.75 -178.99 6.56 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.559 0.744 . . . . 0.0 110.667 176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -113.29 11.61 18.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.52 0.728 . . . . 0.0 110.595 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.5 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.2 p -98.38 121.44 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 121.887 0.851 . . . . 0.0 110.573 179.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 35.2 t -101.06 157.76 16.52 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.035 1.334 . . . . 0.0 109.625 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 93.7 m -142.94 143.84 32.15 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.419 0.688 . . . . 0.0 109.31 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.8 tp -95.52 124.35 39.5 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.26 0.553 . . . . 0.0 110.205 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -110.72 169.53 8.7 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.386 1.074 . . . . 0.0 109.484 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.594 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.9 t70 -79.54 133.88 36.48 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 165.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.442 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.1 -46.55 86.81 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 0.0 110.944 -174.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -73.25 -30.39 63.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.034 0.534 . . . . 0.0 111.609 -175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.5 -44.34 29.1 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.491 0.716 . . . . 0.0 110.71 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.571 ' O ' HG23 ' A' ' 153' ' ' VAL . 52.2 t80 -71.08 -40.93 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 123.808 0.693 . . . . 0.0 109.456 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -61.13 -49.72 76.12 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.238 0.615 . . . . 0.0 111.569 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.452 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 19.2 ptp180 -63.57 -36.29 83.32 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -59.31 -45.88 90.09 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.62 1.168 . . . . 0.0 110.271 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.757 HG22 HG21 ' A' ' 166' ' ' ILE . 74.7 t -61.86 -45.54 98.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.619 176.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -66.2 -27.0 72.64 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.865 -176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 51.7 mm-40 -76.2 -17.17 59.65 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.214 0.606 . . . . 0.0 111.315 175.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.83 25.1 46.98 Favored Glycine 0 C--N 1.339 0.733 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 -177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.31 141.94 40.24 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.695 0.798 . . . . 0.0 109.703 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.571 ' HG2' ' HD2' ' A' ' 163' ' ' ARG . 66.0 Cg_endo -74.01 170.88 19.1 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.674 2.249 . . . . 0.0 111.879 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.424 ' HA ' HD11 ' A' ' 166' ' ' ILE . 25.6 t-80 -55.76 129.87 71.56 Favored Pre-proline 0 CA--C 1.557 1.22 0 C-N-CA 124.083 0.953 . . . . 0.0 112.883 -168.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.55 -28.04 84.45 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 123.551 2.834 . . . . 0.0 114.551 -175.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 134' ' ' ASN . 56.0 mt -79.96 -68.43 0.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.601 HG23 ' HG2' ' A' ' 164' ' ' GLU . 12.0 t -129.91 17.0 5.71 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 118.066 0.394 . . . . 0.0 111.97 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.571 ' HD2' ' HG2' ' A' ' 158' ' ' PRO . 34.0 mmt180 69.32 32.35 3.57 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.069 0.947 . . . . 0.0 112.257 170.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.632 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 25.3 mm-40 -62.84 159.42 45.36 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 124.454 1.102 . . . . 0.0 111.763 173.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.15 104.16 1.01 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.432 2.088 . . . . 0.0 110.648 170.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.757 HG21 HG22 ' A' ' 153' ' ' VAL . 59.6 mt -66.42 112.69 2.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 CA-C-O 121.332 0.587 . . . . 0.0 109.458 175.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.2 t -135.87 171.19 14.82 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.875 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.435 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -66.54 -26.61 67.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.098 0.559 . . . . 0.0 111.031 175.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.4 t -65.01 -44.5 89.0 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.026 0.93 . . . . 0.0 112.482 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.7 pt -66.55 -25.25 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-N 117.842 0.292 . . . . 0.0 111.347 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.518 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.87 118.23 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 20.0 m -109.45 165.63 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 123.676 0.79 . . . . 0.0 110.304 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -76.11 175.2 9.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.843 0.857 . . . . 0.0 111.682 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.523 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 55.1 t-80 -67.25 -38.7 85.59 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.387 176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 47.3 mt-10 -57.5 -44.93 85.36 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 124.248 0.967 . . . . 0.0 110.783 174.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 41.0 mt-10 -68.59 14.0 0.08 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -169.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.685 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 39.0 m -148.84 108.33 3.97 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.32 1.418 . . . . 0.0 108.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.2 pt -124.97 120.31 58.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -66.69 108.57 2.52 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 120.977 0.418 . . . . 0.0 109.904 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -99.4 121.0 40.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -61.06 -38.71 87.15 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 124.214 0.946 . . . . 0.0 112.163 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 91.2 m -65.18 -41.42 94.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.049 0.54 . . . . 0.0 110.936 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 -84.42 -25.14 29.23 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.06 0.544 . . . . 0.0 110.482 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.89 28.97 61.68 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.876 0.735 . . . . 0.0 112.704 178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -168.51 167.48 11.62 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -173.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.5 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 80.9 m-85 -72.28 129.87 39.45 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.813 0.845 . . . . 0.0 111.135 175.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 32.4 mm -112.88 151.72 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 176' ' ' GLU . 50.0 mm -71.66 119.5 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -174.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 175' ' ' GLU . 14.2 tmtt? -109.83 84.65 1.96 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 169.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.31 86.67 0.12 Allowed Glycine 0 C--N 1.338 0.681 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.344 -175.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 C--O 1.249 1.06 0 C-N-CA 123.935 0.894 . . . . 0.0 108.997 175.112 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 36.1 m . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.534 ' HG3' HG12 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -51.06 -43.53 60.98 Favored 'General case' 0 C--O 1.206 -1.224 0 C-N-CA 124.311 1.044 . . . . 0.0 113.277 -171.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -58.27 -41.61 84.68 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.664 0.666 . . . . 0.0 111.324 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.6 t -69.48 -38.27 77.62 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.05 0.54 . . . . 0.0 110.014 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.616 HG23 HD11 ' A' ' 171' ' ' ILE . 65.4 mt -69.58 -45.25 78.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.418 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 28.3 mm-40 -64.91 -43.56 92.42 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.214 1.006 . . . . 0.0 110.324 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 67.8 m-20 -57.33 -42.46 81.95 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.403 0.681 . . . . 0.0 110.696 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.458 ' HG3' ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -59.28 -54.21 49.45 Favored 'General case' 0 C--O 1.21 -0.978 0 O-C-N 124.038 0.837 . . . . 0.0 109.889 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 130' ' ' ILE . 59.4 mt -65.74 -19.66 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.175 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.234 -176.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.45 ' HA ' ' NZ ' ' A' ' 102' ' ' LYS . 39.1 t -75.91 -42.11 49.95 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.162 0.585 . . . . 0.0 112.055 178.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.3 pt20 -107.51 -39.31 5.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 87.0 m -66.35 -16.81 64.35 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.158 0.983 . . . . 0.0 112.547 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.45 ' NZ ' ' HA ' ' A' ' 99' ' ' SER . 7.8 ptpp? -64.99 170.49 4.31 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-O 121.4 0.619 . . . . 0.0 111.309 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -158.2 165.37 35.07 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.121 -177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 24.4 p -72.13 101.7 2.84 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.549 175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.423 HG23 ' H ' ' A' ' 129' ' ' GLY . 92.8 t -79.32 89.94 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.059 0 CA-C-O 121.76 0.791 . . . . 0.0 109.918 176.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.4 m -123.79 132.44 24.29 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.147 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.85 -32.64 55.14 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 123.028 2.485 . . . . 0.0 112.382 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.547 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 9.4 pt-20 -62.75 -26.97 68.97 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.553 1.141 . . . . 0.0 112.215 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.547 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 18.5 mmt180 -93.46 -51.99 4.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.715 0.806 . . . . 0.0 110.271 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.13 -9.49 58.49 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.911 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 59.41 28.69 18.11 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.256 1.022 . . . . 0.0 111.458 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.74 143.96 50.91 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.84 0.856 . . . . 0.0 109.273 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.416 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 18.2 Cg_endo -58.69 169.79 3.04 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.373 2.716 . . . . 0.0 113.478 177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.453 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -59.35 -55.02 40.09 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.865 0.866 . . . . 0.0 111.689 -173.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 38.5 mt-10 -62.44 -28.12 69.58 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.36 0.664 . . . . 0.0 111.958 -178.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -61.04 -42.22 98.06 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.105 0.878 . . . . 0.0 111.209 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 36.2 pt -104.5 9.88 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.138 -174.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.594 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 4.9 tt0 -73.64 136.35 43.85 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.04 0.536 . . . . 0.0 110.705 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.573 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.4 t -71.02 120.39 79.18 Favored Pre-proline 0 CA--C 1.54 0.592 0 O-C-N 123.975 0.797 . . . . 0.0 109.901 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.1 -26.52 82.87 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 123.279 2.652 . . . . 0.0 112.952 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 48.8 mt -74.71 -50.99 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 123.445 0.698 . . . . 0.0 110.106 -176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p -98.36 0.68 45.9 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.098 0.559 . . . . 0.0 112.49 -173.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 43.05 32.71 0.45 Allowed 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.167 1.787 . . . . 0.0 113.55 -176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.75 175.51 10.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.958 0.503 . . . . 0.0 109.871 -175.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB2' HD21 ' A' ' 114' ' ' LEU . 31.1 tt0 -61.89 117.95 33.97 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.575 0.75 . . . . 0.0 109.441 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.0 Cg_exo -52.06 -47.26 27.55 Favored 'Trans proline' 0 C--N 1.368 1.596 0 C-N-CA 122.371 2.047 . . . . 0.0 113.919 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 75.47 -44.07 0.51 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.688 1.195 . . . . 0.0 109.843 -172.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -135.2 104.28 5.84 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 170.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -136.86 -172.71 12.63 Favored Glycine 0 CA--C 1.504 -0.627 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.6 tt -149.58 139.07 15.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 C-N-CA 122.598 0.359 . . . . 0.0 110.231 -174.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.555 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 21.4 m-85 -74.65 117.74 16.82 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.858 176.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.1 t -132.65 140.71 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 123.867 0.867 . . . . 0.0 108.757 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -51.1 126.58 16.85 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.827 0.851 . . . . 0.0 111.47 171.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' HB3' HG13 ' A' ' 140' ' ' VAL . 22.1 t-20 -62.66 -46.63 87.29 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 107.491 -1.299 . . . . 0.0 107.491 166.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 138' ' ' SER . 57.0 m -139.14 133.49 31.55 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.531 ' HB2' HG22 ' A' ' 170' ' ' ILE . 28.0 t70 -67.86 -36.78 80.89 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.031 0.932 . . . . 0.0 111.468 -174.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -100.11 24.25 32.82 Favored Glycine 0 C--N 1.348 1.246 0 O-C-N 123.383 0.427 . . . . 0.0 112.652 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.468 ' HB2' ' HB2' ' A' ' 135' ' ' SER . 28.5 m -140.85 151.29 44.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.121 0.968 . . . . 0.0 108.472 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -84.06 30.76 0.51 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.779 0.432 . . . . 0.0 111.946 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.424 HG23 ' ND2' ' A' ' 185' ' ' ASN . 7.7 p -106.32 121.93 59.47 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 C-N-CA 123.75 0.82 . . . . 0.0 109.981 178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 43.7 t -111.14 161.67 15.71 Favored 'General case' 0 C--O 1.241 0.658 0 C-N-CA 123.645 0.778 . . . . 0.0 109.809 174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 87.3 m -146.79 144.3 29.26 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.63 0.772 . . . . 0.0 109.057 177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.8 tp -96.19 124.9 40.36 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -113.37 168.22 9.92 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.854 0.862 . . . . 0.0 109.21 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 30.5 t70 -76.45 135.78 39.41 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 167.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.45 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -63.24 -47.74 81.19 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.834 0.708 . . . . 0.0 111.245 -174.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.22 -30.42 60.58 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.545 0.338 . . . . 0.0 111.287 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -74.59 -40.35 61.64 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.441 0.696 . . . . 0.0 111.177 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.513 ' O ' HG23 ' A' ' 153' ' ' VAL . 39.1 t80 -74.45 -36.4 63.35 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.786 177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 33.0 t -66.72 -43.71 83.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.032 0.533 . . . . 0.0 111.527 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.49 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 12.1 ptp180 -66.6 -37.28 84.55 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.8 -46.3 84.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.514 1.126 . . . . 0.0 110.489 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -67.51 -39.75 83.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.004 175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -65.2 -23.19 69.69 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.333 -177.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.517 ' HB2' ' HG ' ' A' ' 157' ' ' LEU . 17.9 mm-40 -82.62 -29.86 29.83 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.081 0.552 . . . . 0.0 110.277 171.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.45 38.39 5.62 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.564 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 41.0 mt -94.56 147.35 33.07 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 123.444 0.697 . . . . 0.0 110.178 -174.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -69.49 165.78 29.5 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.786 2.324 . . . . 0.0 111.651 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.533 ' HA ' HD11 ' A' ' 166' ' ' ILE . 28.1 t-80 -54.97 127.37 62.29 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 123.518 0.727 . . . . 0.0 112.097 -170.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.03 -32.59 79.85 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.403 2.735 . . . . 0.0 113.527 -174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 34.5 mt -84.73 -61.88 1.68 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.021 0.528 . . . . 0.0 111.914 -176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 164' ' ' GLU . 8.9 t -116.26 -6.31 11.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -166.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 68.0 29.58 6.36 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.296 1.038 . . . . 0.0 112.742 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.474 ' HG2' HG23 ' A' ' 162' ' ' THR . 50.1 mm-40 -72.1 156.16 91.02 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 123.143 0.577 . . . . 0.0 111.059 171.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -63.37 106.04 0.54 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.768 2.312 . . . . 0.0 111.499 174.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.65 HG21 HG22 ' A' ' 153' ' ' VAL . 71.3 mt -67.78 124.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-O 121.121 0.486 . . . . 0.0 110.756 177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.7 t -154.89 179.8 8.77 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.808 177.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.25 -21.03 65.98 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.813 0.845 . . . . 0.0 112.088 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.2 t -65.17 -32.83 74.71 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.82 0.848 . . . . 0.0 112.292 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.546 HD11 HG23 ' A' ' 166' ' ' ILE . 35.9 pt -87.59 -26.7 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 122.225 -0.297 . . . . 0.0 111.627 -178.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.616 HD11 HG23 ' A' ' 94' ' ' ILE . 71.9 mt -69.07 113.43 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.663 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 30.4 m -115.3 166.29 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.156 0.503 . . . . 0.0 111.36 -173.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -83.49 -173.49 4.74 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.241 -177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -81.14 -23.75 38.1 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.827 -173.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 189' ' ' LYS . 4.9 mp0 -66.62 -57.92 6.23 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.663 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 21.6 mm-40 -29.12 -77.97 0.02 OUTLIER 'General case' 0 C--N 1.353 0.729 0 O-C-N 125.992 2.058 . . . . 0.0 113.169 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 10.7 m -88.37 110.04 20.47 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 120.765 0.316 . . . . 0.0 110.873 -165.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.92 115.46 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 123.89 0.876 . . . . 0.0 108.897 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -65.43 109.55 2.35 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -90.95 129.63 36.96 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 171.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.55 -45.42 87.17 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.128 0.971 . . . . 0.0 111.537 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 32.3 m -63.72 -39.84 95.29 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.663 0.602 . . . . 0.0 110.552 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -80.5 -29.69 37.3 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.011 176.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 68.67 35.14 79.85 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.351 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.424 ' ND2' HG23 ' A' ' 140' ' ' VAL . 7.9 t30 -164.57 160.81 20.62 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 122.977 0.511 . . . . 0.0 110.772 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -72.93 122.98 22.55 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 123.591 0.756 . . . . 0.0 110.673 175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.6 mm -97.82 164.23 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 20.6 mm -94.54 140.8 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-O 121.011 0.434 . . . . 0.0 111.134 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.549 ' H ' ' HA ' ' A' ' 176' ' ' GLU . 53.1 tptt -147.13 94.64 2.43 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.139 1.375 . . . . 0.0 108.235 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 175.38 97.05 0.1 Allowed Glycine 0 C--O 1.238 0.387 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -175.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.552 1.026 0 C-N-CA 125.309 1.443 . . . . 0.0 110.046 -174.152 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.639 0.257 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -71.03 -32.6 69.39 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.794 0.838 . . . . 0.0 110.217 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -64.6 -28.74 69.83 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.17 0.988 . . . . 0.0 111.918 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.6 t -67.28 -37.73 83.9 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.8 mt -73.58 -45.56 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.78 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -58.5 -48.29 81.31 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.253 1.021 . . . . 0.0 112.511 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 17.7 m-80 -65.8 -33.94 77.02 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.897 0.479 . . . . 0.0 111.043 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.584 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 1.8 tppt? -58.71 -49.14 78.68 Favored 'General case' 0 C--O 1.2 -1.529 0 O-C-N 123.762 0.664 . . . . 0.0 109.71 175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.601 ' HA ' HD12 ' A' ' 130' ' ' ILE . 49.4 mt -65.82 -25.22 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.86 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.444 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 30.7 t -73.29 -43.11 61.59 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.37 0.668 . . . . 0.0 111.981 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 7.9 pt20 -98.1 -38.76 9.21 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.001 0.52 . . . . 0.0 112.336 -175.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 97' ' ' LYS . 87.1 m -80.74 -5.48 57.17 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.156 0.983 . . . . 0.0 112.633 -176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 18.7 ptpt -66.7 174.65 2.76 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.114 0.483 . . . . 0.0 110.842 166.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -163.91 167.26 20.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.441 0.696 . . . . 0.0 109.869 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.518 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 58.7 p -74.11 99.1 3.27 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.236 0.614 . . . . 0.0 110.652 176.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 60.6 t -80.35 89.23 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.756 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 28.6 m -117.0 132.75 23.28 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 172.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.97 -20.65 57.55 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.084 2.523 . . . . 0.0 113.321 -177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.4 -37.42 77.5 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.506 0.504 . . . . 0.0 110.844 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.5 mmt85 -75.44 -50.7 15.01 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.614 0.766 . . . . 0.0 110.075 -175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.3 mt -73.14 -19.49 61.12 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.702 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 60.24 29.54 19.09 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.556 1.142 . . . . 0.0 111.717 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.7 m -116.95 157.1 47.31 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.513 1.125 . . . . 0.0 108.752 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -69.36 164.0 35.8 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 121.923 1.748 . . . . 0.0 111.094 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.548 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.26 -48.63 79.83 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.929 0.891 . . . . 0.0 111.099 -172.616 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 46.5 mt-10 -61.27 -31.49 71.31 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.506 0.722 . . . . 0.0 112.424 -178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.52 80.38 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.508 0.723 . . . . 0.0 111.396 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.408 ' HB ' HD23 ' A' ' 143' ' ' LEU . 35.8 pt -103.91 5.74 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.735 0.814 . . . . 0.0 110.917 -176.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 8.4 tt0 -71.64 135.22 46.82 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.274 0.629 . . . . 0.0 110.892 -167.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.512 ' SG ' ' HB ' ' A' ' 121' ' ' ILE . 32.4 t -69.96 116.91 48.79 Favored Pre-proline 0 CA--C 1.539 0.53 0 O-C-N 123.786 0.679 . . . . 0.0 109.343 172.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.54 ' HB2' HD21 ' A' ' 161' ' ' LEU . 16.6 Cg_exo -66.17 -20.0 56.47 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.741 2.294 . . . . 0.0 112.75 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.512 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 64.9 mt -73.43 -50.48 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 C-N-CA 123.585 0.754 . . . . 0.0 109.946 179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p -99.0 1.69 45.66 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.343 0.657 . . . . 0.0 112.475 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.72 28.17 0.52 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 126.147 1.779 . . . . 0.0 113.946 -176.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -150.83 176.84 10.68 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.045 0.538 . . . . 0.0 110.216 -176.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HB2' HD21 ' A' ' 114' ' ' LEU . 27.3 tt0 -58.28 123.85 67.84 Favored Pre-proline 0 C--N 1.353 0.727 0 O-C-N 124.055 0.847 . . . . 0.0 109.944 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.512 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 52.1 Cg_exo -53.57 -49.66 16.55 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 122.194 1.929 . . . . 0.0 113.188 171.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.94 -46.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 124.641 1.176 . . . . 0.0 109.66 -173.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 35.2 mmtp -133.63 112.54 11.53 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 127.031 2.132 . . . . 0.0 105.814 166.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -150.17 -175.77 22.61 Favored Glycine 0 CA--C 1.504 -0.621 0 CA-C-O 120.193 -0.226 . . . . 0.0 112.683 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.3 tt -145.26 140.33 22.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.142 0.496 . . . . 0.0 110.918 -170.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.583 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 26.6 m-85 -75.39 111.18 10.41 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.287 172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.7 t -131.75 136.22 57.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.624 ' HE2' ' HA ' ' A' ' 139' ' ' ASP . 3.2 mmmp? -61.86 135.8 57.72 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.627 1.171 . . . . 0.0 112.781 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -80.65 -1.16 41.26 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 124.562 1.145 . . . . 0.0 110.437 171.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 138' ' ' SER . 24.8 p -172.88 145.22 1.4 Allowed 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.598 1.159 . . . . 0.0 108.684 174.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -71.24 -57.65 4.29 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -64.82 -18.99 64.89 Favored Glycine 0 CA--C 1.536 1.358 0 N-CA-C 114.909 0.724 . . . . 0.0 114.909 -172.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.478 ' HB2' ' OG ' ' A' ' 135' ' ' SER . 18.5 m -114.87 146.55 40.98 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 117.49 0.645 . . . . 0.0 109.852 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.624 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 34.5 m-20 -82.79 22.92 0.86 Allowed 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -172.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.0 p -78.34 102.63 4.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 122.141 0.972 . . . . 0.0 110.271 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 44.9 t -90.47 134.06 34.61 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.057 173.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 161' ' ' LEU . 62.5 m -123.4 135.82 54.32 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.531 0.732 . . . . 0.0 109.607 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 117' ' ' ILE . 21.2 tp -92.39 118.69 31.19 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -108.74 175.75 5.35 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.651 1.181 . . . . 0.0 109.169 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.512 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 24.4 t70 -84.75 139.41 31.99 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 169.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.475 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -65.38 -47.32 76.76 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.459 0.704 . . . . 0.0 110.897 -175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.72 -38.21 67.52 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.036 0.534 . . . . 0.0 111.056 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.15 -45.92 62.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.823 0.849 . . . . 0.0 110.913 -176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 153' ' ' VAL . 46.9 t80 -71.78 -38.32 70.33 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.191 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.52 -42.92 81.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.451 0.301 . . . . 0.0 111.534 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 31.5 ptt180 -65.99 -34.87 79.08 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.2 tt -60.32 -44.63 95.28 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.554 1.141 . . . . 0.0 109.991 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.636 HG22 HG21 ' A' ' 166' ' ' ILE . 92.2 t -64.74 -41.22 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.496 176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.94 -27.87 72.75 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.906 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 8.0 mm-40 -72.49 -39.12 67.93 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.245 0.618 . . . . 0.0 110.849 175.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.42 45.6 4.62 Favored Glycine 0 C--N 1.342 0.903 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 92.9 mt -106.96 151.41 40.63 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.199 1.0 . . . . 0.0 110.068 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 169.78 6.35 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.784 2.323 . . . . 0.0 112.569 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -56.39 131.63 76.3 Favored Pre-proline 0 CA--C 1.557 1.236 0 C-N-CA 122.945 0.498 . . . . 0.0 111.145 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 123.282 2.655 . . . . 0.0 113.771 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.54 HD21 ' HB2' ' A' ' 120' ' ' PRO . 35.1 mt -94.77 -58.94 2.03 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 164' ' ' GLU . 8.2 t -104.72 -18.07 14.41 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.206 0.602 . . . . 0.0 111.664 -166.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? 65.24 30.97 11.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.725 1.21 . . . . 0.0 112.33 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.556 ' H ' HG23 ' A' ' 162' ' ' THR . 52.5 mt-10 -77.93 158.18 78.04 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.966 0.906 . . . . 0.0 110.261 169.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.16 107.28 0.35 Allowed 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.256 1.971 . . . . 0.0 111.224 174.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.636 HG21 HG22 ' A' ' 153' ' ' VAL . 88.5 mt -61.46 118.91 4.49 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 172.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.6 t -138.11 156.07 48.12 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 124.092 0.957 . . . . 0.0 109.288 -177.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.584 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -58.83 -25.73 63.48 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.133 0.973 . . . . 0.0 111.05 173.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.1 t -62.96 -44.76 95.18 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.594 1.158 . . . . 0.0 112.426 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.3 pt -78.56 -15.43 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-N 118.018 0.372 . . . . 0.0 111.603 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 54.7 mt -72.18 122.25 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 171.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.7 162.03 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 123.567 0.747 . . . . 0.0 110.369 -177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -82.31 -179.39 7.4 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.946 -179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -70.66 -45.82 64.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.886 0.875 . . . . 0.0 111.375 -174.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.58 -28.22 67.59 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.831 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 189' ' ' LYS . 7.6 mm-40 -54.86 -58.14 8.79 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.775 0.83 . . . . 0.0 110.583 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 57.9 m -89.22 113.21 24.4 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.407 -168.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -121.78 115.58 46.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 114.572 -1.194 . . . . 0.0 108.161 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.69 106.37 2.2 Favored 'General case' 0 C--O 1.241 0.61 0 O-C-N 121.709 -0.619 . . . . 0.0 109.717 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -89.48 125.4 35.17 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 175.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.89 -45.22 86.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.618 1.167 . . . . 0.0 111.085 -177.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 34.8 m -72.25 -31.53 65.88 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.772 0.829 . . . . 0.0 111.646 -175.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -83.97 -25.89 29.68 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 122.909 0.484 . . . . 0.0 110.658 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 69.76 27.4 73.3 Favored Glycine 0 C--N 1.349 1.3 0 O-C-N 123.652 0.595 . . . . 0.0 113.246 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -165.22 162.36 19.88 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.743 0.417 . . . . 0.0 111.002 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 60.0 m-85 -72.62 122.13 20.89 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.233 1.013 . . . . 0.0 111.188 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 14.3 mm -100.0 157.35 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.469 HD11 ' HD3' ' A' ' 133' ' ' LYS . 48.9 mm -90.86 137.43 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 118.733 0.697 . . . . 0.0 111.262 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 1.4 tmmm? -147.48 97.03 2.79 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -153.41 -75.31 0.01 OUTLIER Glycine 0 C--N 1.341 0.849 0 CA-C-N 116.491 -0.322 . . . . 0.0 112.669 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 8.1 t30 . . . . . 0 C--O 1.259 1.556 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.221 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.507 0.67 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.564 ' HG3' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -71.21 -37.26 72.09 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.853 -174.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -58.53 -34.91 71.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.848 0.459 . . . . 0.0 111.565 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.405 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 34.0 t -70.5 -43.28 70.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.556 0.742 . . . . 0.0 109.578 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.637 HG21 HG11 ' A' ' 153' ' ' VAL . 72.0 mt -64.05 -44.03 97.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.158 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 27.0 mm-40 -64.97 -42.41 94.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.484 1.114 . . . . 0.0 110.829 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 80.7 m-20 -58.73 -40.24 83.18 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.384 0.673 . . . . 0.0 110.177 175.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.52 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.2 OUTLIER -61.9 -52.88 62.29 Favored 'General case' 0 C--O 1.202 -1.437 0 O-C-N 123.757 0.66 . . . . 0.0 109.287 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' HA ' HD12 ' A' ' 130' ' ' ILE . 66.7 mt -62.5 -19.01 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 122.844 0.457 . . . . 0.0 111.051 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.8 t -85.01 -41.1 16.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.682 0.793 . . . . 0.0 111.92 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 8.0 pt20 -106.7 -34.57 7.26 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 9.0 t -72.63 -13.46 61.38 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.989 0.915 . . . . 0.0 111.438 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -64.5 172.26 2.74 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.265 0.626 . . . . 0.0 111.643 174.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -158.12 162.92 38.04 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.765 0.826 . . . . 0.0 110.227 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.1 p -69.04 103.26 1.81 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.272 0.629 . . . . 0.0 110.89 177.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 129' ' ' GLY . 98.9 t -88.61 96.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.288 0.635 . . . . 0.0 111.395 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 107' ' ' PRO . 12.4 t -130.16 148.19 68.73 Favored Pre-proline 0 C--O 1.24 0.581 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 172.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.615 ' HD2' ' SG ' ' A' ' 106' ' ' CYS . 56.0 Cg_endo -64.15 -17.54 60.14 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.436 2.091 . . . . 0.0 111.921 177.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -77.58 -42.67 34.33 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 124.403 1.081 . . . . 0.0 110.227 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.595 ' HG2' ' HB3' ' A' ' 106' ' ' CYS . 16.7 mmt85 -68.88 -53.58 20.4 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.382 0.673 . . . . 0.0 110.629 -176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.14 -16.16 59.26 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.165 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 63.07 16.46 9.34 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.463 1.105 . . . . 0.0 112.029 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 179' ' ' TYR . 60.1 m -109.62 150.76 41.67 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.556 1.142 . . . . 0.0 108.713 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -56.78 159.6 13.85 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.706 2.271 . . . . 0.0 112.589 176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.556 HD21 ' HB2' ' A' ' 125' ' ' GLN . 1.1 tm? -60.01 -47.97 83.64 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.037 0.935 . . . . 0.0 110.537 -173.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 118' ' ' GLN . 37.2 mt-10 -58.89 -34.43 71.65 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.699 0.8 . . . . 0.0 112.042 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.2 -27.16 64.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.799 0.84 . . . . 0.0 112.332 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.2 pt -108.85 5.86 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.615 0.766 . . . . 0.0 110.583 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' GLU . 5.5 tt0 -70.87 131.48 43.82 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.104 0.562 . . . . 0.0 110.324 -168.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.558 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 19.2 t -65.4 117.53 41.38 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 123.603 0.761 . . . . 0.0 109.623 176.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.5 -25.85 80.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.146 2.564 . . . . 0.0 112.528 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.504 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 58.8 mt -72.45 -52.02 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 123.709 0.803 . . . . 0.0 110.236 -177.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.4 p -100.92 2.61 40.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.465 0.706 . . . . 0.0 112.512 -172.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 47.06 28.11 0.86 Allowed 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 125.957 1.703 . . . . 0.0 113.607 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -147.5 176.6 9.92 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.103 0.561 . . . . 0.0 109.888 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.556 ' HB2' HD21 ' A' ' 114' ' ' LEU . 30.8 tt0 -59.63 127.99 85.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 122.997 0.519 . . . . 0.0 110.099 174.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 61.3 Cg_exo -55.35 -50.56 12.49 Favored 'Trans proline' 0 CA--C 1.554 1.484 0 C-N-CA 122.342 2.028 . . . . 0.0 114.376 167.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 77.18 -47.02 0.5 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 125.397 1.479 . . . . 0.0 110.16 -170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -133.67 104.6 6.42 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.411 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -137.1 -174.47 13.33 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.7 tt -148.38 138.1 16.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 122.767 0.427 . . . . 0.0 109.858 -172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.624 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 15.2 m-85 -75.09 123.05 24.51 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.227 174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 66.5 t -136.03 138.32 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 124.23 1.012 . . . . 0.0 108.501 176.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 31.6 mmtm -53.88 141.98 25.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.792 0.837 . . . . 0.0 111.455 171.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -66.53 -47.15 73.8 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 165.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 p -138.33 150.62 46.78 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 123.18 0.592 . . . . 0.0 109.545 172.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -62.17 -59.28 5.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.446 1.098 . . . . 0.0 112.363 -167.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -92.2 47.56 2.65 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 116.169 -0.469 . . . . 0.0 113.16 -174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.4 m -137.38 176.54 8.62 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.206 0.602 . . . . 0.0 111.075 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -96.28 4.79 52.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.713 0.805 . . . . 0.0 111.066 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.71 116.79 39.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-O 121.306 0.574 . . . . 0.0 111.555 -174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 49.2 t -110.99 160.29 16.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.499 0.72 . . . . 0.0 109.591 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.416 HG21 HD11 ' A' ' 161' ' ' LEU . 85.9 m -147.77 143.79 27.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.78 0.832 . . . . 0.0 109.297 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 22.2 tp -96.34 124.82 40.48 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.222 0.609 . . . . 0.0 109.848 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -116.45 164.47 14.51 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.102 0.961 . . . . 0.0 109.268 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 17.0 t70 -73.29 134.82 44.32 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 170.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.08 80.75 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.574 0.546 . . . . 0.0 111.373 -175.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.61 -29.74 61.41 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 122.658 0.383 . . . . 0.0 111.523 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -77.91 -37.98 46.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.917 0.887 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.5 t80 -76.19 -32.25 58.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.7 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.2 t -71.0 -45.57 63.75 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.804 0.442 . . . . 0.0 111.011 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -63.91 -37.34 87.04 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 157' ' ' LEU . 5.8 tt -53.59 -56.62 15.61 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.134 1.374 . . . . 0.0 110.44 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 94' ' ' ILE . 21.4 t -68.48 -37.75 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.122 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.0 -29.09 73.89 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.48 0.487 . . . . 0.0 112.864 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -80.56 -25.8 38.36 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.711 0.804 . . . . 0.0 111.03 172.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.06 9.73 Favored Glycine 0 N--CA 1.471 0.974 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.571 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.517 ' HB2' HD23 ' A' ' 152' ' ' LEU . 34.3 mt -83.76 147.26 51.46 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.987 0.915 . . . . 0.0 108.782 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -75.83 176.44 10.01 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.394 2.063 . . . . 0.0 111.954 178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' ILE . 40.0 t-80 -59.04 129.16 85.86 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 0.0 110.518 -175.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -54.42 -39.0 89.54 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 122.856 2.37 . . . . 0.0 112.944 -174.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 142' ' ' THR . 39.1 mt -85.4 -62.1 1.61 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.886 -172.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 164' ' ' GLU . 12.6 t -99.88 -14.33 18.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -170.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 70.41 26.37 4.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 124.682 1.193 . . . . 0.0 112.715 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 162' ' ' THR . 20.1 mm-40 -77.07 157.24 81.52 Favored Pre-proline 0 N--CA 1.481 1.09 0 C-N-CA 123.757 0.823 . . . . 0.0 111.51 172.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 111.23 2.57 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.252 1.968 . . . . 0.0 110.158 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 170' ' ' ILE . 92.5 mt -63.74 132.08 29.49 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 CA-C-O 121.493 0.663 . . . . 0.0 110.591 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 t -139.5 160.77 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.232 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.52 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -60.54 -26.23 66.74 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.62 0.768 . . . . 0.0 111.264 171.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.1 t -65.36 -37.74 87.95 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.449 1.1 . . . . 0.0 112.775 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.458 HD11 HG23 ' A' ' 166' ' ' ILE . 45.0 pt -79.1 -24.26 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 CA-C-N 117.594 0.179 . . . . 0.0 111.211 178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.531 HD11 HG23 ' A' ' 94' ' ' ILE . 73.0 mt -64.74 116.74 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 16.3 m -119.61 167.89 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.631 0.729 . . . . 0.0 112.254 -174.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -79.17 174.23 11.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.77 1.228 . . . . 0.0 113.013 -171.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.515 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 49.7 t-80 -70.65 -35.05 72.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.758 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 28.1 tp10 -70.89 -36.08 72.58 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.101 0.961 . . . . 0.0 110.884 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -51.89 -66.4 0.39 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.014 1.326 . . . . 0.0 111.68 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 7.5 m -91.59 114.98 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 122.597 0.359 . . . . 0.0 110.847 -166.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.81 118.71 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.433 ' HB3' ' SG ' ' A' ' 112' ' ' CYS . 45.7 t80 -64.32 111.85 2.81 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.1 0.476 . . . . 0.0 110.526 -177.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -98.84 122.43 42.08 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 114.897 -1.047 . . . . 0.0 108.486 172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.89 -37.62 88.06 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.201 1.001 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.5 m -62.72 -46.09 89.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.56 0.537 . . . . 0.0 110.746 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -80.56 -29.49 37.05 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.151 0.581 . . . . 0.0 110.5 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 78.8 32.19 41.64 Favored Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.471 -178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -169.5 167.81 9.65 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.733 0.413 . . . . 0.0 110.545 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.572 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 96.0 m-85 -71.2 123.8 23.03 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.536 1.135 . . . . 0.0 111.358 176.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 19.8 mm -105.18 158.41 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.993 1.317 . . . . 0.0 107.688 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . . . . . . . . . 31.0 mm -84.64 139.03 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.528 0.68 . . . . 0.0 112.117 -174.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -147.92 84.06 1.52 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -109.55 -116.35 3.84 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.238 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 C--O 1.254 1.336 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.244 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.478 0.954 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 153' ' ' VAL . 1.6 mp0 -59.85 -48.34 82.09 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.607 0.763 . . . . 0.0 112.101 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -51.64 -46.88 63.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.904 0.882 . . . . 0.0 112.093 -169.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.417 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 46.6 t -61.55 -40.04 93.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.532 0.733 . . . . 0.0 110.52 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.715 HG23 HD11 ' A' ' 171' ' ' ILE . 81.5 mt -73.25 -44.59 55.17 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.297 -174.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 91' ' ' GLN . 24.8 mm-40 -61.23 -45.21 95.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.718 0.807 . . . . 0.0 110.261 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.526 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 46.1 m-80 -58.86 -48.41 81.46 Favored 'General case' 0 C--N 1.362 1.14 0 O-C-N 123.526 0.516 . . . . 0.0 110.236 173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.485 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.8 OUTLIER -54.99 -53.38 56.53 Favored 'General case' 0 C--O 1.19 -2.049 0 O-C-N 124.627 1.205 . . . . 0.0 110.255 -176.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.498 ' HA ' HD12 ' A' ' 130' ' ' ILE . 91.3 mt -60.64 -34.72 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 110.494 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.589 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 66.6 m -65.78 -38.99 90.52 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.091 0.556 . . . . 0.0 112.279 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.526 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 10.1 pt20 -104.4 -21.22 13.51 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.415 ' SG ' ' HG3' ' A' ' 97' ' ' LYS . 80.5 m -96.66 -7.69 33.52 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.493 1.117 . . . . 0.0 112.097 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.5 ptpt -67.18 178.03 1.61 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.021 0.438 . . . . 0.0 111.483 171.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -166.96 165.59 15.84 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.378 -178.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.595 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 35.1 t -72.38 95.5 1.76 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.39 0.676 . . . . 0.0 110.937 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.03 92.45 1.52 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.979 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.364 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.577 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 38.6 m -128.99 138.82 34.01 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.505 -1.225 . . . . 0.0 107.898 174.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.21 -22.64 66.89 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.626 2.217 . . . . 0.0 112.696 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -66.78 -38.56 86.78 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.815 0.846 . . . . 0.0 111.684 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.577 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 25.7 mmt85 -75.47 -56.02 5.11 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.528 0.68 . . . . 0.0 109.512 -175.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.3 mt -71.49 -19.08 62.25 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.223 -177.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 58.32 30.1 19.06 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.601 1.16 . . . . 0.0 111.444 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.4 m -124.08 151.49 65.54 Favored Pre-proline 0 N--CA 1.473 0.706 0 CA-C-N 114.36 -1.291 . . . . 0.0 109.657 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.407 ' HG2' ' HB2' ' A' ' 116' ' ' ALA . 34.1 Cg_endo -60.68 159.5 28.16 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.107 2.538 . . . . 0.0 112.544 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -57.29 -49.36 76.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.96 0.904 . . . . 0.0 109.829 -178.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -51.01 -41.97 60.12 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.141 0.977 . . . . 0.0 113.049 177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 113' ' ' PRO . . . -63.38 -42.43 98.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.737 -177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 143' ' ' LEU . 26.1 pt -96.77 4.14 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.998 -172.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -73.99 132.17 42.13 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.03 0.532 . . . . 0.0 110.63 -167.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.483 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 22.7 t -67.14 118.08 52.4 Favored Pre-proline 0 CA--C 1.537 0.442 0 O-C-N 123.852 0.72 . . . . 0.0 109.884 172.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -61.52 -28.39 83.24 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.991 2.461 . . . . 0.0 112.681 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 27.5 mt -72.27 -47.14 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.511 0.724 . . . . 0.0 110.487 -174.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 44.9 p -102.55 3.81 37.81 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.26 0.624 . . . . 0.0 111.755 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 41.97 31.59 0.24 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 125.88 1.672 . . . . 0.0 113.554 -175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.22 176.9 8.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.989 0.515 . . . . 0.0 110.098 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.546 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.7 tt0 -61.98 121.43 65.41 Favored Pre-proline 0 C--N 1.35 0.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.586 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 88.7 Cg_exo -50.59 -42.79 48.41 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 122.464 2.11 . . . . 0.0 113.894 172.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 75.98 -49.59 0.6 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.122 1.369 . . . . 0.0 109.695 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.595 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 47.7 mmtm -131.59 118.0 19.49 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 126.763 2.025 . . . . 0.0 105.779 165.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.85 -170.9 17.77 Favored Glycine 0 CA--C 1.499 -0.951 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.498 HD12 ' HA ' ' A' ' 98' ' ' ILE . 13.1 tt -147.33 137.14 16.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 C-N-CA 122.717 0.407 . . . . 0.0 110.217 -170.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.648 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 20.8 m-85 -73.97 112.98 10.62 Favored 'General case' 0 C--N 1.351 0.636 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.783 175.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 92.4 t -130.42 136.56 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.498 ' HD3' HD11 ' A' ' 188' ' ' ILE . 8.9 mmmm -61.22 138.76 58.22 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.818 . . . . 0.0 111.007 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.486 ' HB3' HG13 ' A' ' 140' ' ' VAL . 3.5 t30 -59.86 -50.34 74.18 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.431 ' O ' ' HE2' ' A' ' 133' ' ' LYS . 25.9 p -146.06 135.42 22.95 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.949 -1.023 . . . . 0.0 108.604 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -56.57 -48.99 76.16 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.931 1.292 . . . . 0.0 112.167 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -81.87 35.84 2.51 Favored Glycine 0 N--CA 1.474 1.215 0 N-CA-C 114.449 0.54 . . . . 0.0 114.449 -176.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 m -137.57 -173.05 3.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.031 0.933 . . . . 0.0 109.825 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -109.4 -2.45 17.74 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.638 0.775 . . . . 0.0 110.803 173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.486 HG13 ' HB3' ' A' ' 134' ' ' ASN . 7.3 p -86.14 111.92 21.9 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 CA-C-O 122.121 0.962 . . . . 0.0 110.571 -173.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 48.8 t -102.6 152.99 20.54 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.039 -1.437 . . . . 0.0 108.705 172.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.48 HG21 HD11 ' A' ' 161' ' ' LEU . 75.1 m -140.22 142.4 35.84 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 117' ' ' ILE . 15.6 tp -95.89 122.53 38.79 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.16 0.505 . . . . 0.0 109.713 -177.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.66 162.99 15.56 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.139 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.586 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 22.6 t70 -73.66 131.41 41.62 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.461 ' HB1' ' HE2' ' A' ' 102' ' ' LYS . . . -60.83 -44.39 97.02 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.269 0.628 . . . . 0.0 111.376 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.08 -42.1 69.82 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.185 -177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.0 -39.29 72.5 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.971 0.909 . . . . 0.0 111.702 -174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' O ' HG23 ' A' ' 153' ' ' VAL . 37.7 t80 -75.59 -40.34 56.69 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.797 -178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -64.36 -43.64 93.9 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.585 0.354 . . . . 0.0 111.345 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -70.97 -32.7 69.63 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.207 0.203 . . . . 0.0 110.753 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.9 tt -57.34 -51.23 70.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.972 0.909 . . . . 0.0 110.002 173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 149' ' ' PHE . 97.3 t -64.63 -45.08 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 114.766 -1.107 . . . . 0.0 110.643 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.22 -33.99 82.48 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.096 0.873 . . . . 0.0 113.043 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -65.55 -36.36 83.55 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.448 0.699 . . . . 0.0 111.015 172.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.0 34.65 5.09 Favored Glycine 0 N--CA 1.467 0.717 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 -175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 96.4 mt -92.09 150.49 40.52 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 123.711 0.804 . . . . 0.0 110.645 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.93 169.38 21.42 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.834 2.356 . . . . 0.0 112.191 177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.467 ' HA ' HD11 ' A' ' 166' ' ' ILE . 52.4 t-80 -56.22 130.33 74.68 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.422 0.689 . . . . 0.0 111.03 -176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.82 -31.98 93.74 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.11 2.54 . . . . 0.0 113.209 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 142' ' ' THR . 53.3 mt -87.02 -68.22 0.76 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 122.755 0.422 . . . . 0.0 111.334 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.1 t -106.84 -9.83 16.24 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.885 0.474 . . . . 0.0 112.175 -166.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 68.54 31.32 4.83 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.358 1.063 . . . . 0.0 112.342 175.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -70.25 155.35 93.58 Favored Pre-proline 0 CA--C 1.552 1.05 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.741 169.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.64 103.36 0.56 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.651 2.234 . . . . 0.0 110.821 172.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.467 HD11 ' HA ' ' A' ' 159' ' ' HIS . 90.7 mt -60.7 124.29 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.19 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.8 t -139.0 167.87 21.08 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.24 1.016 . . . . 0.0 109.812 -175.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -63.7 -26.21 68.55 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.182 0.593 . . . . 0.0 111.096 173.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 21.7 t -64.15 -36.07 82.84 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.013 0.925 . . . . 0.0 112.644 -179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.8 pt -79.26 -22.07 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 CA-C-N 117.893 0.315 . . . . 0.0 111.253 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.715 HD11 HG23 ' A' ' 94' ' ' ILE . 69.2 mt -70.65 118.32 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.744 0.418 . . . . 0.0 110.116 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.477 ' HB ' ' HG3' ' A' ' 176' ' ' GLU . 16.0 m -128.3 171.79 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 123.556 0.743 . . . . 0.0 111.247 -173.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -97.76 -172.67 2.43 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.42 0.688 . . . . 0.0 112.397 -176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 58.7 t60 -69.71 -39.07 77.09 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.085 0.954 . . . . 0.0 112.438 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -62.7 -41.15 98.98 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.914 0.759 . . . . 0.0 109.391 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 172' ' ' VAL . 11.8 mm-40 -53.77 -70.97 0.08 Allowed 'General case' 0 C--N 1.353 0.758 0 O-C-N 124.734 1.271 . . . . 0.0 110.502 171.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.648 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 31.3 m -87.5 110.63 20.46 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 122.61 0.364 . . . . 0.0 110.695 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 36.8 pt -123.01 126.09 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -66.42 108.53 2.4 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.813 -0.554 . . . . 0.0 110.32 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -92.0 113.26 25.48 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 169.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -60.78 -38.75 86.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.051 0.844 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 42.3 m -68.54 -34.73 76.36 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.028 0.531 . . . . 0.0 110.577 -176.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -84.89 -25.87 27.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.057 0.543 . . . . 0.0 110.132 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.91 21.22 76.84 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.982 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -151.01 166.21 31.39 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.095 0.958 . . . . 0.0 109.858 -172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.505 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 98.4 m-85 -80.93 128.43 33.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.276 0.631 . . . . 0.0 109.3 172.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 25.4 mm -115.11 150.2 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.39 1.076 . . . . 0.0 108.194 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.498 HD11 ' HD3' ' A' ' 133' ' ' LYS . 47.1 mm -78.99 141.89 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.476 0.655 . . . . 0.0 112.595 -174.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.8 tmtm? -147.52 103.59 3.55 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.777 1.631 . . . . 0.0 106.972 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.97 1.28 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 . . . . . 0 CA--C 1.554 1.128 0 C-N-CA 123.846 0.859 . . . . 0.0 109.381 177.716 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 94' ' ' ILE . 25.4 m . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -56.07 -40.05 72.99 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.995 0.918 . . . . 0.0 111.417 -177.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -60.74 -39.13 87.54 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.297 0.639 . . . . 0.0 111.186 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.418 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 45.7 m -70.6 -35.76 73.18 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.098 0.559 . . . . 0.0 110.022 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 90' ' ' SER . 50.8 mt -66.22 -47.75 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.207 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -59.58 -45.82 90.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.962 0.905 . . . . 0.0 110.625 177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -58.11 -41.3 83.28 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.58 0.752 . . . . 0.0 110.745 176.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.577 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.1 OUTLIER -62.33 -47.54 83.78 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 123.634 0.584 . . . . 0.0 109.86 176.714 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.489 ' HA ' HD12 ' A' ' 130' ' ' ILE . 68.8 mt -60.88 -21.61 24.54 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.716 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 43.3 m -84.24 -47.24 11.01 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.847 0.859 . . . . 0.0 111.938 -176.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 17.8 pt20 -99.34 -28.77 13.14 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 123.602 0.761 . . . . 0.0 112.533 -173.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.9 t -83.17 -14.11 54.14 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.537 0.735 . . . . 0.0 111.294 -177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 99' ' ' SER . 19.0 ptpt -64.66 173.71 2.09 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.073 0.549 . . . . 0.0 111.822 176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -163.49 169.9 18.12 Favored 'General case' 0 C--O 1.243 0.761 0 C-N-CA 123.592 0.757 . . . . 0.0 110.624 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 32.8 p -69.19 98.86 1.06 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.062 0.945 . . . . 0.0 111.434 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 129' ' ' GLY . 60.5 t -84.9 88.63 2.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 CA-C-O 121.883 0.849 . . . . 0.0 110.192 175.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 75.5 m -133.75 138.42 30.91 Favored Pre-proline 0 CA--C 1.544 0.744 0 CA-C-N 114.691 -1.14 . . . . 0.0 108.051 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.86 -22.68 68.92 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.836 2.357 . . . . 0.0 112.802 -174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.446 ' HG3' ' HG2' ' A' ' 109' ' ' ARG . 8.0 pt-20 -60.51 -45.57 93.33 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 123.794 0.838 . . . . 0.0 111.176 169.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' HG2' ' HG3' ' A' ' 108' ' ' GLU . 30.2 mmt180 -76.71 -55.35 5.58 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.578 0.751 . . . . 0.0 111.104 -173.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.1 mp -71.35 -17.25 62.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.039 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 69.41 1.14 3.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.92 1.288 . . . . 0.0 111.811 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 53.5 m -96.41 152.66 38.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.867 1.267 . . . . 0.0 109.192 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.11 165.72 16.19 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.687 2.258 . . . . 0.0 112.121 177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.436 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -58.31 -50.28 74.18 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.758 0.823 . . . . 0.0 109.562 -177.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -48.33 -45.92 35.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.9 1.28 . . . . 0.0 112.316 177.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -62.98 -40.97 99.35 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.83 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.6 pt -98.28 4.03 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.069 -172.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.68 134.51 46.35 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.098 0.559 . . . . 0.0 109.599 -169.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.576 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 36.9 t -68.17 117.7 51.79 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.068 0.547 . . . . 0.0 110.117 176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -64.0 -18.42 63.63 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 123.064 2.509 . . . . 0.0 112.872 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.477 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 27.4 mt -78.34 -50.86 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 123.285 0.634 . . . . 0.0 109.867 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 63.5 p -104.15 6.19 35.54 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -172.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 46.12 26.6 0.45 Allowed 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 126.005 1.722 . . . . 0.0 114.258 178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -147.17 175.22 10.9 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB2' HD21 ' A' ' 114' ' ' LEU . 24.0 tt0 -60.25 124.64 78.74 Favored Pre-proline 0 C--N 1.35 0.623 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.576 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 52.6 Cg_exo -53.71 -48.41 21.98 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.11 1.873 . . . . 0.0 113.476 170.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 76.56 -45.22 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 125.376 1.47 . . . . 0.0 110.031 -170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -136.27 106.96 6.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 126.452 1.901 . . . . 0.0 106.575 172.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -145.0 -170.63 14.18 Favored Glycine 0 CA--C 1.506 -0.492 0 N-CA-C 112.162 -0.375 . . . . 0.0 112.162 -178.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tt -149.04 137.44 14.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 C-N-CA 123.132 0.573 . . . . 0.0 110.265 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.463 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 31.8 m-85 -74.86 119.22 18.75 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.35 173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 49.0 t -131.31 140.56 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.652 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.9 mmmm -62.42 146.08 52.37 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.374 1.07 . . . . 0.0 111.317 175.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 7.2 t30 -62.58 -48.11 80.88 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.011 0.819 . . . . 0.0 109.225 166.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.7 p -147.71 161.44 41.19 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.819 -178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.37 -49.23 19.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.273 0.629 . . . . 0.0 110.692 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -91.05 36.43 3.62 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.872 -175.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.9 m -155.2 122.89 5.68 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.0 39.78 0.31 Allowed 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 123.907 0.883 . . . . 0.0 113.308 -173.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.2 p -104.56 110.4 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.308 1.043 . . . . 0.0 108.833 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.3 t -97.34 154.57 17.36 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 124.39 1.076 . . . . 0.0 109.804 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.422 HG21 HD11 ' A' ' 161' ' ' LEU . 42.1 m -144.98 144.37 31.01 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.639 0.775 . . . . 0.0 109.198 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.5 tp -96.49 124.56 40.52 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 123.06 0.544 . . . . 0.0 110.386 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -117.08 167.58 11.04 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.255 1.022 . . . . 0.0 109.517 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.559 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.4 t70 -79.9 141.51 36.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 172.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.52 -46.9 74.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.3 0.64 . . . . 0.0 111.315 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -68.62 -36.28 78.43 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.044 0.537 . . . . 0.0 111.035 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.61 -41.77 53.52 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.188 0.995 . . . . 0.0 111.683 -176.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 153' ' ' VAL . 29.6 t80 -75.13 -33.64 61.59 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.416 ' HB2' HG21 ' A' ' 98' ' ' ILE . 31.6 t -66.13 -45.16 82.05 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.876 0.47 . . . . 0.0 111.252 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 16.1 ptm180 -68.03 -38.32 82.41 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 157' ' ' LEU . 3.4 tt -56.72 -51.58 68.29 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.401 1.08 . . . . 0.0 110.863 178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.51 HG22 HG21 ' A' ' 166' ' ' ILE . 61.6 t -66.74 -38.89 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.175 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -63.13 -34.08 88.99 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 123.635 0.584 . . . . 0.0 112.865 -177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 21.2 mm-40 -72.34 -33.12 67.07 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.524 0.729 . . . . 0.0 110.284 173.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.63 36.04 7.06 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.697 -173.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' A' ' 155' ' ' GLU . 92.7 mt -83.19 146.99 52.57 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 123.764 0.826 . . . . 0.0 109.784 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -69.8 168.92 20.21 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.738 2.292 . . . . 0.0 112.218 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -53.72 128.79 54.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.899 0.88 . . . . 0.0 112.062 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.08 -28.99 81.43 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.399 2.732 . . . . 0.0 113.09 -174.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 142' ' ' THR . 38.7 mt -86.11 -79.36 0.25 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.947 175.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 9.8 t -96.57 -3.06 43.69 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.72 0.808 . . . . 0.0 112.834 -161.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 73.9 mmt-85 66.33 19.64 11.0 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.601 1.16 . . . . 0.0 112.993 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -69.41 154.4 94.92 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 122.769 0.428 . . . . 0.0 110.645 173.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.31 108.69 0.72 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.361 2.041 . . . . 0.0 110.369 173.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 153' ' ' VAL . 82.6 mt -61.34 131.98 26.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 122.984 0.514 . . . . 0.0 110.35 176.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 t -137.63 161.69 35.8 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.47 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.577 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -67.29 -26.15 66.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.812 0.445 . . . . 0.0 110.152 173.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -62.75 -26.81 68.89 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.327 1.051 . . . . 0.0 112.775 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 40.6 pt -92.02 -5.21 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-N 118.241 0.473 . . . . 0.0 111.924 176.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.422 HD11 HG23 ' A' ' 94' ' ' ILE . 54.5 mt -79.6 126.22 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 O-C-N 121.543 -0.723 . . . . 0.0 109.86 176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.2 m -117.36 168.6 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.973 0.909 . . . . 0.0 110.166 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 173' ' ' LYS . 0.1 OUTLIER -90.1 -175.65 4.62 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.671 0.788 . . . . 0.0 111.006 -174.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 25.5 t-80 -66.03 -54.39 26.5 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.746 -175.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -68.49 -25.06 64.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.288 0.635 . . . . 0.0 111.677 -176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 29.6 mm-40 -60.3 -16.95 39.24 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 113.653 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 42.0 m -130.59 126.89 37.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.282 0.947 . . . . 0.0 110.313 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 29.0 pt -128.41 127.13 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -65.09 121.07 13.87 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.175 0.512 . . . . 0.0 110.693 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -110.88 107.42 16.89 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.19 -28.02 69.1 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 124.174 0.921 . . . . 0.0 112.705 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 27.7 m -65.97 -42.03 90.41 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.016 0.526 . . . . 0.0 110.552 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.445 ' HG3' HD11 ' A' ' 187' ' ' ILE . 31.7 mmm180 -80.44 -33.73 36.62 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.98 0.512 . . . . 0.0 110.494 177.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 77.93 20.36 73.44 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.478 -168.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -139.3 159.25 42.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.222 1.009 . . . . 0.0 109.43 -170.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.563 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 95.5 m-85 -85.11 136.33 33.6 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 172.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.445 HD11 ' HG3' ' A' ' 183' ' ' ARG . 16.7 mm -108.19 146.81 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -174.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.574 HD11 ' HD3' ' A' ' 133' ' ' LYS . 31.4 mm -71.16 128.49 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 O-C-N 123.561 0.538 . . . . 0.0 111.017 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -144.08 99.77 3.45 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.813 0.845 . . . . 0.0 109.167 -173.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -140.43 34.37 1.98 Allowed Glycine 0 C--N 1.344 0.981 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.783 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 CA--C 1.546 0.808 0 C-N-CA 124.849 1.259 . . . . 0.0 107.995 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 119.427 -0.321 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -57.68 -49.1 77.61 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.543 0.737 . . . . 0.0 112.479 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -68.2 -27.34 66.31 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 122.445 0.298 . . . . 0.0 110.876 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.7 m -72.23 -38.81 68.87 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.677 0.791 . . . . 0.0 109.119 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.656 HG21 HG11 ' A' ' 153' ' ' VAL . 87.7 mt -62.66 -47.23 93.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.534 1.133 . . . . 0.0 109.397 174.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -61.69 -36.41 80.79 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.017 0.927 . . . . 0.0 111.094 178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 25.1 m-80 -59.31 -43.25 92.68 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 122.59 0.356 . . . . 0.0 110.176 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.603 ' HB3' HG21 ' A' ' 171' ' ' ILE . 0.4 OUTLIER -63.2 -46.93 84.72 Favored 'General case' 0 C--O 1.211 -0.955 0 O-C-N 123.689 0.618 . . . . 0.0 109.974 178.727 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 130' ' ' ILE . 43.8 mt -66.21 -16.58 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.885 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 t -88.45 -43.92 11.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.747 0.819 . . . . 0.0 111.216 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 23.8 pt20 -98.21 -40.43 8.38 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.191 0.597 . . . . 0.0 112.002 -175.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 173' ' ' LYS . 7.5 t -73.66 -14.05 61.09 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.411 0.684 . . . . 0.0 111.732 -174.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -62.84 168.15 4.11 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -163.02 165.73 24.51 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.306 -176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 128' ' ' LYS . 15.3 m -70.74 95.92 1.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.495 0.718 . . . . 0.0 110.564 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 129' ' ' GLY . 95.5 t -80.72 99.85 4.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.63 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 73.0 m -138.85 141.47 30.53 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.72 0.808 . . . . 0.0 109.3 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.434 ' HD3' ' NE2' ' A' ' 125' ' ' GLN . 57.7 Cg_endo -66.64 -40.23 13.88 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 123.533 2.822 . . . . 0.0 114.239 -163.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -31.47 60.27 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.514 0.326 . . . . 0.0 110.964 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -65.4 -53.8 37.89 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.591 0.71 . . . . 0.0 109.725 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.8 -13.77 61.79 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.806 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 64.67 22.61 12.64 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.941 1.297 . . . . 0.0 112.144 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 16.3 m -115.0 157.73 42.62 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.0 0.92 . . . . 0.0 110.031 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.43 159.11 49.24 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.989 1.793 . . . . 0.0 111.283 168.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -48.46 79.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.345 0.658 . . . . 0.0 110.291 -177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.15 -33.83 65.57 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.722 0.809 . . . . 0.0 112.787 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -67.29 -39.67 86.01 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.051 0.54 . . . . 0.0 111.345 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.0 pt -96.49 3.31 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.071 -176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.86 130.27 41.8 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.387 0.675 . . . . 0.0 110.685 -167.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.541 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 28.2 t -65.42 113.34 11.16 Favored Pre-proline 0 CA--C 1.536 0.423 0 O-C-N 123.951 0.782 . . . . 0.0 109.522 173.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.95 -28.06 86.56 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.981 2.454 . . . . 0.0 113.057 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.431 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 59.9 mt -68.91 -47.97 72.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.802 0.841 . . . . 0.0 110.756 -179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 70.2 p -106.64 4.48 27.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 42.99 32.29 0.4 Allowed 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 126.371 1.868 . . . . 0.0 114.054 -177.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -145.76 176.42 9.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.018 0.527 . . . . 0.0 109.702 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.434 ' NE2' ' HD3' ' A' ' 107' ' ' PRO . 22.7 tt0 -62.65 122.76 76.06 Favored Pre-proline 0 C--N 1.351 0.653 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.551 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 77.3 Cg_exo -50.45 -46.26 30.24 Favored 'Trans proline' 0 C--N 1.367 1.506 0 C-N-CA 122.385 2.057 . . . . 0.0 113.323 171.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 76.41 -47.48 0.55 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.834 1.254 . . . . 0.0 109.6 -174.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.555 ' HD2' ' HA ' ' A' ' 104' ' ' SER . 14.3 mmmm -135.45 108.76 7.8 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 167.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.424 ' H ' HG23 ' A' ' 105' ' ' VAL . . . -143.49 -174.71 15.97 Favored Glycine 0 CA--C 1.505 -0.573 0 CA-C-O 119.834 -0.425 . . . . 0.0 112.852 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 98' ' ' ILE . 9.5 tt -144.45 138.19 23.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 C-N-CA 122.716 0.406 . . . . 0.0 110.172 -172.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.632 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 23.3 m-85 -75.54 111.45 10.86 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.628 172.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.85 134.28 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 123.892 0.877 . . . . 0.0 108.654 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 12.3 mmmm -63.63 149.9 45.42 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.149 0.98 . . . . 0.0 112.002 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.443 ' HB3' HG13 ' A' ' 140' ' ' VAL . 6.4 t30 -77.6 -47.58 19.02 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.683 -1.144 . . . . 0.0 109.023 169.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 p -140.09 151.19 45.16 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.837 0.855 . . . . 0.0 109.511 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.65 -43.74 65.54 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.529 0.732 . . . . 0.0 111.496 -174.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.63 -49.99 46.11 Favored Glycine 0 N--CA 1.472 1.093 0 CA-C-N 115.768 -0.651 . . . . 0.0 113.409 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 m -76.58 155.37 33.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.155 0.582 . . . . 0.0 109.858 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -92.25 30.49 1.45 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.03 0.532 . . . . 0.0 111.342 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.1 p -90.42 102.45 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 122.121 0.962 . . . . 0.0 109.736 -177.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 42.7 t -97.68 146.01 25.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.638 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.547 HG21 HD11 ' A' ' 161' ' ' LEU . 21.7 m -130.78 134.61 47.01 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.039 0.536 . . . . 0.0 109.61 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.1 tp -93.85 118.12 31.02 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -111.8 170.16 8.33 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.817 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.551 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 18.9 t70 -78.33 136.14 37.64 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 168.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -64.03 -45.96 86.58 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.563 0.539 . . . . 0.0 111.638 -174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.81 62.14 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.849 0.46 . . . . 0.0 110.802 -174.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -71.3 -37.92 71.79 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.921 0.888 . . . . 0.0 110.768 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.561 ' O ' HG23 ' A' ' 153' ' ' VAL . 51.3 t80 -73.73 -42.8 60.65 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.452 ' HB2' HG21 ' A' ' 98' ' ' ILE . 23.1 t -61.43 -43.42 98.9 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.173 0.589 . . . . 0.0 111.656 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 14.6 ptm180 -68.53 -36.15 78.44 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.638 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 8.0 tt -58.23 -48.85 79.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.199 0.999 . . . . 0.0 110.755 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 94' ' ' ILE . 7.0 t -64.4 -42.98 96.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 O-C-N 123.943 0.777 . . . . 0.0 109.728 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.05 -19.44 69.97 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.414 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 54.1 mm-40 -76.23 -34.26 59.22 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.902 0.481 . . . . 0.0 110.189 169.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.53 40.75 4.37 Favored Glycine 0 C--N 1.337 0.631 0 O-C-N 123.683 0.614 . . . . 0.0 111.663 -175.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 94.8 mt -98.97 152.0 37.61 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 123.849 0.86 . . . . 0.0 110.137 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.9 -179.17 4.01 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.639 2.226 . . . . 0.0 112.028 174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.492 ' HA ' HD11 ' A' ' 166' ' ' ILE . 30.5 t-80 -60.43 127.01 85.97 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 122.837 0.455 . . . . 0.0 110.969 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.15 -26.97 83.9 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.962 2.441 . . . . 0.0 113.349 -173.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.547 HD11 HG21 ' A' ' 142' ' ' THR . 68.3 mt -84.77 -66.61 0.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.213 0.605 . . . . 0.0 111.434 178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 10.3 t -113.33 -7.88 13.49 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.79 -162.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 67.29 31.6 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.892 1.277 . . . . 0.0 112.004 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -71.18 156.62 91.6 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.543 168.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -67.26 105.4 1.02 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.454 2.103 . . . . 0.0 111.551 175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.536 ' HA ' HD11 ' A' ' 170' ' ' ILE . 74.3 mt -66.51 117.81 8.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 CA-C-O 121.347 0.594 . . . . 0.0 110.38 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 13.1 t -155.57 177.79 10.98 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.428 177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.05 -29.56 65.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.031 0.932 . . . . 0.0 112.206 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.6 t -57.73 -39.11 76.55 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.904 0.881 . . . . 0.0 112.776 -178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 44.0 pt -90.82 -19.24 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-O 119.729 -0.177 . . . . 0.0 111.402 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.603 HG21 ' HB3' ' A' ' 97' ' ' LYS . 65.4 mt -70.09 123.42 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 121.675 -0.64 . . . . 0.0 109.987 176.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.7 m -121.83 166.52 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.554 0.742 . . . . 0.0 111.213 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 101' ' ' CYS . 43.4 mtmt -81.04 177.21 9.2 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.308 1.043 . . . . 0.0 111.589 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.533 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 60.2 t-80 -67.17 -44.43 79.72 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.647 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -68.83 -28.18 66.51 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.187 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -56.35 -58.83 6.3 Favored 'General case' 0 C--O 1.217 -0.65 0 O-C-N 123.957 0.786 . . . . 0.0 110.053 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 26.7 m -90.15 112.11 23.48 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.176 0.512 . . . . 0.0 110.312 -170.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 pt -119.32 134.22 63.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.292 1.037 . . . . 0.0 108.247 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -66.95 124.41 22.92 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.528 0.331 . . . . 0.0 110.484 -177.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -121.51 116.03 23.93 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.21 -40.45 86.42 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.217 0.948 . . . . 0.0 111.758 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 49.7 m -57.57 -45.15 85.53 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.418 0.687 . . . . 0.0 111.57 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -81.21 -32.73 33.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.271 0.628 . . . . 0.0 109.689 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.31 35.64 52.12 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.073 -172.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -161.64 163.99 29.56 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.119 0.567 . . . . 0.0 110.257 -176.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 87.7 m-85 -79.66 127.49 32.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 177.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 12.3 mm -107.81 157.26 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -177.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.51 HD11 ' HD3' ' A' ' 133' ' ' LYS . 46.9 mm -87.82 136.52 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 121.22 0.533 . . . . 0.0 112.24 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 189' ' ' LYS . 0.3 OUTLIER -144.68 91.16 2.14 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 125.816 1.646 . . . . 0.0 108.367 -175.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -141.46 1.09 1.81 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 114.552 -1.204 . . . . 0.0 112.065 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 CA--C 1.547 0.861 0 C-N-CA 124.528 1.131 . . . . 0.0 108.106 179.063 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.449 HE22 HG12 ' A' ' 153' ' ' VAL . 7.5 tp-100 -52.98 -42.26 65.37 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.388 1.075 . . . . 0.0 111.898 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -53.05 -43.66 66.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.022 0.929 . . . . 0.0 111.666 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.423 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 27.3 t -70.54 -37.29 74.03 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.752 HG21 HG11 ' A' ' 153' ' ' VAL . 53.3 mt -63.89 -48.96 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.898 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -61.05 -46.75 89.42 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.006 0.922 . . . . 0.0 110.677 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 13.1 m-80 -58.83 -38.38 78.55 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.854 176.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.508 ' HE3' ' HB1' ' A' ' 168' ' ' ALA . 0.5 OUTLIER -57.71 -54.12 50.48 Favored 'General case' 0 C--O 1.208 -1.086 0 O-C-N 123.723 0.639 . . . . 0.0 109.995 177.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 HG21 ' A' ' 130' ' ' ILE . 21.7 mt -68.56 -15.56 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.039 -174.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.6 t -79.83 -46.85 16.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.81 0.844 . . . . 0.0 111.976 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 18.6 pt20 -94.97 -48.04 6.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.591 0.356 . . . . 0.0 111.799 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 99.2 m -69.35 -10.68 59.0 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.179 1.391 . . . . 0.0 113.322 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -63.17 167.58 4.94 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 120.956 0.407 . . . . 0.0 110.688 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -156.28 164.97 37.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.273 0.629 . . . . 0.0 109.803 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 30.7 p -72.34 97.1 1.96 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 121.496 0.665 . . . . 0.0 110.934 177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.86 100.18 2.98 Favored 'Isoleucine or valine' 0 C--O 1.246 0.903 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.912 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 109' ' ' ARG . 42.1 m -135.72 140.11 32.77 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.527 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.88 -25.63 45.1 Favored 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 122.751 2.301 . . . . 0.0 112.658 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.3 -27.92 66.72 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.166 0.986 . . . . 0.0 111.841 175.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 106' ' ' CYS . 16.5 mmt180 -89.31 -54.57 4.04 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.455 0.702 . . . . 0.0 110.846 -175.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 51.7 mt -71.67 -16.48 62.26 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.388 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 67.25 11.37 8.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.598 1.159 . . . . 0.0 112.383 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 11.7 m -107.27 148.01 36.29 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.195 0.998 . . . . 0.0 108.663 -176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.71 167.03 14.34 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.385 2.056 . . . . 0.0 111.985 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.85 -51.59 68.41 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.539 0.736 . . . . 0.0 110.382 -175.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -50.39 -40.87 51.01 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.045 0.938 . . . . 0.0 112.555 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.12 87.89 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.703 -175.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 38.2 pt -96.09 0.87 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.959 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -69.14 128.09 35.42 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 123.648 0.779 . . . . 0.0 110.215 -167.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.548 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 29.1 t -64.59 114.3 13.92 Favored Pre-proline 0 CA--C 1.537 0.455 0 O-C-N 123.97 0.794 . . . . 0.0 109.34 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -63.22 -20.4 70.7 Favored 'Trans proline' 0 C--N 1.372 1.815 0 C-N-CA 122.985 2.457 . . . . 0.0 112.764 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.446 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 43.3 mt -74.47 -51.68 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 123.853 0.861 . . . . 0.0 109.829 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.7 p -102.58 6.59 39.88 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.341 0.656 . . . . 0.0 112.167 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 43.14 32.56 0.46 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 126.396 1.878 . . . . 0.0 113.82 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.1 174.85 11.18 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.885 0.474 . . . . 0.0 109.94 -175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -62.26 123.8 79.82 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.163 174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.548 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.3 Cg_exo -51.93 -49.43 17.33 Favored 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.314 2.009 . . . . 0.0 113.545 172.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 76.9 -47.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 124.617 1.167 . . . . 0.0 109.542 -172.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 46.6 mmtm -131.54 110.75 11.19 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 167.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -145.33 -170.75 14.48 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 112.181 -0.368 . . . . 0.0 112.181 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 HG23 ' A' ' 98' ' ' ILE . 15.3 tt -151.17 135.76 9.52 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 C-N-CA 122.744 0.417 . . . . 0.0 110.091 -171.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.655 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 24.9 m-85 -76.75 112.59 13.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.46 0.704 . . . . 0.0 110.631 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.9 t -129.69 140.09 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 C-N-CA 123.61 0.764 . . . . 0.0 109.267 178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 170' ' ' ILE . 14.0 mmmm -63.14 139.25 58.75 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.323 1.049 . . . . 0.0 111.773 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.413 ' HA ' ' CE1' ' A' ' 159' ' ' HIS . 37.4 t30 -68.04 -47.6 67.93 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.044 -0.98 . . . . 0.0 108.789 165.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.8 p -137.56 138.66 39.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.512 0.725 . . . . 0.0 109.118 174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -61.74 -47.4 85.39 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.284 1.034 . . . . 0.0 112.027 -173.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -72.5 -49.08 20.76 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.824 -174.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 m -76.8 151.59 35.89 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.226 0.513 . . . . 0.0 109.952 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -81.51 45.48 0.88 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.488 0.585 . . . . 0.0 112.203 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 134' ' ' ASN . 3.9 p -111.79 103.53 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 122.004 0.907 . . . . 0.0 110.185 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' LYS . 51.9 t -104.42 154.34 19.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.736 173.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.1 m -144.78 145.03 31.47 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.396 0.679 . . . . 0.0 109.358 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 19.2 tp -94.05 122.78 36.91 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.426 0.691 . . . . 0.0 110.089 -177.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -115.17 167.35 10.91 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.115 0.966 . . . . 0.0 109.303 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 28.1 t70 -78.98 137.62 37.68 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.25 -42.05 89.13 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.231 0.612 . . . . 0.0 111.83 -174.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.53 -43.0 67.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.864 0.465 . . . . 0.0 110.453 -177.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.419 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -70.78 -39.56 73.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.117 0.967 . . . . 0.0 111.508 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.576 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.4 t80 -74.16 -44.86 51.94 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 123.665 0.603 . . . . 0.0 109.704 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.6 t -59.36 -44.26 92.73 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.677 0.391 . . . . 0.0 111.401 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -71.01 -33.24 70.19 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 119.715 -0.183 . . . . 0.0 110.815 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.4 tt -59.71 -51.46 69.68 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.956 0.902 . . . . 0.0 110.447 177.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.752 HG11 HG21 ' A' ' 94' ' ' ILE . 9.1 t -63.77 -44.04 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.576 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -62.16 -31.53 79.28 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-N 115.488 -0.778 . . . . 0.0 113.353 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.41 -21.68 59.52 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.912 0.885 . . . . 0.0 111.485 175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.36 17.64 54.81 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.407 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 78.6 mt -74.33 141.71 77.46 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 123.497 0.719 . . . . 0.0 109.712 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.36 172.04 13.98 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.312 2.008 . . . . 0.0 111.367 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.5 ' HA ' HD11 ' A' ' 166' ' ' ILE . 36.7 t-80 -55.73 127.55 67.67 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.38 0.672 . . . . 0.0 111.612 -173.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.47 -32.27 42.39 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.751 2.967 . . . . 0.0 113.459 -175.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 20.3 mt -88.73 -68.77 0.75 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.506 -178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 13.3 t -108.65 -2.57 18.62 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.494 0.718 . . . . 0.0 112.776 -164.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 66.92 27.75 8.83 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.643 1.177 . . . . 0.0 112.072 175.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -68.83 153.37 96.05 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.736 0.815 . . . . 0.0 111.121 170.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.44 106.89 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.499 2.133 . . . . 0.0 110.57 171.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 159' ' ' HIS . 64.1 mt -67.6 130.61 33.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 CA-C-O 121.006 0.431 . . . . 0.0 110.298 -177.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.8 t -143.81 172.36 12.94 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.76 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.508 ' HB1' ' HE3' ' A' ' 97' ' ' LYS . . . -69.84 -26.76 64.37 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.466 0.706 . . . . 0.0 111.356 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.3 t -63.05 -42.42 99.72 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.694 0.798 . . . . 0.0 111.941 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 45.4 pt -73.63 -23.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 CA-C-N 117.665 0.211 . . . . 0.0 111.185 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 94' ' ' ILE . 72.2 mt -68.68 115.94 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.407 HG23 ' SG ' ' A' ' 177' ' ' CYS . 12.8 m -121.18 166.07 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.483 0.713 . . . . 0.0 111.355 -172.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.73 ' HB2' ' HG2' ' A' ' 176' ' ' GLU . 18.2 mtpp -63.67 160.32 17.2 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.384 1.073 . . . . 0.0 112.305 -176.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.49 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 56.1 t-80 -62.15 -35.26 78.24 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.454 171.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.71 -44.9 84.68 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.348 1.059 . . . . 0.0 109.787 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.73 ' HG2' ' HB2' ' A' ' 173' ' ' LYS . 51.0 mm-40 -52.05 -55.58 19.78 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 124.347 1.03 . . . . 0.0 111.309 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 131' ' ' PHE . 21.6 m -87.24 111.33 20.91 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 0.0 110.138 -170.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.0 pt -117.42 136.62 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.398 1.079 . . . . 0.0 108.129 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -72.65 128.98 37.19 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 122.121 -0.362 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -126.35 110.54 13.48 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 173.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -62.95 -34.34 77.28 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.284 1.034 . . . . 0.0 112.628 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 87.7 m -66.56 -36.95 83.9 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.719 0.407 . . . . 0.0 111.203 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -84.77 -28.7 26.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.858 0.463 . . . . 0.0 109.76 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 29.13 60.37 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.435 -178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -162.51 178.14 8.86 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -174.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.67 133.52 36.93 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.359 0.664 . . . . 0.0 110.474 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 16.3 mm -109.94 156.63 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.886 1.275 . . . . 0.0 107.764 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 141' ' ' CYS . 45.1 mm -91.95 134.02 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 CA-C-N 118.394 0.543 . . . . 0.0 111.569 -176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 108.26 2.09 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.698 1.599 . . . . 0.0 109.677 -171.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 158.22 -72.92 0.23 Allowed Glycine 0 C--N 1.338 0.641 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 7.8 t30 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 124.981 1.313 . . . . 0.0 110.518 177.095 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 92.1 p . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -61.97 -33.95 75.24 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.638 0.775 . . . . 0.0 110.055 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.49 -41.59 85.69 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.431 1.092 . . . . 0.0 111.129 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.8 t -69.41 -40.04 77.55 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -175.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 HG23 HD11 ' A' ' 171' ' ' ILE . 72.7 mt -64.19 -46.74 92.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.078 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -60.13 -47.87 84.08 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.842 0.857 . . . . 0.0 111.181 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.548 ' O ' ' HG2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -59.67 -37.96 80.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 110.697 177.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.4 -51.16 70.68 Favored 'General case' 0 C--O 1.198 -1.655 0 O-C-N 123.678 0.611 . . . . 0.0 109.712 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 130' ' ' ILE . 52.0 mt -63.48 -18.6 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.956 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.3 m -81.74 -42.78 19.32 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.441 0.696 . . . . 0.0 111.826 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.548 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 22.7 pt20 -105.58 -33.2 8.16 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.348 0.659 . . . . 0.0 112.154 -173.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t -81.99 -5.11 58.07 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.397 1.079 . . . . 0.0 111.595 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 146' ' ' ALA . 19.4 ptpt -65.0 179.15 0.72 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-O 121.218 0.532 . . . . 0.0 111.533 169.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -163.74 161.72 23.57 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.699 0.8 . . . . 0.0 109.774 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 128' ' ' LYS . 19.5 m -71.71 99.25 2.09 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.256 0.622 . . . . 0.0 111.164 177.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 95.3 t -85.02 98.45 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.187 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 66.8 m -138.21 136.67 19.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.61 -52.37 3.9 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.869 3.046 . . . . 0.0 113.76 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -29.29 69.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.677 0.791 . . . . 0.0 111.507 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -68.72 -54.47 15.9 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.455 0.645 . . . . 0.0 109.548 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.14 -9.43 52.78 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.805 1.242 . . . . 0.0 113.447 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 70.87 3.85 4.79 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 124.825 1.25 . . . . 0.0 112.202 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 57.2 m -104.82 161.51 22.55 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.219 1.008 . . . . 0.0 110.022 -173.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.2 163.26 39.26 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.018 1.812 . . . . 0.0 111.356 169.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.499 HD21 ' HB2' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -56.84 -51.32 69.47 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.064 0.945 . . . . 0.0 110.291 -177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.5 -35.35 67.9 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.935 0.894 . . . . 0.0 112.959 -177.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.12 86.42 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.194 0.597 . . . . 0.0 111.122 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.406 ' HB ' HD23 ' A' ' 143' ' ' LEU . 34.6 pt -103.5 2.86 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -72.51 128.04 34.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.166 0.587 . . . . 0.0 110.127 -167.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.581 ' HB2' ' HG3' ' A' ' 126' ' ' PRO . 34.9 t -64.19 119.12 53.06 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 123.769 0.828 . . . . 0.0 110.329 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -63.41 -21.31 71.22 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.954 2.436 . . . . 0.0 113.077 177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' HB ' ' SG ' ' A' ' 119' ' ' CYS . 40.4 mt -80.26 -52.04 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 123.29 0.636 . . . . 0.0 109.757 -176.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.6 p -102.28 8.33 40.44 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 43.78 36.42 1.31 Allowed 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 125.944 1.698 . . . . 0.0 113.765 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.99 177.87 10.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.513 0.325 . . . . 0.0 110.428 -174.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HD21 ' A' ' 114' ' ' LEU . 20.1 tt0 -62.73 121.72 69.76 Favored Pre-proline 0 CA--C 1.545 0.761 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 172.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.581 ' HG3' ' HB2' ' A' ' 119' ' ' CYS . 71.6 Cg_exo -51.91 -46.68 30.74 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 122.818 2.345 . . . . 0.0 113.846 171.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 76.73 -46.9 0.52 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.313 1.445 . . . . 0.0 110.0 -172.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.547 ' HD3' ' HA ' ' A' ' 104' ' ' SER . 48.9 mmtm -134.74 110.75 9.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.523 1.929 . . . . 0.0 105.936 167.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA2' ' N ' ' A' ' 146' ' ' ALA . . . -144.16 -175.03 16.92 Favored Glycine 0 CA--C 1.505 -0.544 0 N-CA-C 111.671 -0.571 . . . . 0.0 111.671 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 98' ' ' ILE . 14.4 tt -145.44 138.83 21.56 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 CA-C-N 117.002 0.401 . . . . 0.0 110.387 -170.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.489 ' HB3' ' SG ' ' A' ' 177' ' ' CYS . 13.0 m-85 -75.79 113.44 13.25 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.889 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 ' CZ ' ' A' ' 149' ' ' PHE . 82.6 t -130.01 136.29 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.698 ' HD3' HD11 ' A' ' 188' ' ' ILE . 10.7 mmmm -59.35 138.52 57.61 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.249 1.019 . . . . 0.0 111.937 177.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.478 ' HB3' HG13 ' A' ' 140' ' ' VAL . 4.3 t30 -62.4 -50.64 70.74 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 167.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 7.6 p -138.68 133.98 33.04 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.291 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -59.27 -53.57 56.8 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.459 1.103 . . . . 0.0 112.497 -171.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -86.79 38.46 3.12 Favored Glycine 0 N--CA 1.473 1.143 0 CA-C-N 116.247 -0.433 . . . . 0.0 113.475 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.8 m -133.56 -173.66 3.29 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.343 1.057 . . . . 0.0 109.086 175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -112.97 8.67 18.58 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.375 0.67 . . . . 0.0 111.226 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.478 HG13 ' HB3' ' A' ' 134' ' ' ASN . 4.4 p -93.11 116.33 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-O 121.792 0.806 . . . . 0.0 110.615 -175.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' CYS . . . . . . . . . . . . . 45.5 t -106.59 150.25 26.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.807 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.484 HG21 HD11 ' A' ' 161' ' ' LEU . 33.6 m -140.0 142.07 36.3 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.406 HD23 ' HB ' ' A' ' 117' ' ' ILE . 13.1 tp -95.72 123.32 39.23 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.467 0.651 . . . . 0.0 110.1 -178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -114.88 169.46 9.07 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.214 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.571 ' HA ' ' HB3' ' A' ' 126' ' ' PRO . 33.0 t70 -78.23 138.05 38.44 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' N ' ' HA2' ' A' ' 129' ' ' GLY . . . -66.29 -47.58 73.16 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.705 0.628 . . . . 0.0 110.868 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -69.22 -35.56 76.31 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.151 0.58 . . . . 0.0 111.326 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . . . -76.04 -41.24 51.39 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.837 0.855 . . . . 0.0 111.005 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.485 ' O ' HG23 ' A' ' 153' ' ' VAL . 38.9 t80 -73.84 -33.96 64.34 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.917 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -65.73 -50.19 65.72 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.786 0.434 . . . . 0.0 110.973 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.558 ' O ' ' HG2' ' A' ' 155' ' ' GLU . 8.9 ptm180 -60.81 -40.17 91.73 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.26 -51.57 61.8 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.526 1.53 . . . . 0.0 110.884 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.544 HG22 HG21 ' A' ' 166' ' ' ILE . 59.4 t -61.72 -44.45 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.234 177.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.97 73.4 Favored Glycine 0 CA--C 1.537 1.461 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.357 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 151' ' ' ARG . 7.3 mm-40 -75.0 -24.83 58.47 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.084 0.553 . . . . 0.0 109.904 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.6 31.38 10.37 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.665 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 97.1 mt -94.49 152.92 40.37 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.918 0.887 . . . . 0.0 110.528 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -78.44 178.72 7.24 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.964 2.443 . . . . 0.0 111.964 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -60.69 127.3 86.91 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.981 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.79 -32.82 68.03 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 123.724 2.949 . . . . 0.0 113.971 -174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 142' ' ' THR . 29.9 mt -81.68 -65.27 1.03 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.934 0.397 . . . . 0.0 111.903 -176.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 8.8 t -119.94 -6.05 10.05 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.002 -163.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 10.2 mpt_? 71.83 40.06 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.822 1.249 . . . . 0.0 112.17 177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 135' ' ' SER . 7.2 mm-40 -63.96 148.84 94.51 Favored Pre-proline 0 N--CA 1.474 0.768 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.25 165.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.88 100.53 0.72 Allowed 'Trans proline' 0 CA--C 1.551 1.367 0 C-N-CA 122.057 1.838 . . . . 0.0 109.417 168.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.544 HG21 HG22 ' A' ' 153' ' ' VAL . 97.1 mt -58.04 126.98 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 122.936 0.494 . . . . 0.0 111.111 -175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 170' ' ' ILE . 6.0 t -145.82 166.04 27.11 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.972 -170.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -65.22 -25.53 67.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.822 0.849 . . . . 0.0 110.816 173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.3 t -65.84 -36.37 83.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.356 1.062 . . . . 0.0 112.093 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 133' ' ' LYS . 41.7 pt -81.43 -23.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-N 117.637 0.199 . . . . 0.0 111.222 177.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.492 HD11 HG23 ' A' ' 94' ' ' ILE . 75.1 mt -72.32 124.4 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.445 HG21 ' SG ' ' A' ' 177' ' ' CYS . 16.3 m -126.9 170.46 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 124.037 0.935 . . . . 0.0 110.297 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -88.79 -179.92 6.09 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.706 0.802 . . . . 0.0 111.486 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . 0.456 ' HA ' ' HD2' ' A' ' 131' ' ' PHE . 57.2 t-80 -63.7 -43.5 96.42 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.079 -177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -71.98 -35.46 69.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.76 0.824 . . . . 0.0 110.35 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 188' ' ' ILE . 49.7 mt-10 -66.12 -0.3 2.39 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 186' ' ' PHE . 53.5 m -142.99 123.32 13.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.482 1.037 . . . . 0.0 108.67 172.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.5 pt -126.93 127.85 70.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -62.1 108.0 0.98 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -93.24 120.14 33.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -65.71 -38.39 89.07 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 124.337 1.023 . . . . 0.0 111.883 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 30.4 m -68.84 -32.46 72.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.263 0.625 . . . . 0.0 110.902 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -84.34 -30.75 25.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.207 0.603 . . . . 0.0 110.208 175.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.81 23.81 71.35 Favored Glycine 0 C--N 1.346 1.091 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.692 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -160.86 168.18 25.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.548 ' HB3' ' HB3' ' A' ' 177' ' ' CYS . 59.2 m-85 -77.91 125.85 29.96 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.503 1.121 . . . . 0.0 110.744 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 mm -112.48 149.74 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ILE . . . . . 0.698 HD11 ' HD3' ' A' ' 133' ' ' LYS . 45.2 mm -67.98 125.54 25.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.149 0.5 . . . . 0.0 112.212 -175.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 176' ' ' GLU . 7.2 tmtm? -127.62 74.64 1.54 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 173.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -97.51 -12.11 49.04 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.047 175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.688 0.795 . . . . 0.0 109.62 -175.008 . . . . . . . . 0 0 . 1 stop_ save_